1	Letters	NNS	O	letter	_	0	SENT_1	[p1l1747t84r1845b108],
2	to	TO	O	to	_	0	SENT_1	[p1l1858t88r1882b108],
3	the	DT	O	the	det	4	SENT_1	[p1l1897t83r1936b108],
4	Editor	NNP	O	Editor	prep_to	1	SENT_1	[p1l1949t83r2036b108],
5	373	CD	NUMBER	373	num	4	SENT_1	[p1l2052t81r2110b108],

1	The	DT	O	the	det	5	SENT_2	[p1l47t174r164b231],
2	VKORC1	NN	O	vkorc1	nn	5	SENT_2	[p1l202t177r484b231],
3	and	CC	O	and	_	0	SENT_2	[p1l513t174r626b231],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_2	[p1l665t177r929b231],
5	genotypes	NNS	O	genotype	nsubjpass	7	SENT_2	[p1l951t179r1282b248],
6	are	VBP	O	be	auxpass	7	SENT_2	[p1l1312t191r1408b231],
7	associated	VBN	O	associate	_	0	SENT_2	[p1l1436t174r1771b231],
8	with	IN	O	with	_	0	SENT_2	[p1l1801t174r1941b231],
9	over-anticoagulation	NN	O	over-anticoagulation	prep_with	7	SENT_2	[p1l48t256r717b330],
10	during	IN	O	during	_	0	SENT_2	[p1l749t256r957b330],
11	initiation	NN	O	initiation	prep_during	7	SENT_2	[p1l987t260r1272b313],
12	of	IN	O	of	_	0	SENT_2	[p1l1304t255r1368b313],
13	warfarin	NN	O	warfarin	nn	14	SENT_2	[p1l1394t255r1658b313],
14	therapy	NN	O	therapy	prep_of	11	SENT_2	[p1l1689t256r1931b330],
15	in	IN	O	in	_	0	SENT_2	[p1l1962t260r2015b312],
16	children	NNS	O	child	prep_in	14	SENT_2	[p1l48t338r303b396],

1	T.	FW	O	t.	dep	103	SENT_3	[p1l46t469r79b495],
2	T.	FW	O	t.	dep	103	SENT_3	[p1l100t469r133b495],
3	B	NN	O	b	dep	103	SENT_3	[p1l157t468r276b501],
4	|	CD	NUMBER	|	dep	103	SENT_3	[p1l157t468r276b501],
5	SS	NN	O	ss	dep	103	SENT_3	[p1l157t468r276b501],
6	,	,	O	,	_	0	SENT_3	[p1l157t468r276b501],
7	*	CD	NUMBER	*	dep	103	SENT_3	[p1l157t468r276b501],
8	P.	NNP	PERSON	P.	dep	103	SENT_3	[p1l300t469r330b495],
9	J.	NNP	PERSON	J.	dep	103	SENT_3	[p1l351t469r376b496],
10	AVERY	NNP	PERSON	AVERY	dep	103	SENT_3	[p1l397t468r570b503],
11	,	,	O	,	_	0	SENT_3	[p1l397t468r570b503],
12	T	NN	O	t	dep	103	SENT_3	[p1l397t468r570b503],
13	M.	NN	O	m.	dep	103	SENT_3	[p1l591t469r637b496],
14	D.	NNP	O	D.	dep	103	SENT_3	[p1l661t469r697b495],
15	W	NNP	O	W	dep	103	SENT_3	[p1l718t468r966b503],
16	|	VBD	O	|	dep	103	SENT_3	[p1l718t468r966b503],
17	LLlAMS	NN	O	lllam	dep	103	SENT_3	[p1l718t468r966b503],
18	,3	CD	NUMBER	,3	dep	103	SENT_3	[p1l718t468r966b503],
19	:	:	O	:	_	0	SENT_3	[p1l718t468r966b503],
20	L.	NNP	PERSON	L.	dep	103	SENT_3	[p1l989t469r1017b495],
21	R.	NNP	PERSON	R.	dep	103	SENT_3	[p1l1041t469r1074b496],
22	BRANDAO	NNP	PERSON	BRANDAO	dep	103	SENT_3	[p1l1098t460r1338b501],
23	,	,	O	,	_	0	SENT_3	[p1l1098t460r1338b501],
24	§	NNP	O	§	dep	103	SENT_3	[p1l1098t460r1338b501],
25	J.	NNP	PERSON	J.	dep	103	SENT_3	[p1l1358t469r1383b496],
26	D.	NNP	PERSON	D.	dep	103	SENT_3	[p1l1407t469r1443b495],
27	GRAlNCuER1l	NNP	PERSON	GRAlNCuER1l	dep	103	SENT_3	[p1l1466t468r1705b498],
28	and	CC	O	and	dep	103	SENT_3	[p1l1728t466r1784b496],
29	F.	NNP	O	F.	dep	103	SENT_3	[p1l1802t469r1830b495],
30	KAMAL	NNP	O	KAMAL	dep	103	SENT_3	[p1l1854t468r2037b496],
31	|	VBD	O	|	dep	103	SENT_3	[p1l1854t468r2037b496],
32	*	CD	NUMBER	*	dep	103	SENT_3	[p1l1854t468r2037b496],
33	*	CD	NUMBER	*	dep	103	SENT_3	[p1l51t516r181b541],
34	lnstitute	NN	O	lnstitute	dep	103	SENT_3	[p1l51t516r181b541],
35	of	IN	O	of	dep	103	SENT_3	[p1l194t515r224b541],
36	Cellular	JJ	O	cellular	dep	103	SENT_3	[p1l235t515r347b541],
37	Medicine	NN	O	medicine	dep	103	SENT_3	[p1l357t515r496b545],
38	,	,	O	,	_	0	SENT_3	[p1l357t515r496b545],
39	Newcastle	NNP	ORGANIZATION	Newcastle	dep	103	SENT_3	[p1l512t515r658b541],
40	University	NNP	ORGANIZATION	University	dep	103	SENT_3	[p1l672t516r823b548],
41	;	:	O	;	_	0	SENT_3	[p1l672t516r823b548],
42	tSchooI	NN	ORGANIZATION	tschoous	dep	103	SENT_3	[p1l837t515r948b547],
43	of	IN	ORGANIZATION	of	dep	103	SENT_3	[p1l960t515r990b541],
44	Mathematics	NNP	ORGANIZATION	Mathematics	dep	103	SENT_3	[p1l999t515r1185b541],
45	&	CC	ORGANIZATION	&	dep	103	SENT_3	[p1l1198t516r1218b541],
46	Statistics	NNPS	ORGANIZATION	Statistics	dep	103	SENT_3	[p1l1231t516r1361b545],
47	,	,	O	,	_	0	SENT_3	[p1l1231t516r1361b545],
48	Newcastle	NNP	ORGANIZATION	Newcastle	dep	103	SENT_3	[p1l1377t515r1523b541],
49	University	NNP	ORGANIZATION	University	dep	103	SENT_3	[p1l1537t516r1685b548],
50	,	,	O	,	_	0	SENT_3	[p1l1537t516r1685b548],
51	Newcastle	NNP	ORGANIZATION	Newcastle	dep	103	SENT_3	[p1l1701t515r1846b541],
52	upon	IN	O	upon	dep	103	SENT_3	[p1l1860t523r1930b548],
53	Tyne	NNP	PERSON	Tyne	dep	103	SENT_3	[p1l1946t516r2020b548],
54	;	:	O	;	_	0	SENT_3	[p1l1946t516r2020b548],
55	3	CD	NUMBER	3	dep	103	SENT_3	[p1l48t562r234b594],
56	:	:	O	:	_	0	SENT_3	[p1l48t562r234b594],
57	Depaitment	NN	O	depaitment	dep	103	SENT_3	[p1l48t562r234b594],
58	of	IN	O	of	dep	103	SENT_3	[p1l245t561r276b587],
59	Haematology	NNP	O	Haematology	dep	103	SENT_3	[p1l285t561r481b594],
60	,	,	O	,	_	0	SENT_3	[p1l285t561r481b594],
61	Birmingham	NNP	LOCATION	Birmingham	dep	103	SENT_3	[p1l497t561r669b594],
62	Children	NNP	LOCATION	Children	dep	103	SENT_3	[p1l684t561r803b587],
63	'	POS	O	'	_	0	SENT_3	[p1l809t562r827b587],
64	5	CD	NUMBER	5	dep	103	SENT_3	[p1l809t562r827b587],
65	Hospital	NN	ORGANIZATION	hospital	dep	103	SENT_3	[p1l839t561r963b594],
66	,	,	O	,	_	0	SENT_3	[p1l839t561r963b594],
67	Birmingham	NNP	LOCATION	Birmingham	dep	103	SENT_3	[p1l979t561r1158b594],
68	,	,	O	,	_	0	SENT_3	[p1l979t561r1158b594],
69	UK	NNP	LOCATION	UK	dep	103	SENT_3	[p1l1176t562r1225b591],
70	;	:	O	;	_	0	SENT_3	[p1l1176t562r1225b591],
71	§	CD	NUMBER	§	dep	103	SENT_3	[p1l1240t562r1372b589],
72	Division	NN	O	division	dep	103	SENT_3	[p1l1240t562r1372b589],
73	of	IN	O	of	dep	103	SENT_3	[p1l1386t561r1416b587],
74	Hematology/Oncology	NN	O	hematology/oncology	dep	103	SENT_3	[p1l1426t561r1759b594],
75	,	,	O	,	_	0	SENT_3	[p1l1426t561r1759b594],
76	The	DT	O	the	dep	103	SENT_3	[p1l1777t561r1826b587],
77	Hospital	NN	O	hospital	dep	103	SENT_3	[p1l1840t561r1958b594],
78	for	IN	O	for	dep	103	SENT_3	[p1l1971t561r2011b587],
79	Sick	NNP	O	Sick	dep	103	SENT_3	[p1l2021t561r2078b587],
80	Children	NNP	O	Children	dep	103	SENT_3	[p1l48t606r174b636],
81	,	,	O	,	_	0	SENT_3	[p1l48t606r174b636],
82	Toronto	NNP	LOCATION	Toronto	dep	103	SENT_3	[p1l192t608r308b636],
83	,	,	O	,	_	0	SENT_3	[p1l192t608r308b636],
84	ON	NNP	O	ON	dep	103	SENT_3	[p1l325t607r379b636],
85	,	,	O	,	_	0	SENT_3	[p1l325t607r379b636],
86	Canada	NNP	LOCATION	Canada	dep	103	SENT_3	[p1l397t606r510b636],
87	;	:	O	;	_	0	SENT_3	[p1l397t606r510b636],
88	and	CC	O	and	dep	103	SENT_3	[p1l524t606r578b632],
89	‘	CD	NUMBER	‘	dep	103	SENT_3	[p1l589t608r779b639],
90	|	CD	NUMBER	|	dep	103	SENT_3	[p1l589t608r779b639],
91	lDepartment	NN	O	ldepartment	dep	103	SENT_3	[p1l589t608r779b639],
92	of	IN	O	of	dep	103	SENT_3	[p1l790t606r821b632],
93	Haematology	NNP	LOCATION	Haematology	dep	103	SENT_3	[p1l831t606r1026b639],
94	,	,	O	,	_	0	SENT_3	[p1l831t606r1026b639],
95	Royal	NNP	ORGANIZATION	Royal	dep	103	SENT_3	[p1l1042t606r1122b639],
96	Manchester	NNP	ORGANIZATION	Manchester	dep	103	SENT_3	[p1l1134t606r1302b632],
97	Children	NNP	ORGANIZATION	Children	dep	103	SENT_3	[p1l1314t606r1433b632],
98	’s	POS	ORGANIZATION	’s	dep	103	SENT_3	[p1l1439t608r1457b632],
99	Hospital	NNP	ORGANIZATION	Hospital	dep	103	SENT_3	[p1l1469t606r1593b639],
100	,	,	O	,	_	0	SENT_3	[p1l1469t606r1593b639],
101	Manchester	NNP	LOCATION	Manchester	dep	103	SENT_3	[p1l1608t606r1780b636],
102	,	,	O	,	_	0	SENT_3	[p1l1608t606r1780b636],
103	UK	NNP	LOCATION	UK	_	0	SENT_3	[p1l1798t607r1841b632],

1	To	TO	O	to	aux	2	SENT_4	[p1l46t750r82b774],
2	cite	VB	O	cite	csubjpass	29	SENT_4	[p1l96t750r146b774],
3	this	DT	O	this	det	4	SENT_4	[p1l160t748r212b774],
4	article	NN	O	article	dobj	2	SENT_4	[p1l226t748r321b774],
5	:	:	O	:	_	0	SENT_4	[p1l226t748r321b774],
6	Biss	NNP	O	Biss	nn	7	SENT_4	[p1l339t750r386b774],
7	TT	NN	O	tt	dep	4	SENT_4	[p1l400t750r443b778],
8	,	,	O	,	_	0	SENT_4	[p1l400t750r443b778],
9	Avery	NNP	PERSON	Avery	nn	10	SENT_4	[p1l459t750r541b781],
10	PJ	NNP	PERSON	PJ	dep	4	SENT_4	[p1l556t750r590b778],
11	,	,	O	,	_	0	SENT_4	[p1l556t750r590b778],
12	Williams	NNP	ORGANIZATION	Williams	nn	13	SENT_4	[p1l605t748r723b774],
13	MD	NNP	ORGANIZATION	MD	dep	4	SENT_4	[p1l738t750r799b778],
14	,	,	O	,	_	0	SENT_4	[p1l738t750r799b778],
15	Brandao	NNP	ORGANIZATION	Brandao	nn	16	SENT_4	[p1l816t748r930b774],
16	LR	NNP	ORGANIZATION	LR	dep	4	SENT_4	[p1l946t750r987b778],
17	,	,	O	,	_	0	SENT_4	[p1l946t750r987b778],
18	Grainger	NNP	PERSON	Grainger	nn	19	SENT_4	[p1l1004t749r1126b781],
19	JD	NNP	O	JD	dep	4	SENT_4	[p1l1138t750r1180b778],
20	,	,	O	,	_	0	SENT_4	[p1l1138t750r1180b778],
21	Kamali	NNP	PERSON	Kamali	nn	24	SENT_4	[p1l1197t748r1288b774],
22	F.	NNP	O	F.	nn	24	SENT_4	[p1l1305t750r1326b774],
23	The	NNP	O	The	nn	24	SENT_4	[p1l1345t748r1397b774],
24	VKORC1	NN	O	vkorc1	conj_and	7	SENT_4	[p1l1414t749r1538b774],
25	and	CC	O	and	_	0	SENT_4	[p1l1555t748r1605b774],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_4	[p1l1622t749r1738b774],
27	genotypes	NNS	O	genotype	conj_and	7	SENT_4	[p1l1753t750r1898b782],
28	are	VBP	O	be	auxpass	29	SENT_4	[p1l1912t756r1954b774],
29	associated	VBN	O	associate	_	0	SENT_4	[p1l1969t748r2111b774],
30	with	IN	O	with	_	0	SENT_4	[p1l47t791r106b817],
31	over-anticoagulation	NN	O	over-anticoagulation	prep_with	29	SENT_4	[p1l120t791r411b824],
32	during	IN	O	during	_	0	SENT_4	[p1l425t791r515b824],
33	initiation	NN	O	initiation	prep_during	29	SENT_4	[p1l528t793r647b817],
34	of	IN	O	of	_	0	SENT_4	[p1l661t791r689b817],
35	warfarin	NN	O	warfarin	nn	36	SENT_4	[p1l701t791r816b817],
36	therapy	NN	O	therapy	prep_of	33	SENT_4	[p1l829t791r937b825],
37	in	IN	O	in	_	0	SENT_4	[p1l950t793r971b817],
38	children	NNS	O	child	prep_in	36	SENT_4	[p1l986t791r1103b817],
39	.	.	O	.	_	0	SENT_4	[p1l986t791r1103b817],

1	J	NNP	O	J	nn	3	SENT_5	[p1l1116t793r1129b817],
2	Thromb	NNP	O	Thromb	nn	3	SENT_5	[p1l1143t792r1251b817],
3	Haemost	NNP	O	Haemost	_	0	SENT_5	[p1l1264t793r1391b817],
4	2013	CD	DATE	2013	num	3	SENT_5	[p1l1402t793r1481b821],
5	;	:	O	;	_	0	SENT_5	[p1l1402t793r1481b821],
6	11	CD	NUMBER	11	num	8	SENT_5	[p1l1496t794r1538b817],
7	:	:	O	:	_	0	SENT_5	[p1l1496t794r1538b817],
8	373-5	CD	NUMBER	373-5	dep	3	SENT_5	[p1l1552t793r1648b817],
9	.	.	O	.	_	0	SENT_5	[p1l1552t793r1648b817],

1	The	DT	O	the	det	2	SENT_6	[p1l8t1058r144b1119],
2	prediction	NN	O	prediction	nsubj	10	SENT_6	[p1l176t1058r541b1136],
3	of	IN	O	of	_	0	SENT_6	[p1l575t1058r653b1119],
4	warfarin	NN	O	warfarin	nn	6	SENT_6	[p1l676t1058r982b1119],
5	dose	NN	O	dose	nn	6	SENT_6	[p1l1015t1058r1174b1119],
6	requirement	NN	O	requirement	prep_of	2	SENT_6	[p1l1206t1058r1641b1136],
7	in	IN	O	in	_	0	SENT_6	[p1l1672t1058r1739b1119],
8	children	NNS	O	child	prep_in	6	SENT_6	[p1l1771t1058r2061b1119],
9	is	VBZ	O	be	cop	10	SENT_6	[p1l2092t1058r2143b1119],
10	difﬁcult	NN	O	difﬁcult	_	0	SENT_6	[p1l8t1165r284b1226],
11	and	CC	O	and	_	0	SENT_6	[p1l354t1165r485b1226],
12	over-anticoagulation	NN	O	over-anticoagulation	conj_and	10	SENT_6	[p1l556t1165r1304b1243],
13	during	IN	O	during	_	0	SENT_6	[p1l1373t1165r1608b1243],
14	initiation	NN	O	initiation	prep_during	10	SENT_6	[p1l1676t1165r2004b1226],
15	of	IN	O	of	_	0	SENT_6	[p1l2075t1165r2153b1226],
16	warfarin	NN	O	warfarin	prep_of	14	SENT_6	[p1l7t1270r313b1332],
17	is	VBZ	O	be	cop	19	SENT_6	[p1l351t1270r402b1332],
18	not	RB	O	not	neg	19	SENT_6	[p1l441t1279r561b1332],
19	uncommon	JJ	O	uncommon	rcmod	10	SENT_6	[p1l598t1290r1023b1332],
20	.	.	O	.	_	0	SENT_6	[p1l598t1290r1023b1332],

1	The	DT	O	the	det	2	SENT_7	[p1l1067t1270r1203b1332],
2	role	NN	O	role	nsubj	40	SENT_7	[p1l1242t1270r1377b1332],
3	of	IN	O	of	_	0	SENT_7	[p1l1418t1270r1496b1332],
4	genetic	JJ	O	genetic	amod	5	SENT_7	[p1l1526t1270r1774b1348],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_7	[p1l1811t1271r2143b1348, p1l7t1377r223b1456],
6	in	IN	O	in	_	0	SENT_7	[p1l254t1377r321b1438],
7	determining	VBG	O	determine	prepc_in	5	SENT_7	[p1l353t1376r783b1456],
8	a	DT	O	a	det	9	SENT_7	[p1l816t1397r853b1439],
9	response	NN	O	response	dobj	7	SENT_7	[p1l885t1397r1193b1456],
10	to	TO	O	to	_	0	SENT_7	[p1l1227t1386r1296b1439],
11	warfarin	NN	O	warfarin	prep_to	7	SENT_7	[p1l1328t1377r1635b1439],
12	during	IN	O	during	_	0	SENT_7	[p1l1667t1376r1902b1456],
13	initiation	NN	O	initiation	nn	14	SENT_7	[p1l1933t1377r2142b1439, p1l8t1483r149b1545],
14	therapy	NN	O	therapy	prep_during	17	SENT_7	[p1l233t1483r505b1561],
15	is	VBZ	O	be	auxpass	17	SENT_7	[p1l588t1483r639b1545],
16	well	RB	O	well	advmod	17	SENT_7	[p1l723t1483r864b1545],
17	established	VBN	O	establish	_	0	SENT_7	[p1l948t1483r1340b1545],
18	in	IN	O	in	_	0	SENT_7	[p1l1423t1483r1490b1544],
19	adult	JJ	O	adult	amod	20	SENT_7	[p1l1575t1483r1757b1545],
20	patients	NNS	O	patient	prep_in	17	SENT_7	[p1l1839t1483r2141b1561],
21	;	:	O	;	_	0	SENT_7	[p1l1839t1483r2141b1561],
22	individuals	NNS	O	individual	dep	20	SENT_7	[p1l7t1589r399b1650],
23	who	WP	O	who	nsubj	24	SENT_7	[p1l434t1589r584b1650],
24	possess	VBP	O	possess	rcmod	22	SENT_7	[p1l620t1609r877b1667],
25	the	DT	O	the	det	27	SENT_7	[p1l913t1589r1021b1650],
26	C	NN	O	c	nn	27	SENT_7	[p1l1062t1591r1118b1651],
27	YP2C9	NN	O	yp2c9	nsubj	31	SENT_7	[p1l1129t1591r1377b1651],
28	and	CC	O	and	_	0	SENT_7	[p1l1413t1589r1544b1650],
29	VKORC1	NN	O	vkorc1	nn	30	SENT_7	[p1l1589t1591r1922b1651],
30	polymorphisms	NNS	O	polymorphism	conj_and	27	SENT_7	[p1l1960t1589r2143b1667, p1l6t1696r404b1774],
31	have	VBP	O	have	ccomp	24	SENT_7	[p1l444t1696r608b1757],
32	a	DT	O	a	det	34	SENT_7	[p1l649t1716r687b1757],
33	greater	JJR	O	greater	amod	34	SENT_7	[p1l727t1704r976b1774],
34	sensitivity	NN	O	sensitivity	dobj	31	SENT_7	[p1l1016t1696r1370b1774],
35	to	TO	O	to	_	0	SENT_7	[p1l1410t1704r1479b1757],
36	warfarin	NN	O	warfarin	prep_to	31	SENT_7	[p1l1519t1696r1825b1757],
37	and	CC	O	and	_	0	SENT_7	[p1l1866t1696r1997b1757],
38	are	VBP	O	be	cop	40	SENT_7	[p1l2038t1716r2144b1757],
39	more	RBR	O	more	advmod	40	SENT_7	[p1l7t1821r190b1863],
40	likely	JJ	O	likely	conj_and	17	SENT_7	[p1l254t1801r446b1879],
41	to	TO	O	to	aux	42	SENT_7	[p1l510t1810r579b1863],
42	have	VB	O	have	xcomp	40	SENT_7	[p1l644t1801r809b1863],
43	a	DT	O	a	det	50	SENT_7	[p1l874t1821r912b1863],
44	supra-therapeutic	JJ	O	supra-therapeutic	amod	50	SENT_7	[p1l978t1801r1608b1879],
45	International	NNP	O	International	nn	50	SENT_7	[p1l1672t1801r2144b1863],
46	Normalized	NNP	O	Normalized	nn	50	SENT_7	[p1l7t1907r432b1969],
47	Ratio	NNP	O	Ratio	nn	50	SENT_7	[p1l497t1907r695b1969],
48	(	NNP	O	(	nn	50	SENT_7	[p1l761t1908r978b1985],
49	INR	NNP	O	INR	nn	50	SENT_7	[p1l761t1908r978b1985],
50	)	NN	O	)	dobj	42	SENT_7	[p1l761t1908r978b1985],
51	and	CC	O	and	_	0	SENT_7	[p1l1044t1907r1175b1969],
52	serious	JJ	O	serious	amod	53	SENT_7	[p1l1240t1907r1484b1969],
53	bleeding	NN	O	bleeding	conj_and	50	SENT_7	[p1l1548t1907r1848b1985],
54	during	IN	O	during	_	0	SENT_7	[p1l1911t1907r2146b1985],
55	warfarin	NN	O	warfarin	nn	56	SENT_7	[p1l7t2014r313b2075],
56	initiation	NN	O	initiation	prep_during	42	SENT_7	[p1l359t2014r688b2075],
57	than	IN	O	than	_	0	SENT_7	[p1l735t2014r895b2075],
58	those	DT	O	those	prep_than	56	SENT_7	[p1l942t2014r1130b2075],
59	who	WP	O	who	nsubj	60	SENT_7	[p1l1176t2014r1325b2075],
60	do	VBP	O	do	rcmod	58	SENT_7	[p1l1376t2014r1463b2075],
61	not	RB	O	not	neg	64	SENT_7	[p1l1511t2022r1630b2075],
62	[	JJ	O	[	amod	64	SENT_7	[p1l1680t2015r1845b2091],
63	1,2	CD	NUMBER	1,2	num	64	SENT_7	[p1l1680t2015r1845b2091],
64	]	NN	O	]	dobj	60	SENT_7	[p1l1680t2015r1845b2091],
65	.	.	O	.	_	0	SENT_7	[p1l1680t2015r1845b2091],

1	Recent	JJ	O	recent	amod	2	SENT_8	[p1l1899t2016r2145b2075],
2	reports	NNS	O	report	nsubj	4	SENT_8	[p1l8t2128r260b2197],
3	have	VBP	O	have	aux	4	SENT_8	[p1l309t2119r474b2181],
4	indicated	VBN	O	indicate	_	0	SENT_8	[p1l523t2119r850b2181],
5	that	IN	O	that	complm	12	SENT_8	[p1l900t2119r1042b2181],
6	the	DT	O	the	det	7	SENT_8	[p1l1090t2119r1198b2181],
7	VKORC1	NN	O	vkorc1	nsubj	12	SENT_8	[p1l1257t2122r1591b2181],
8	and	CC	O	and	_	0	SENT_8	[p1l1645t2119r1776b2181],
9	C	NN	O	c	nn	11	SENT_8	[p1l1829t2122r1885b2181],
10	YP2C9	NN	O	yp2c9	nn	11	SENT_8	[p1l1897t2122r2145b2181],
11	genotypes	NNS	O	genotype	nsubj	12	SENT_8	[p1l8t2234r363b2305],
12	inﬂuence	VBP	O	inﬂuence	ccomp	4	SENT_8	[p1l425t2226r743b2288],
13	the	DT	O	the	det	16	SENT_8	[p1l806t2225r913b2288],
14	warfarin	NN	O	warfarin	nn	16	SENT_8	[p1l974t2226r1280b2288],
15	maintenance	NN	O	maintenance	nn	16	SENT_8	[p1l1340t2226r1795b2288],
16	dose	NN	O	dose	nsubj	19	SENT_8	[p1l1858t2225r2017b2288],
17	in	IN	O	in	_	0	SENT_8	[p1l2079t2226r2145b2287],
18	children	NNS	O	child	prep_in	16	SENT_8	[p1l7t2332r297b2394],
19	[	VBP	O	[	ccomp	12	SENT_8	[p1l334t2334r478b2410],
20	3,4	CD	NUMBER	3,4	number	21	SENT_8	[p1l334t2334r478b2410],
21	]	CD	NUMBER	]	dobj	19	SENT_8	[p1l334t2334r478b2410],
22	but	CC	O	but	_	0	SENT_8	[p1l515t2332r634b2394],
23	their	PRP$	O	they	poss	24	SENT_8	[p1l667t2332r832b2394],
24	inﬂuence	NN	O	inﬂuence	nsubjpass	33	SENT_8	[p1l865t2332r1182b2394],
25	on	IN	O	on	_	0	SENT_8	[p1l1218t2352r1306b2394],
26	outcomes	NNS	O	outcome	prep_on	24	SENT_8	[p1l1342t2341r1681b2394],
27	during	IN	O	during	_	0	SENT_8	[p1l1716t2332r1951b2410],
28	warfarin	NN	O	warfarin	nn	29	SENT_8	[p1l1983t2352r2143b2394, p1l8t2438r177b2499],
29	initiation	NN	O	initiation	prep_during	26	SENT_8	[p1l237t2438r565b2499],
30	has	VBZ	O	have	aux	33	SENT_8	[p1l626t2438r744b2499],
31	not	RB	O	not	neg	33	SENT_8	[p1l806t2446r925b2499],
32	been	VBN	O	be	auxpass	33	SENT_8	[p1l986t2438r1150b2499],
33	investigated	VBN	O	investigate	conj_but	4	SENT_8	[p1l1211t2438r1655b2516],
34	.	.	O	.	_	0	SENT_8	[p1l1211t2438r1655b2516],

1	This	DT	O	this	det	3	SENT_9	[p1l1722t2438r1876b2499],
2	crosssectional	JJ	O	crosssectional	amod	3	SENT_9	[p1l1938t2458r2143b2499, p1l10t2545r321b2606],
3	study	NN	O	study	nsubj	4	SENT_9	[p1l370t2545r562b2623],
4	evaluated	VBD	O	evaluate	_	0	SENT_9	[p1l610t2545r951b2606],
5	the	DT	O	the	det	6	SENT_9	[p1l1000t2545r1108b2606],
6	inﬂuence	NN	O	inﬂuence	dobj	4	SENT_9	[p1l1155t2545r1473b2606],
7	of	IN	O	of	_	0	SENT_9	[p1l1523t2545r1602b2606],
8	the	DT	O	the	det	12	SENT_9	[p1l1641t2545r1749b2606],
9	VKORC1	NN	O	vkorc1	nn	12	SENT_9	[p1l1808t2547r2140b2607],
10	and	CC	O	and	_	0	SENT_9	[p1l9t2650r135b2712],
11	CYP2C9	NN	O	cyp2c9	nn	12	SENT_9	[p1l169t2653r474b2712],
12	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_9	[p1l502t2650r1032b2728],
13	on	IN	O	on	_	0	SENT_9	[p1l1063t2670r1149b2712],
14	an	DT	O	a	det	16	SENT_9	[p1l1180t2670r1262b2712],
15	anticoagulation	NN	O	anticoagulation	nn	16	SENT_9	[p1l1292t2650r1823b2728],
16	response	NN	O	response	prep_on	4	SENT_9	[p1l1852t2670r2145b2728],
17	to	TO	O	to	_	0	SENT_9	[p1l8t2764r77b2818],
18	Warfarin	NNP	MISC	Warfarin	prep_to	4	SENT_9	[p1l110t2756r416b2818],
19	in	IN	O	in	_	0	SENT_9	[p1l448t2756r514b2817],
20	children	NNS	O	child	prep_in	18	SENT_9	[p1l546t2756r835b2818],
21	during	IN	O	during	_	0	SENT_9	[p1l868t2756r1103b2834],
22	initiation	NN	O	initiation	prep_during	4	SENT_9	[p1l1134t2756r1462b2818],
23	of	IN	O	of	_	0	SENT_9	[p1l1495t2756r1573b2818],
24	therapy	NN	O	therapy	prep_of	22	SENT_9	[p1l1597t2756r1888b2834],
25	.	.	O	.	_	0	SENT_9	[p1l1597t2756r1888b2834],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_10	[p1l95t2863r386b2941],
2	were	VBD	O	be	auxpass	3	SENT_10	[p1l440t2883r604b2924],
3	recruited	VBN	O	recruit	_	0	SENT_10	[p1l658t2863r976b2924],
4	from	IN	O	from	_	0	SENT_10	[p1l1029t2863r1204b2924],
5	three	CD	NUMBER	three	num	7	SENT_10	[p1l1257t2863r1435b2924],
6	UK	NNP	LOCATION	UK	nn	7	SENT_10	[p1l1490t2865r1625b2924],
7	centres	NNS	O	centre	prep_from	3	SENT_10	[p1l1678t2871r1925b2924],
8	(	CD	NUMBER	(	dep	7	SENT_10	[p1l1982t2863r2143b2941, p1l6t2968r345b3046],
9	Birmingham	NNP	LOCATION	Birmingham	nn	10	SENT_10	[p1l1982t2863r2143b2941, p1l6t2968r345b3046],
10	Children	NNP	O	Children	poss	12	SENT_10	[p1l385t2968r751b3030],
11	’s	POS	O	’s	_	0	SENT_10	[p1l385t2968r751b3030],
12	Hospital	NN	O	hospital	dep	8	SENT_10	[p1l793t2968r1120b3046],
13	;	:	O	;	_	0	SENT_10	[p1l793t2968r1120b3046],
14	The	DT	O	the	det	15	SENT_10	[p1l1163t2968r1299b3030],
15	Newcastle	NNP	ORGANIZATION	Newcastle	conj_and	7	SENT_10	[p1l1339t2968r1703b3030],
16	upon	IN	O	upon	_	0	SENT_10	[p1l1742t2988r1926b3046],
17	Tyne	NNP	ORGANIZATION	Tyne	nn	21	SENT_10	[p1l1966t2971r2144b3046],
18	Hospitals	NNPS	ORGANIZATION	Hospitals	nn	21	SENT_10	[p1l8t3075r348b3153],
19	NHS	NNP	ORGANIZATION	NHS	nn	21	SENT_10	[p1l382t3076r563b3136],
20	Foundation	NNP	ORGANIZATION	Foundation	nn	21	SENT_10	[p1l600t3075r1026b3136],
21	Trust	NNP	ORGANIZATION	Trust	prep_upon	15	SENT_10	[p1l1059t3077r1272b3149],
22	;	:	O	;	_	0	SENT_10	[p1l1059t3077r1272b3149],
23	and	CC	O	and	_	0	SENT_10	[p1l1310t3075r1440b3136],
24	Royal	NNP	ORGANIZATION	Royal	nn	26	SENT_10	[p1l1477t3075r1691b3153],
25	Manchester	NNP	ORGANIZATION	Manchester	nn	26	SENT_10	[p1l1725t3075r2145b3136],
26	Children	NNP	ORGANIZATION	Children	poss	29	SENT_10	[p1l9t3180r375b3242],
27	’s	POS	ORGANIZATION	’s	_	0	SENT_10	[p1l9t3180r375b3242],
28	Hospital	NNP	ORGANIZATION	Hospital	nn	29	SENT_10	[p1l414t3180r749b3258],
29	)	NN	O	)	prep_from	3	SENT_10	[p1l414t3180r749b3258],
30	and	CC	O	and	_	0	SENT_10	[p1l790t3180r921b3242],
31	The	DT	O	the	det	32	SENT_10	[p1l958t3180r1094b3242],
32	Hospital	NN	O	hospital	conj_and	7	SENT_10	[p1l1134t3180r1442b3258],
33	for	IN	O	for	_	0	SENT_10	[p1l1480t3180r1584b3242],
34	Sick	NNP	O	Sick	nn	35	SENT_10	[p1l1624t3180r1771b3242],
35	Children	NNP	O	Children	prep_for	32	SENT_10	[p1l1810t3180r2141b3255],
36	,	,	O	,	_	0	SENT_10	[p1l1810t3180r2141b3255],
37	Toronto	NNP	LOCATION	Toronto	nn	39	SENT_10	[p1l8t3288r328b3360],
38	,	,	O	,	_	0	SENT_10	[p1l8t3288r328b3360],
39	Canada	NNP	LOCATION	Canada	appos	35	SENT_10	[p1l398t3286r692b3348],
40	.	.	O	.	_	0	SENT_10	[p1l398t3286r692b3348],

1	The	DT	O	the	det	2	SENT_11	[p1l761t3286r897b3347],
2	study	NN	O	study	nsubj	3	SENT_11	[p1l965t3286r1157b3364],
3	recruited	VBD	O	recruit	_	0	SENT_11	[p1l1221t3286r1538b3347],
4	children	NNS	O	child	dobj	3	SENT_11	[p1l1603t3286r1912b3360],
5	,	,	O	,	_	0	SENT_11	[p1l1603t3286r1912b3360],
6	aged	VBN	O	age	partmod	4	SENT_11	[p1l1981t3286r2145b3364],
7	18	CD	DURATION	18	num	8	SENT_11	[p1l16t3394r86b3454],
8	years	NNS	NUMBER	year	dobj	6	SENT_11	[p1l123t3413r306b3471],
9	and	CC	O	and	_	0	SENT_11	[p1l343t3393r474b3454],
10	under	IN	O	under	dobj	6	SENT_11	[p1l509t3393r736b3467],
11	,	,	O	,	_	0	SENT_11	[p1l509t3393r736b3467],
12	who	WP	O	who	nsubjpass	14	SENT_11	[p1l772t3393r922b3454],
13	were	VBD	O	be	auxpass	14	SENT_11	[p1l958t3413r1123b3454],
14	anticoagulated	VBN	O	anticoagulate	conj_and	14	SENT_11	[p1l1160t3393r1688b3471],
15	with	IN	O	with	_	0	SENT_11	[p1l1722t3393r1879b3454],
16	warfarin	NN	O	warfarin	prep_with	14	SENT_11	[p1l1913t3393r2143b3454, p1l8t3498r106b3559],
17	for	IN	O	for	_	0	SENT_11	[p1l139t3498r244b3560],
18	at	IN	DURATION	at	quantmod	20	SENT_11	[p1l278t3507r344b3560],
19	least	JJS	DURATION	least	mwe	18	SENT_11	[p1l377t3498r536b3560],
20	3	CD	DURATION	3	num	21	SENT_11	[p1l572t3500r604b3560],
21	months	NNS	NUMBER	month	prep_for	16	SENT_11	[p1l641t3498r908b3560],
22	to	TO	O	to	_	0	SENT_11	[p1l943t3507r1012b3560],
23	a	DT	O	a	det	26	SENT_11	[p1l1048t3518r1086b3560],
24	target	NN	O	target	nn	26	SENT_11	[p1l1119t3507r1326b3576],
25	INR	NN	O	inr	nn	26	SENT_11	[p1l1359t3501r1524b3559],
26	range	NN	O	range	prep_to	14	SENT_11	[p1l1556t3518r1753b3576],
27	of	IN	O	of	_	0	SENT_11	[p1l1788t3498r1866b3560],
28	2.0-3	CD	NUMBER	2.0-3	number	32	SENT_11	[p1l1891t3500r2143b3560],
29	.0	CD	NUMBER	.0	number	32	SENT_11	[p1l1891t3500r2143b3560],
30	or	CC	O	or	_	0	SENT_11	[p1l9t3624r84b3666],
31	2.5-3	CD	NUMBER	2.5-3	prep_of	26	SENT_11	[p1l120t3606r372b3666],
32	.5	CD	NUMBER	.5	prep_of	26	SENT_11	[p1l120t3606r372b3666],
33	and	CC	O	and	_	0	SENT_11	[p1l411t3604r543b3666],
34	in	IN	O	in	_	0	SENT_11	[p1l579t3604r645b3665],
35	whom	WP	O	whom	dobj	39	SENT_11	[p1l680t3604r903b3666],
36	retrospective	JJ	O	retrospective	amod	37	SENT_11	[p1l939t3604r1396b3682],
37	data	NNS	O	datum	nsubj	39	SENT_11	[p1l1434t3604r1590b3666],
38	were	VBD	O	be	cop	39	SENT_11	[p1l1625t3624r1789b3666],
39	available	JJ	O	available	prepc_in	14	SENT_11	[p1l1828t3604r2144b3666],
40	for	IN	O	for	_	0	SENT_11	[p1l8t3711r112b3772],
41	the	DT	O	the	det	42	SENT_11	[p1l147t3711r254b3772],
42	ﬁrst	NN	O	ﬁrst	prep_for	39	SENT_11	[p1l289t3711r427b3772],
43	3	CD	DURATION	3	num	44	SENT_11	[p1l464t3712r496b3772],
44	months	NNS	NUMBER	month	tmod	42	SENT_11	[p1l533t3711r801b3772],
45	of	IN	O	of	_	0	SENT_11	[p1l838t3711r916b3772],
46	warfarin	NN	O	warfarin	nn	47	SENT_11	[p1l941t3711r1248b3772],
47	therapy	NN	O	therapy	prep_of	42	SENT_11	[p1l1283t3711r1573b3789],
48	.	.	O	.	_	0	SENT_11	[p1l1283t3711r1573b3789],

1	The	DT	O	the	det	2	SENT_12	[p1l1613t3711r1749b3772],
2	study	NN	O	study	nsubjpass	4	SENT_12	[p1l1786t3711r1978b3789],
3	was	VBD	O	be	auxpass	4	SENT_12	[p1l2011t3731r2144b3772],
4	approved	VBN	O	approve	_	0	SENT_12	[p2l9t20r345b100],
5	by	IN	O	by	_	0	SENT_12	[p2l407t20r492b99],
6	the	DT	O	the	det	9	SENT_12	[p2l552t20r660b83],
7	Regional	NNP	ORGANIZATION	Regional	nn	9	SENT_12	[p2l724t21r1044b100],
8	Ethics	NNPS	ORGANIZATION	Ethics	nn	9	SENT_12	[p2l1106t21r1324b83],
9	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_12	[p2l1387t21r1782b83],
10	and	CC	O	and	_	0	SENT_12	[p2l1844t20r1975b83],
11	the	DT	O	the	det	14	SENT_12	[p2l2037t20r2144b83],
12	Institutional	JJ	MISC	institutional	amod	14	SENT_12	[p2l8t128r452b189],
13	Review	NN	MISC	review	nn	14	SENT_12	[p2l494t128r754b189],
14	Boards	NNS	MISC	board	agent	4	SENT_12	[p2l794t128r1046b189],
15	for	IN	O	for	_	0	SENT_12	[p2l1086t128r1191b189],
16	each	DT	O	each	prep_for	4	SENT_12	[p2l1229t128r1389b189],
17	of	IN	O	of	_	0	SENT_12	[p2l1429t128r1507b189],
18	the	DT	O	the	det	20	SENT_12	[p2l1539t128r1646b189],
19	participating	VBG	O	participate	amod	20	SENT_12	[p2l1685t128r2145b206],
20	sites	NNS	O	site	prep_of	16	SENT_12	[p2l10t233r175b295],
21	.	.	O	.	_	0	SENT_12	[p2l10t233r175b295],

1	Written	VBN	O	write	_	0	SENT_13	[p2l257t233r535b295],
2	informed	JJ	O	informed	amod	3	SENT_13	[p2l612t233r940b295],
3	consent	NN	O	consent	dobj	1	SENT_13	[p2l1018t242r1291b295],
4	was	VBD	O	be	auxpass	5	SENT_13	[p2l1367t253r1499b295],
5	obtained	VBN	O	obtain	auxpass	1	SENT_13	[p2l1580t233r1893b295],
6	from	IN	O	from	_	0	SENT_13	[p2l1971t233r2145b295],
7	patients	NNS	O	patient	prep_from	5	SENT_13	[p2l7t339r288b417],
8	aged	JJ	O	aged	dep	7	SENT_13	[p2l324t339r488b417],
9	16	CD	DURATION	16	num	10	SENT_13	[p2l530t341r602b400],
10	years	NNS	NUMBER	year	dep	8	SENT_13	[p2l637t359r820b417],
11	or	CC	O	or	_	0	SENT_13	[p2l856t359r931b400],
12	over	IN	O	over	dep	7	SENT_13	[p2l966t359r1120b400],
13	and	CC	O	and	_	0	SENT_13	[p2l1154t339r1285b400],
14	from	IN	O	from	conj_and	12	SENT_13	[p2l1319t339r1493b400],
15	a	DT	O	a	det	16	SENT_13	[p2l1528t359r1566b400],
16	parent/carer	NN	O	parent/carer	pobj	12	SENT_13	[p2l1598t339r2040b417],
17	of	IN	O	of	_	0	SENT_13	[p2l2075t339r2153b400],
18	children	NNS	O	child	prep_of	16	SENT_13	[p2l7t446r297b507],
19	<	JJR	O	<	nsubjpass	1	SENT_13	[p2l368t457r415b497],
20	16	CD	DURATION	16	num	21	SENT_13	[p2l475t447r547b507],
21	years	NNS	NUMBER	year	npadvmod	22	SENT_13	[p2l582t466r765b524],
22	old	JJ	DURATION	old	amod	19	SENT_13	[p2l822t446r951b507],
23	.	.	O	.	_	0	SENT_13	[p2l822t446r951b507],

1	The	DT	O	the	det	2	SENT_14	[p2l1009t446r1145b507],
2	study	NN	O	study	nsubj	3	SENT_14	[p2l1202t446r1394b524],
3	complied	VBD	O	comply	_	0	SENT_14	[p2l1447t446r1773b524],
4	with	IN	O	with	_	0	SENT_14	[p2l1826t446r1983b507],
5	the	DT	O	the	det	6	SENT_14	[p2l2037t446r2144b507],
6	Declaration	NN	O	declaration	prep_with	3	SENT_14	[p2l8t551r433b613],
7	of	IN	O	of	_	0	SENT_14	[p2l475t551r553b613],
8	Helsinki	NNP	LOCATION	Helsinki	prep_of	6	SENT_14	[p2l585t551r901b613],
9	.	.	O	.	_	0	SENT_14	[p2l585t551r901b613],

1	Details	NNS	O	detail	_	0	SENT_15	[p2l947t551r1198b613],
2	of	IN	O	of	_	0	SENT_15	[p2l1241t551r1319b613],
3	indication	NN	O	indication	prep_of	1	SENT_15	[p2l1351t551r1711b613],
4	for	IN	O	for	_	0	SENT_15	[p2l1752t551r1856b613],
5	anticoCorrespondence	NN	O	anticocorrespondence	prep_for	3	SENT_15	[p2l1897t551r2143b613, p2l9t766r514b832],
6	:	:	O	:	_	0	SENT_15	[p2l1897t551r2143b613, p2l9t766r514b832],

1	Tina	NNP	PERSON	Tina	nn	2	SENT_16	[p2l546t766r685b818],
2	Biss	NNP	PERSON	Biss	_	0	SENT_16	[p2l713t766r848b829],
3	,	,	O	,	_	0	SENT_16	[p2l713t766r848b829],
4	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_16	[p2l878t766r1130b818],
5	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l1159t766r1225b818],
6	Cellular	JJ	ORGANIZATION	cellular	amod	7	SENT_16	[p2l1247t766r1487b818],
7	Medicine	NN	ORGANIZATION	medicine	prep_of	4	SENT_16	[p2l1514t766r1808b829],
8	,	,	O	,	_	0	SENT_16	[p2l1514t766r1808b829],
9	Newcastle	NNP	ORGANIZATION	Newcastle	nn	18	SENT_16	[p2l1838t766r2145b818],
10	University	NNP	ORGANIZATION	University	nn	18	SENT_16	[p2l8t863r339b930],
11	,	,	O	,	_	0	SENT_16	[p2l8t863r339b930],
12	Newcastle	NNP	ORGANIZATION	Newcastle	dep	18	SENT_16	[p2l367t863r674b916],
13	upon	IN	O	upon	dep	12	SENT_16	[p2l700t880r856b930],
14	Tyne	NNP	PERSON	Tyne	nn	16	SENT_16	[p2l882t865r1032b930],
15	NE1	NNP	O	NE1	nn	16	SENT_16	[p2l1059t865r1191b915],
16	7RU	NNP	O	7RU	pobj	13	SENT_16	[p2l1226t865r1388b927],
17	,	,	O	,	_	0	SENT_16	[p2l1226t865r1388b927],
18	UK	NNP	LOCATION	UK	appos	2	SENT_16	[p2l1418t865r1547b916],
19	.	.	O	.	_	0	SENT_16	[p2l1418t865r1547b916],

1	Tel.	NNP	O	Tel.	_	0	SENT_17	[p2l7t961r136b1012],
2	:	:	O	:	_	0	SENT_17	[p2l7t961r136b1012],
3	+44 191 2829516	CD	NUMBER	+44 191 2829516	dep	1	SENT_17	[p2l469t962r732b1023],[p2l180t962r307b1011],
4	;	:	O	;	_	0	SENT_17	[p2l469t962r732b1023],
5	fax	NN	O	fax	dep	1	SENT_17	[p2l762t960r869b1012],
6	:	:	O	:	_	0	SENT_17	[p2l762t960r869b1012],
7	+44 191 2820814	CD	NUMBER	+44 191 2820814	dep	5	SENT_17	[p2l1201t962r1463b1013],[p2l912t962r1039b1011],
8	.	.	O	.	_	0	SENT_17	[p2l1201t962r1463b1013],

1	E-mail	NN	O	e-mail	_	0	SENT_18	[p2l8t1057r223b1109],
2	:	:	O	:	_	0	SENT_18	[p2l8t1057r223b1109],
3	tina.biss@ncl.ac.uk	NN	O	tina.biss@ncl.ac.uk	dep	1	SENT_18	[p2l254t1056r847b1122],

1	DOI	NNP	O	DOI	_	0	SENT_19	[p2l8t1254r160b1306],
2	:	:	O	:	_	0	SENT_19	[p2l8t1254r160b1306],
3	10.1111	CD	NUMBER	10.1111	dep	1	SENT_19	[p2l198t1253r724b1320],
4	/	:	O	/	punct	5	SENT_19	[p2l198t1253r724b1320],
5	jth	NN	O	jth	dep	3	SENT_19	[p2l198t1253r724b1320],
6	.12072	CD	NUMBER	.12072	num	5	SENT_19	[p2l198t1253r724b1320],

1	Received	VBN	O	receive	_	0	SENT_20	[p2l9t1449r278b1502],
2	26	CD	DATE	26	dobj	1	SENT_20	[p2l305t1451r373b1502],
3	October	NNP	DATE	October	tmod	1	SENT_20	[p2l401t1449r645b1502],
4	2012	CD	DATE	2012	num	3	SENT_20	[p2l671t1451r827b1513],
5	,	,	O	,	_	0	SENT_20	[p2l671t1451r827b1513],
6	accepted	VBN	O	accept	partmod	1	SENT_20	[p2l857t1449r1116b1516],
7	8	CD	DATE	8	dobj	6	SENT_20	[p2l1145t1451r1172b1502],
8	November	NNP	DATE	November	tmod	6	SENT_20	[p2l1201t1449r1521b1502],
9	2012	CD	DATE	2012	num	8	SENT_20	[p2l1547t1451r1686b1502],

1	©	RB	O	©	advmod	24	SENT_21	[p2l6t1662r59b1716],
2	2012	CD	DATE	2012	num	4	SENT_21	[p2l83t1665r222b1716],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_21	[p2l250t1663r648b1716],
4	Society	NNP	ORGANIZATION	Society	nsubjpass	24	SENT_21	[p2l676t1663r891b1729],
5	on	IN	O	on	_	0	SENT_21	[p2l918t1680r993b1716],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_21	[p2l1019t1663r1381b1716],
7	and	CC	O	and	_	0	SENT_21	[p2l1409t1663r1520b1716],
8	Haemostasis	NNP	PERSON	Haemostasis	nn	9	SENT_21	[p2l1546t1663r1927b1716],
9	agulation	NN	O	agulation	nsubjpass	24	SENT_21	[p2l8t1761r345b1840],
10	with	IN	O	with	_	0	SENT_21	[p2l393t1760r549b1823],
11	warfarin	NN	O	warfarin	prep_with	9	SENT_21	[p2l596t1761r922b1836],
12	,	,	O	,	_	0	SENT_21	[p2l596t1761r922b1836],
13	target	NN	O	target	nn	15	SENT_21	[p2l974t1769r1181b1840],
14	INR	NN	O	inr	nn	15	SENT_21	[p2l1230t1763r1394b1822],
15	range	NN	O	range	prep_with	9	SENT_21	[p2l1442t1781r1659b1840],
16	,	,	O	,	_	0	SENT_21	[p2l1442t1781r1659b1840],
17	INR	NN	O	inr	nn	18	SENT_21	[p2l1712t1763r1876b1822],
18	values	NNS	O	value	prep_with	9	SENT_21	[p2l1923t1761r2143b1823],
19	and	CC	O	and	_	0	SENT_21	[p2l8t1867r139b1929],
20	corresponding	JJ	O	corresponding	amod	22	SENT_21	[p2l174t1867r689b1945],
21	warfarin	NN	O	warfarin	nn	22	SENT_21	[p2l722t1867r1028b1929],
22	doses	NNS	O	dose	prep_with	9	SENT_21	[p2l1063t1867r1254b1929],
23	were	VBD	O	be	auxpass	24	SENT_21	[p2l1288t1887r1452b1929],
24	obtained	VBN	O	obtain	_	0	SENT_21	[p2l1489t1867r1802b1929],
25	by	IN	O	by	_	0	SENT_21	[p2l1837t1867r1922b1945],
26	questionnaire	NN	O	questionnaire	agent	24	SENT_21	[p2l1957t1887r2142b1945, p2l7t1973r330b2034],
27	and	CC	O	and	_	0	SENT_21	[p2l396t1973r527b2034],
28	review	NN	O	review	agent	24	SENT_21	[p2l592t1973r822b2034],
29	of	IN	O	of	_	0	SENT_21	[p2l888t1973r966b2034],
30	patients	NNS	O	patient	prep_of	26	SENT_21	[p2l1022t1973r1323b2051],
31	’	CD	NUMBER	’	num	33	SENT_21	[p2l1022t1973r1323b2051],
32	medical	JJ	O	medical	amod	33	SENT_21	[p2l1391t1973r1667b2034],
33	records	NNS	O	record	dep	30	SENT_21	[p2l1733t1973r2012b2034],
34	.	.	O	.	_	0	SENT_21	[p2l1733t1973r2012b2034],

1	A	DT	O	a	det	4	SENT_22	[p2l2081t1973r2145b2033],
2	venous	JJ	O	venous	amod	4	SENT_22	[p2l6t2100r255b2142],
3	blood	NN	O	blood	nn	4	SENT_22	[p2l301t2079r507b2142],
4	sample	NN	O	sample	nsubj	22	SENT_22	[p2l555t2080r801b2159],
5	(	CD	NUMBER	(	number	6	SENT_22	[p2l849t2080r995b2159],
6	4-8	CD	NUMBER	4-8	num	8	SENT_22	[p2l849t2080r995b2159],
7	mL	NN	O	ml	nn	8	SENT_22	[p2l1032t2080r1182b2158],
8	)	NN	O	)	nsubjpass	15	SENT_22	[p2l1032t2080r1182b2158],
9	was	VBD	O	be	auxpass	10	SENT_22	[p2l1228t2100r1361b2142],
10	collected	VBN	O	collect	rcmod	4	SENT_22	[p2l1407t2079r1719b2142],
11	from	IN	O	from	_	0	SENT_22	[p2l1766t2080r1940b2142],
12	each	DT	O	each	det	13	SENT_22	[p2l1984t2079r2144b2142],
13	patient	NN	O	patient	prep_from	10	SENT_22	[p2l6t2186r256b2264],
14	and	CC	O	and	_	0	SENT_22	[p2l306t2186r436b2248],
15	stored	VBN	O	store	rcmod	4	SENT_22	[p2l486t2186r705b2248],
16	in	IN	O	in	_	0	SENT_22	[p2l753t2186r820b2247],
17	EDTA	NN	O	edta	nn	18	SENT_22	[p2l869t2186r1113b2247],
18	tubes	NNS	O	tube	prep_in	15	SENT_22	[p2l1161t2186r1348b2248],
19	at	IN	O	at	_	0	SENT_22	[p2l1398t2195r1464b2248],
20	-80	CD	NUMBER	-80	num	21	SENT_22	[p2l1517t2188r1657b2248],
21	°	CD	NUMBER	°	prep_at	15	SENT_22	[p2l1696t2187r1784b2248],
22	C	NN	O	c	_	0	SENT_22	[p2l1696t2187r1784b2248],
23	for	IN	O	for	_	0	SENT_22	[p2l1832t2186r1937b2248],
24	later	JJ	O	later	amod	25	SENT_22	[p2l1984t2186r2145b2248],
25	genotyping	NN	O	genotyping	prep_for	22	SENT_22	[p2l8t2292r424b2370],
26	.	.	O	.	_	0	SENT_22	[p2l8t2292r424b2370],

1	Genomic	JJ	O	genomic	amod	2	SENT_23	[p2l488t2292r813b2354],
2	DNA	NN	O	dna	nsubjpass	4	SENT_23	[p2l870t2292r1071b2353],
3	was	VBD	O	be	auxpass	4	SENT_23	[p2l1126t2312r1259b2353],
4	extracted	VBN	O	extract	_	0	SENT_23	[p2l1317t2292r1645b2353],
5	from	IN	O	from	_	0	SENT_23	[p2l1702t2292r1877b2353],
6	whole	JJ	O	whole	amod	8	SENT_23	[p2l1932t2292r2143b2353],
7	blood	NN	O	blood	nn	8	SENT_23	[p2l7t2399r213b2460],
8	samples	NNS	O	sample	prep_from	4	SENT_23	[p2l268t2399r546b2477],
9	according	VBG	O	accord	_	0	SENT_23	[p2l601t2399r951b2477],
10	to	TO	O	to	prepc_according_to	4	SENT_23	[p2l1005t2407r1074b2460],
11	an	DT	O	a	det	16	SENT_23	[p2l1129t2419r1214b2460],
12	established	JJ	O	established	amod	16	SENT_23	[p2l1267t2399r1659b2460],
13	method	NN	O	method	nn	16	SENT_23	[p2l1711t2399r1983b2460],
14	[	NN	O	[	nn	16	SENT_23	[p2l2040t2400r2139b2476],
15	5	CD	NUMBER	5	num	16	SENT_23	[p2l2040t2400r2139b2476],
16	]	NN	O	]	pobj	4	SENT_23	[p2l2040t2400r2139b2476],
17	.	.	O	.	_	0	SENT_23	[p2l2040t2400r2139b2476],

1	Genotyping	VBG	O	genotype	_	0	SENT_24	[p2l8t2504r434b2582],
2	for	IN	O	for	_	0	SENT_24	[p2l469t2504r573b2565],
3	VKORCI	NNP	O	VKORCI	prep_for	1	SENT_24	[p2l619t2506r951b2566],
4	(	CD	NUMBER	(	num	3	SENT_24	[p2l992t2504r1321b2582],
5	.	.	O	.	_	0	SENT_24	[p2l992t2504r1321b2582],

1	—	NN	O	—	_	0	SENT_25	[p2l992t2504r1321b2582],
2	.	.	O	.	_	0	SENT_25	[p2l992t2504r1321b2582],

1	1639G	NN	O	1639g	npadvmod	2	SENT_26	[p2l992t2504r1321b2582],
2	>	JJR	O	>	_	0	SENT_26	[p2l1372t2515r1419b2555],
3	A	DT	O	a	dep	2	SENT_26	[p2l1469t2504r1551b2579],
4	;	:	O	;	_	0	SENT_26	[p2l1469t2504r1551b2579],
5	rs9923231	NN	O	rs9923231	nn	6	SENT_26	[p2l1590t2504r1975b2582],
6	)	NN	O	)	dep	2	SENT_26	[p2l1590t2504r1975b2582],
7	and	CC	O	and	_	0	SENT_26	[p2l2013t2504r2144b2565],
8	CYP2C9	NN	O	cyp2c9	nn	10	SENT_26	[p2l12t2613r328b2673],
9	(	CD	NUMBER	(	num	10	SENT_26	[p2l383t2611r492b2690],
10	*	NN	O	*	dep	2	SENT_26	[p2l383t2611r492b2690],
11	2	CD	NUMBER	2	number	14	SENT_26	[p2l383t2611r492b2690],
12	and	CC	O	and	_	0	SENT_26	[p2l546t2610r677b2673],
13	*	CD	NUMBER	*	num	15	SENT_26	[p2l736t2611r812b2673],
14	3	CD	NUMBER	3	num	15	SENT_26	[p2l736t2611r812b2673],
15	alleles	NNS	O	allele	dep	10	SENT_26	[p2l868t2611r1101b2686],
16	;	:	O	;	_	0	SENT_26	[p2l868t2611r1101b2686],
17	rsl799853	NN	O	rsl799853	nn	20	SENT_26	[p2l1159t2612r1513b2673],
18	and	CC	O	and	_	0	SENT_26	[p2l1572t2610r1703b2673],
19	rs1057910	NN	O	rs1057910	nn	20	SENT_26	[p2l1758t2611r2142b2689],
20	)	NN	O	)	dep	6	SENT_26	[p2l1758t2611r2142b2689],
21	was	VBD	O	be	auxpass	22	SENT_26	[p2l6t2737r138b2779],
22	performed	VBN	O	perform	rcmod	20	SENT_26	[p2l188t2717r563b2795],
23	[	CD	NUMBER	[	number	24	SENT_26	[p2l615t2719r715b2795],
24	3	CD	NUMBER	3	num	25	SENT_26	[p2l615t2719r715b2795],
25	]	NN	O	]	dobj	22	SENT_26	[p2l615t2719r715b2795],
26	.	.	O	.	_	0	SENT_26	[p2l615t2719r715b2795],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_27	[p2l772t2717r1121b2779],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_27	[p2l1171t2718r1465b2795],
3	were	VBD	O	be	auxpass	4	SENT_27	[p2l1514t2737r1679b2779],
4	carried	VBN	O	carry	_	0	SENT_27	[p2l1729t2717r1977b2779],
5	out	RP	O	out	prt	4	SENT_27	[p2l2028t2726r2145b2779],
6	using	VBG	O	use	xcomp	4	SENT_27	[p2l6t2823r195b2901],
7	MiniTab	NNP	O	MiniTab	nn	8	SENT_27	[p2l263t2823r579b2884],
8	v15	NN	O	v15	dobj	6	SENT_27	[p2l645t2825r834b2885],
9	.0	CD	NUMBER	.0	number	10	SENT_27	[p2l645t2825r834b2885],
10	(	CD	NUMBER	(	dep	8	SENT_27	[p2l903t2823r1239b2901],
11	Minitab	NNP	ORGANIZATION	Minitab	nn	18	SENT_27	[p2l903t2823r1239b2901],
12	,	,	ORGANIZATION	,	_	0	SENT_27	[p2l903t2823r1239b2901],
13	Inc.	NNP	ORGANIZATION	Inc.	appos	18	SENT_27	[p2l1310t2825r1465b2897],
14	,	,	O	,	_	0	SENT_27	[p2l1310t2825r1465b2897],
15	Coventry	NNP	O	Coventry	appos	18	SENT_27	[p2l1536t2824r1888b2901],
16	,	,	O	,	_	0	SENT_27	[p2l1536t2824r1888b2901],
17	UK	NNP	LOCATION	UK	appos	18	SENT_27	[p2l1958t2823r2139b2901],
18	)	NNP	O	)	dep	10	SENT_27	[p2l1958t2823r2139b2901],
19	.	.	O	.	_	0	SENT_27	[p2l1958t2823r2139b2901],

1	Associations	NNS	O	association	nsubjpass	20	SENT_28	[p2l6t2930r460b2991],
2	between	IN	O	between	_	0	SENT_28	[p2l509t2930r799b2991],
3	the	DT	O	the	det	4	SENT_28	[p2l847t2930r954b2991],
4	VKORCI	NN	O	vkorcus	prep_between	1	SENT_28	[p2l1014t2932r1347b2992],
5	and	CC	O	and	_	0	SENT_28	[p2l1399t2930r1530b2991],
6	C	NN	O	c	nn	8	SENT_28	[p2l1583t2932r1639b2992],
7	YP2C9	NN	O	yp2c9	nn	8	SENT_28	[p2l1651t2932r1899b2992],
8	genotypes	NNS	O	genotype	conj_and	4	SENT_28	[p2l1947t2950r2142b3008, p2l7t3044r190b3113],
9	and	CC	O	and	_	0	SENT_28	[p2l238t3035r369b3097],
10	outcome	NN	O	outcome	nn	11	SENT_28	[p2l417t3044r723b3097],
11	variables	NNS	O	variable	conj_and	1	SENT_28	[p2l769t3035r1087b3097],
12	during	IN	O	during	_	0	SENT_28	[p2l1135t3035r1369b3113],
13	the	DT	O	the	det	15	SENT_28	[p2l1415t3035r1522b3097],
14	initiation	NN	O	initiation	nn	15	SENT_28	[p2l1568t3035r1896b3097],
15	phase	NN	O	phase	prep_during	11	SENT_28	[p2l1941t3035r2144b3113],
16	of	IN	O	of	_	0	SENT_28	[p2l9t3141r87b3202],
17	warfarin	NN	O	warfarin	nn	18	SENT_28	[p2l132t3141r438b3202],
18	therapy	NN	O	therapy	prep_of	15	SENT_28	[p2l493t3141r765b3219],
19	were	VBD	O	be	auxpass	20	SENT_28	[p2l819t3161r983b3202],
20	evaluated	VBN	O	evaluate	_	0	SENT_28	[p2l1038t3141r1399b3202],
21	.	.	O	.	_	0	SENT_28	[p2l1038t3141r1399b3202],

1	Analysis	NN	O	analysis	nsubjpass	3	SENT_29	[p2l1457t3141r1761b3219],
2	was	VBD	O	be	auxpass	3	SENT_29	[p2l1815t3161r1948b3202],
3	performed	VBN	O	perform	_	0	SENT_29	[p2l2002t3161r2142b3219, p2l7t3248r264b3309],
4	on	IN	O	on	_	0	SENT_29	[p2l307t3268r396b3309],
5	the	DT	O	the	det	7	SENT_29	[p2l437t3248r545b3309],
6	square	JJ	O	square	amod	7	SENT_29	[p2l588t3268r821b3326],
7	root	NN	O	root	prep_on	3	SENT_29	[p2l862t3256r1013b3309],
8	of	IN	O	of	_	0	SENT_29	[p2l1056t3248r1134b3309],
9	peak	NN	O	peak	nn	10	SENT_29	[p2l1166t3248r1336b3326],
10	INR	NN	O	inr	prep_of	7	SENT_29	[p2l1378t3250r1542b3309],
11	during	IN	O	during	_	0	SENT_29	[p2l1583t3248r1817b3326],
12	the	DT	O	the	det	14	SENT_29	[p2l1858t3248r1966b3309],
13	ﬁrst	NN	O	ﬁrst	nn	14	SENT_29	[p2l2007t3248r2145b3309],
14	week	NN	DURATION	week	prep_during	3	SENT_29	[p2l6t3353r186b3414],
15	of	IN	O	of	_	0	SENT_29	[p2l261t3353r338b3414],
16	therapy	NN	O	therapy	prep_of	14	SENT_29	[p2l405t3353r677b3431],
17	which	WDT	O	which	nsubj	18	SENT_29	[p2l750t3353r962b3414],
18	resulted	VBD	O	result	rcmod	14	SENT_29	[p2l1036t3353r1316b3414],
19	in	IN	O	in	_	0	SENT_29	[p2l1389t3353r1456b3414],
20	an	DT	O	a	det	23	SENT_29	[p2l1531t3373r1616b3414],
21	approximate	JJ	O	approximate	amod	23	SENT_29	[p2l1691t3353r2144b3431],
22	Normal	JJ	O	normal	amod	23	SENT_29	[p2l6t3460r288b3521],
23	distribution	NN	O	distribution	prep_in	18	SENT_29	[p2l384t3459r822b3521],
24	.	.	O	.	_	0	SENT_29	[p2l384t3459r822b3521],

1	The	DT	O	the	det	2	SENT_30	[p2l923t3459r1060b3521],
2	association	NN	O	association	nsubj	11	SENT_30	[p2l1157t3460r1554b3521],
3	between	IN	O	between	_	0	SENT_30	[p2l1650t3459r1940b3521],
4	the	DT	O	the	det	7	SENT_30	[p2l2036t3459r2144b3521],
5	C	NN	O	c	nn	7	SENT_30	[p2l12t3568r68b3627],
6	YP2C9	NN	O	yp2c9	nn	7	SENT_30	[p2l80t3568r328b3627],
7	genotype	NN	O	genotype	prep_between	2	SENT_30	[p2l360t3574r683b3643],
8	and	CC	O	and	_	0	SENT_30	[p2l717t3565r848b3627],
9	peak	NN	O	peak	nn	10	SENT_30	[p2l879t3565r1050b3643],
10	INR	NN	O	inr	prep_between	2	SENT_30	[p2l1082t3568r1246b3626],
11	was	VBD	O	be	_	0	SENT_30	[p2l1277t3585r1409b3627],
12	examined	VBN	O	examine	dep	11	SENT_30	[p2l1442t3565r1783b3627],
13	using	VBG	O	use	xcomp	12	SENT_30	[p2l1815t3565r2004b3643],
14	the	DT	O	the	det	15	SENT_30	[p2l2036t3565r2144b3627],
15	2	CD	NUMBER	2	dobj	13	SENT_30	[p2l11t3679r187b3732],
16	‘	SYM	O	‘	dep	13	SENT_30	[p2l11t3679r187b3732],
17	-	:	O	-	_	0	SENT_30	[p2l11t3679r187b3732],
18	test	NN	O	test	dobj	12	SENT_30	[p2l11t3679r187b3732],
19	and	CC	O	and	_	0	SENT_30	[p2l224t3671r355b3732],
20	between	IN	O	between	dep	11	SENT_30	[p2l391t3671r681b3732],
21	the	DT	O	the	det	23	SENT_30	[p2l718t3671r825b3732],
22	VKORCI	NNP	O	VKORCI	nn	23	SENT_30	[p2l872t3673r1205b3733],
23	genotype	NN	O	genotype	pobj	20	SENT_30	[p2l1246t3680r1569b3749],
24	and	CC	O	and	_	0	SENT_30	[p2l1607t3671r1738b3732],
25	peak	NN	O	peak	nn	26	SENT_30	[p2l1774t3671r1945b3749],
26	INR	NN	O	inr	pobj	20	SENT_30	[p2l1981t3673r2146b3732],

1	using	VBG	O	use	_	0	SENT_31	[p3l6t21r195b99],
2	linear	JJ	O	linear	amod	4	SENT_31	[p3l238t21r440b82],
3	regression	NN	O	regression	nn	4	SENT_31	[p3l482t21r843b99],
4	analysis	NN	O	analysis	dobj	1	SENT_31	[p3l886t21r1185b99],
5	.	.	O	.	_	0	SENT_31	[p3l886t21r1185b99],

1	The	DT	O	the	det	2	SENT_32	[p3l1233t21r1369b82],
2	association	NN	O	association	nsubjpass	21	SENT_32	[p3l1414t21r1811b82],
3	between	IN	O	between	_	0	SENT_32	[p3l1854t21r2144b82],
4	the	DT	O	the	det	5	SENT_32	[p3l7t126r115b188],
5	incidence	NN	O	incidence	prep_between	2	SENT_32	[p3l165t126r496b188],
6	of	IN	O	of	_	0	SENT_32	[p3l548t126r626b188],
7	supra-therapeutic	JJ	O	supra-therapeutic	amod	8	SENT_32	[p3l670t126r1301b204],
8	INR	NN	O	inr	prep_of	5	SENT_32	[p3l1351t129r1515b187],
9	during	IN	O	during	_	0	SENT_32	[p3l1565t126r1799b204],
10	the	DT	DATE	the	det	12	SENT_32	[p3l1849t126r1956b188],
11	ﬁrst	JJ	DATE	ﬁrst	amod	12	SENT_32	[p3l2007t126r2145b188],
12	month	NN	DATE	month	prep_during	8	SENT_32	[p3l6t232r242b293],
13	of	IN	O	of	_	0	SENT_32	[p3l293t232r371b293],
14	warfarin	NN	O	warfarin	nn	15	SENT_32	[p3l410t232r717b294],
15	therapy	NN	O	therapy	prep_of	12	SENT_32	[p3l766t232r1039b310],
16	and	CC	O	and	_	0	SENT_32	[p3l1089t232r1220b293],
17	C	NN	O	c	nn	19	SENT_32	[p3l1274t234r1330b294],
18	YPZC9	NN	O	ypzc9	nn	19	SENT_32	[p3l1342t234r1590b294],
19	genotype	NN	O	genotype	prep_of	12	SENT_32	[p3l1640t240r1962b310],
20	was	VBD	O	be	auxpass	21	SENT_32	[p3l2011t252r2143b294],
21	evaluated	VBN	O	evaluate	_	0	SENT_32	[p3l7t339r349b400],
22	using	VBG	O	use	xcomp	21	SENT_32	[p3l391t339r579b417],
23	a	DT	O	a	det	24	SENT_32	[p3l622t359r660b400],
24	Mann	NNP	O	Mann	dobj	22	SENT_32	[p3l701t339r1267b417],
25	.	.	O	.	_	0	SENT_32	[p3l701t339r1267b417],

1	—	NN	O	—	_	0	SENT_33	[p3l701t339r1267b417],
2	.	.	O	.	_	0	SENT_33	[p3l701t339r1267b417],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_34	[p3l701t339r1267b417],
2	test	NN	O	test	_	0	SENT_34	[p3l1309t347r1432b400],
3	and	CC	O	and	_	0	SENT_34	[p3l1474t339r1605b400],
4	the	DT	O	the	det	6	SENT_34	[p3l1647t339r1754b400],
5	VKORCI	NNP	O	VKORCI	nn	6	SENT_34	[p3l1807t341r2140b401],
6	genotype	NN	O	genotype	conj_and	2	SENT_34	[p3l8t452r330b522],
7	using	VBG	O	use	partmod	2	SENT_34	[p3l371t444r561b522],
8	regression	NN	O	regression	nn	9	SENT_34	[p3l602t444r962b522],
9	analysis	NN	O	analysis	dobj	7	SENT_34	[p3l1004t444r1303b522],
10	.	.	O	.	_	0	SENT_34	[p3l1004t444r1303b522],

1	Results	NNS	O	result	nsubjpass	3	SENT_35	[p3l1351t444r1610b505],
2	are	VBP	O	be	auxpass	3	SENT_35	[p3l1654t464r1761b505],
3	presented	VBN	O	present	_	0	SENT_35	[p3l1801t444r2144b522],
4	as	IN	O	as	_	0	SENT_35	[p3l8t571r77b613],
5	mean	JJ	O	mean	amod	6	SENT_35	[p3l124t571r318b613],
6	i	FW	O	i	prep_as	3	SENT_35	[p3l355t555r412b612],
7	standard	JJ	O	standard	amod	11	SENT_35	[p3l451t550r764b613],
8	deviation	NN	O	deviation	nn	11	SENT_35	[p3l811t550r1144b613],
9	(	CD	NUMBER	(	num	11	SENT_35	[p3l1192t551r1358b630],
10	SD	NN	O	sd	nn	11	SENT_35	[p3l1192t551r1358b630],
11	)	NN	O	)	dep	13	SENT_35	[p3l1192t551r1358b630],
12	unless	IN	O	unless	mark	13	SENT_35	[p3l1406t551r1621b613],
13	stated	VBN	O	state	dep	3	SENT_35	[p3l1671t550r1881b613],
14	otherwise	RB	O	otherwise	advmod	13	SENT_35	[p3l1930t550r2142b613, p3l6t657r175b719],
15	.	.	O	.	_	0	SENT_35	[p3l1930t550r2142b613, p3l6t657r175b719],

1	A	DT	O	a	det	2	SENT_36	[p3l244t657r307b718],
2	P-value	NN	O	p-value	nsubjpass	7	SENT_36	[p3l372t657r644b719],
3	of	IN	O	of	_	0	SENT_36	[p3l712t657r790b719],
4	<	JJR	O	<	prep_of	2	SENT_36	[p3l834t669r880b709],
5	0.05	CD	NUMBER	0.05	dep	4	SENT_36	[p3l933t659r1077b719],
6	was	VBD	O	be	auxpass	7	SENT_36	[p3l1143t677r1276b719],
7	taken	VBN	O	take	_	0	SENT_36	[p3l1342t657r1539b719],
8	as	IN	O	as	_	0	SENT_36	[p3l1606t677r1676b719],
9	statistically	RB	O	statistically	advmod	10	SENT_36	[p3l1743t657r2144b735],
10	signiﬁcant	JJ	O	signiﬁcant	prep_as	7	SENT_36	[p3l9t763r390b841],
11	.	.	O	.	_	0	SENT_36	[p3l9t763r390b841],

1	Fifty-one	CD	NUMBER	fifty-one	num	2	SENT_37	[p3l93t870r425b948],
2	children	NNS	O	child	nsubjpass	4	SENT_37	[p3l471t870r761b931],
3	were	VBD	O	be	auxpass	4	SENT_37	[p3l805t890r970b931],
4	studied	VBN	O	study	_	0	SENT_37	[p3l1018t870r1274b931],
5	with	IN	O	with	_	0	SENT_37	[p3l1319t870r1476b931],
6	a	DT	O	a	det	8	SENT_37	[p3l1522t890r1560b931],
7	median	JJ	O	median	amod	8	SENT_37	[p3l1604t870r1868b931],
8	age	NN	O	age	prep_with	4	SENT_37	[p3l1914t890r2031b948],
9	at	IN	O	at	_	0	SENT_37	[p3l2079t878r2145b931],
10	the	DT	O	the	det	11	SENT_37	[p3l7t975r115b1037],
11	time	NN	O	time	prep_at	4	SENT_37	[p3l162t975r315b1037],
12	of	IN	O	of	_	0	SENT_37	[p3l362t975r440b1037],
13	ﬁrst	JJ	O	ﬁrst	amod	15	SENT_37	[p3l477t975r614b1037],
14	warfarin	NN	O	warfarin	nn	15	SENT_37	[p3l658t975r964b1037],
15	dose	NN	O	dose	prep_of	11	SENT_37	[p3l1010t975r1168b1037],
16	of	IN	O	of	_	0	SENT_37	[p3l1216t975r1294b1037],
17	4	CD	DURATION	4	num	18	SENT_37	[p3l1330t977r1369b1036],
18	years	NNS	NUMBER	year	tmod	19	SENT_37	[p3l1404t995r1587b1053],
19	(	JJ	O	(	amod	20	SENT_37	[p3l1635t976r1877b1053],
20	range	NN	O	range	prep_of	15	SENT_37	[p3l1635t976r1877b1053],
21	:	:	O	:	_	0	SENT_37	[p3l1635t976r1877b1053],
22	1-17	CD	NUMBER	1-17	num	23	SENT_37	[p3l1935t976r2139b1053],
23	)	NN	O	)	dep	20	SENT_37	[p3l1935t976r2139b1053],
24	.	.	O	.	_	0	SENT_37	[p3l1935t976r2139b1053],

1	There	EX	O	there	expl	2	SENT_38	[p3l7t1081r213b1143],
2	were	VBD	O	be	dep	5	SENT_38	[p3l250t1101r414b1143],
3	39	CD	NUMBER	39	num	4	SENT_38	[p3l455t1083r531b1143],
4	males	NNS	O	male	nsubj	2	SENT_38	[p3l569t1081r770b1143],
5	(	VBP	O	(	_	0	SENT_38	[p3l810t1081r1094b1159],
6	76.5	CD	PERCENT	76.5	num	7	SENT_38	[p3l810t1081r1094b1159],
7	%	NN	PERCENT	%	dobj	5	SENT_38	[p3l810t1081r1094b1159],
8	)	CD	NUMBER	)	nsubj	12	SENT_38	[p3l810t1081r1094b1159],
9	and	CC	O	and	_	0	SENT_38	[p3l1135t1081r1266b1143],
10	33	CD	NUMBER	33	num	11	SENT_38	[p3l1306t1083r1380b1143],
11	children	NNS	O	child	conj_and	8	SENT_38	[p3l1421t1081r1710b1143],
12	(	VBP	O	(	rcmod	7	SENT_38	[p3l1750t1081r2034b1159],
13	64.7	CD	PERCENT	64.7	num	14	SENT_38	[p3l1750t1081r2034b1159],
14	%	NN	PERCENT	%	dobj	12	SENT_38	[p3l1750t1081r2034b1159],
15	)	CD	NUMBER	)	nsubj	5	SENT_38	[p3l1750t1081r2034b1159],
16	of	IN	O	of	_	0	SENT_38	[p3l2074t1081r2152b1143],
17	white	JJ	O	white	amod	19	SENT_38	[p3l6t1188r199b1249],
18	Caucasian	JJ	MISC	caucasian	amod	19	SENT_38	[p3l234t1188r603b1249],
19	origin	NN	O	origin	prep_of	15	SENT_38	[p3l638t1188r865b1266],
20	.	.	O	.	_	0	SENT_38	[p3l638t1188r865b1266],

1	The	DT	O	the	det	4	SENT_39	[p3l903t1188r1040b1249],
2	most	RBS	O	most	advmod	4	SENT_39	[p3l1072t1196r1248b1249],
3	frequent	JJ	O	frequent	amod	4	SENT_39	[p3l1281t1188r1581b1266],
4	indications	NNS	O	indication	nsubj	10	SENT_39	[p3l1613t1188r2006b1249],
5	for	IN	O	for	_	0	SENT_39	[p3l2040t1188r2145b1249],
6	anticoagulation	NN	O	anticoagulation	prep_for	4	SENT_39	[p3l8t1293r570b1371],
7	were	VBD	O	be	cop	10	SENT_39	[p3l612t1313r777b1354],
8	the	DT	O	the	det	10	SENT_39	[p3l822t1293r930b1354],
9	Fontan	NNP	O	Fontan	nn	10	SENT_39	[p3l976t1295r1238b1354],
10	procedure	NN	O	procedure	_	0	SENT_39	[p3l1281t1293r1641b1371],
11	(	CD	NUMBER	(	number	12	SENT_39	[p3l1688t1293r1792b1371],
12	28	CD	NUMBER	28	num	13	SENT_39	[p3l1688t1293r1792b1371],
13	patients	NNS	O	patient	dep	10	SENT_39	[p3l1839t1293r2139b1371],
14	:	:	O	:	_	0	SENT_39	[p3l1839t1293r2139b1371],
15	54	CD	PERCENT	54	num	16	SENT_39	[p3l10t1400r221b1479],
16	%	NN	PERCENT	%	dep	10	SENT_39	[p3l10t1400r221b1479],
17	)	CD	NUMBER	)	dep	16	SENT_39	[p3l10t1400r221b1479],
18	,	,	O	,	_	0	SENT_39	[p3l10t1400r221b1479],
19	a	DT	O	a	det	22	SENT_39	[p3l279t1420r317b1462],
20	prosthetic	JJ	O	prosthetic	amod	22	SENT_39	[p3l369t1400r726b1479],
21	heart	NN	O	heart	nn	22	SENT_39	[p3l779t1399r963b1462],
22	valve	NN	O	valve	appos	10	SENT_39	[p3l1015t1400r1199b1462],
23	(	CD	NUMBER	(	number	24	SENT_39	[p3l1255t1400r1474b1479],
24	seven	CD	NUMBER	seven	num	25	SENT_39	[p3l1255t1400r1474b1479],
25	patients	NNS	O	patient	dep	22	SENT_39	[p3l1526t1400r1826b1479],
26	:	:	O	:	_	0	SENT_39	[p3l1526t1400r1826b1479],
27	13.7	CD	PERCENT	13.7	num	28	SENT_39	[p3l1893t1400r2142b1478],
28	%	NN	PERCENT	%	dep	10	SENT_39	[p3l1893t1400r2142b1478],
29	)	CD	NUMBER	)	dep	28	SENT_39	[p3l1893t1400r2142b1478],
30	and	CC	O	and	_	0	SENT_39	[p3l8t1506r139b1569],
31	cardiomyopathy	NN	O	cardiomyopathy	conj_and	28	SENT_39	[p3l202t1506r793b1585],
32	(	CD	NUMBER	(	num	34	SENT_39	[p3l856t1506r1005b1586],
33	ﬁve	NN	O	ﬁve	nn	34	SENT_39	[p3l856t1506r1005b1586],
34	patients	NNS	O	patient	dep	31	SENT_39	[p3l1067t1506r1367b1585],
35	:	:	O	:	_	0	SENT_39	[p3l1067t1506r1367b1585],
36	9.8	CD	PERCENT	9.8	num	37	SENT_39	[p3l1436t1507r1670b1585],
37	%	NN	PERCENT	%	dep	10	SENT_39	[p3l1436t1507r1670b1585],
38	)	CD	NUMBER	)	dep	37	SENT_39	[p3l1436t1507r1670b1585],
39	.	.	O	.	_	0	SENT_39	[p3l1436t1507r1670b1585],

1	The	DT	O	the	det	4	SENT_40	[p3l1738t1506r1874b1569],
2	target	NN	O	target	nn	4	SENT_40	[p3l1937t1515r2145b1585],
3	INR	NN	O	inr	nn	4	SENT_40	[p3l8t1615r172b1674],
4	range	NN	O	range	nsubj	7	SENT_40	[p3l210t1633r407b1691],
5	was	VBD	O	be	cop	7	SENT_40	[p3l446t1633r578b1674],
6	2.0-3	CD	NUMBER	2.0-3	num	7	SENT_40	[p3l620t1614r872b1675],
7	.0	CD	NUMBER	.0	_	0	SENT_40	[p3l620t1614r872b1675],
8	in	IN	O	in	_	0	SENT_40	[p3l912t1613r979b1674],
9	46	CD	PERCENT	46	number	10	SENT_40	[p3l1018t1614r1098b1674],
10	(	CD	PERCENT	(	num	12	SENT_40	[p3l1140t1613r1424b1691],
11	90.2	CD	PERCENT	90.2	num	12	SENT_40	[p3l1140t1613r1424b1691],
12	%	NN	PERCENT	%	prep_in	7	SENT_40	[p3l1140t1613r1424b1691],
13	)	CD	NUMBER	)	dep	12	SENT_40	[p3l1140t1613r1424b1691],
14	and	CC	O	and	_	0	SENT_40	[p3l1467t1613r1597b1674],
15	2.5-3	CD	NUMBER	2.5-3	num	16	SENT_40	[p3l1637t1614r1889b1674],
16	.5	CD	NUMBER	.5	prep_in	7	SENT_40	[p3l1637t1614r1889b1674],
17	in	IN	O	in	_	0	SENT_40	[p3l1930t1613r1997b1674],
18	the	DT	O	the	det	19	SENT_40	[p3l2036t1613r2144b1674],
19	remainder	NN	O	remainder	prep_in	16	SENT_40	[p3l7t1720r390b1781],
20	.	.	O	.	_	0	SENT_40	[p3l7t1720r390b1781],

1	The	DT	O	the	det	4	SENT_41	[p3l433t1720r569b1781],
2	mean	NN	O	mean	nn	4	SENT_41	[p3l607t1740r801b1781],
3	warfarin	NN	O	warfarin	nn	4	SENT_41	[p3l838t1720r1145b1781],
4	dose	NN	O	dose	nsubj	18	SENT_41	[p3l1183t1720r1342b1781],
5	given	VBN	O	give	prep	4	SENT_41	[p3l1382t1720r1569b1798],
6	on	IN	O	on	pcomp	5	SENT_41	[p3l1609t1740r1697b1781],
7	days	NNS	DURATION	day	pobj	6	SENT_41	[p3l1736t1720r1895b1798],
8	1	CD	NUMBER	1	num	7	SENT_41	[p3l1943t1721r1965b1780],
9	and	CC	O	and	_	0	SENT_41	[p3l2013t1720r2144b1781],
10	2	CD	NUMBER	2	conj_and	7	SENT_41	[p3l8t1827r45b1887],
11	of	IN	O	of	_	0	SENT_41	[p3l88t1825r165b1888],
12	initiation	NN	O	initiation	nn	13	SENT_41	[p3l196t1826r524b1888],
13	therapy	NN	O	therapy	prep_of	7	SENT_41	[p3l565t1825r837b1904],
14	was	VBD	O	be	cop	18	SENT_41	[p3l876t1846r1008b1888],
15	0.14	CD	NUMBER	0.14	num	18	SENT_41	[p3l1050t1827r1195b1888],
16	mg	NN	O	mg	nn	18	SENT_41	[p3l1229t1846r1339b1904],
17	kg	NN	O	kg	nn	18	SENT_41	[p3l1374t1809r1535b1904],
18	”	NN	O	”	_	0	SENT_41	[p3l1374t1809r1535b1904],
19	(	CD	NUMBER	(	dep	18	SENT_41	[p3l1582t1826r1667b1904],
20	:	:	O	:	_	0	SENT_41	[p3l1582t1826r1667b1904],
21	l	NN	O	l	dep	18	SENT_41	[p3l1582t1826r1667b1904],
22	:	:	O	:	_	0	SENT_41	[p3l1582t1826r1667b1904],
23	0.06	CD	NUMBER	0.06	num	24	SENT_41	[p3l1705t1826r1899b1904],
24	)	NN	O	)	dep	21	SENT_41	[p3l1705t1826r1899b1904],
25	,	,	O	,	_	0	SENT_41	[p3l1705t1826r1899b1904],
26	based	VBN	O	base	partmod	24	SENT_41	[p3l1942t1825r2144b1888],
27	on	IN	O	on	_	0	SENT_41	[p3l9t1953r97b1994],
28	the	DT	O	the	det	30	SENT_41	[p3l129t1932r237b1994],
29	recommended	VBN	O	recommend	amod	30	SENT_41	[p3l270t1932r774b1994],
30	dose	NN	O	dose	prep_on	26	SENT_41	[p3l807t1932r965b1994],
31	of	IN	O	of	_	0	SENT_41	[p3l999t1932r1077b1994],
32	0.2	CD	NUMBER	0.2	num	36	SENT_41	[p3l1101t1934r1205b1995],
33	mg	NN	O	mg	nn	36	SENT_41	[p3l1238t1952r1349b2011],
34	kg	NN	O	kg	nn	36	SENT_41	[p3l1383t1916r1544b2011],
35	”	CD	NUMBER	”	num	36	SENT_41	[p3l1383t1916r1544b2011],
36	(	NN	O	(	prep_of	30	SENT_41	[p3l1583t1932r1679b2011],
37	to	TO	O	to	dep	36	SENT_41	[p3l1583t1932r1679b2011],
38	a	DT	O	a	quantmod	39	SENT_41	[p3l1714t1952r1752b1994],
39	maximum	NN	O	maximum	num	46	SENT_41	[p3l1783t1932r2145b1994],
40	of	IN	O	of	quantmod	39	SENT_41	[p3l9t2040r87b2101],
41	5	CD	NUMBER	5	number	39	SENT_41	[p3l173t2042r205b2101],
42	mg	NN	O	mg	nn	46	SENT_41	[p3l241t2040r378b2118],
43	)	NN	O	)	nn	46	SENT_41	[p3l241t2040r378b2118],
44	[	CD	NUMBER	[	number	45	SENT_41	[p3l473t2041r572b2117],
45	6	CD	NUMBER	6	num	46	SENT_41	[p3l473t2041r572b2117],
46	]	NN	O	]	dep	36	SENT_41	[p3l473t2041r572b2117],
47	.	.	O	.	_	0	SENT_41	[p3l473t2041r572b2117],

1	Genotype	NN	O	genotype	nn	2	SENT_42	[p3l669t2041r1018b2118],
2	frequencies	NNS	O	frequency	nsubj	13	SENT_42	[p3l1110t2040r1510b2118],
3	for	IN	O	for	_	0	SENT_42	[p3l1602t2040r1707b2101],
4	VKORCI	NNP	O	VKORCI	prep_for	2	SENT_42	[p3l1807t2042r2140b2102],
5	(	CD	NUMBER	(	number	6	SENT_42	[p3l9t2145r337b2223],
6	-1639	CD	NUMBER	-1639	num	7	SENT_42	[p3l9t2145r337b2223],
7	G	NN	O	g	npadvmod	8	SENT_42	[p3l9t2145r337b2223],
8	>	JJR	O	>	dep	4	SENT_42	[p3l388t2156r435b2196],
9	A	DT	O	a	dep	8	SENT_42	[p3l486t2145r568b2219],
10	;	:	O	;	_	0	SENT_42	[p3l486t2145r568b2219],
11	rs9923231	NN	O	rs9923231	nn	12	SENT_42	[p3l667t2145r1052b2223],
12	)	NN	O	)	dep	4	SENT_42	[p3l667t2145r1052b2223],
13	were	VBD	O	be	_	0	SENT_42	[p3l1149t2165r1331b2206],
14	:	:	O	:	_	0	SENT_42	[p3l1149t2165r1331b2206],
15	GG	NNS	O	gg	dobj	13	SENT_42	[p3l1433t2146r1587b2219],
16	,	,	O	,	_	0	SENT_42	[p3l1433t2146r1587b2219],
17	19	CD	NUMBER	19	num	18	SENT_42	[p3l1695t2146r1765b2206],
18	patients	NNS	O	patient	appos	15	SENT_42	[p3l1862t2145r2143b2223],
19	(	IN	O	(	_	0	SENT_42	[p3l9t2252r314b2331],
20	37.3	CD	PERCENT	37.3	num	21	SENT_42	[p3l9t2252r314b2331],
21	%	NN	PERCENT	%	prep_(	18	SENT_42	[p3l9t2252r314b2331],
22	)	CD	NUMBER	)	dep	18	SENT_42	[p3l9t2252r314b2331],
23	;	:	O	;	_	0	SENT_42	[p3l9t2252r314b2331],
24	GA	NNP	O	GA	dep	18	SENT_42	[p3l351t2252r501b2327],
25	,	,	O	,	_	0	SENT_42	[p3l351t2252r501b2327],
26	26	CD	PERCENT	26	number	27	SENT_42	[p3l537t2253r617b2314],
27	(	CD	PERCENT	(	appos	24	SENT_42	[p3l651t2252r891b2331],
28	51	CD	PERCENT	51	num	29	SENT_42	[p3l651t2252r891b2331],
29	%	NN	PERCENT	%	dep	27	SENT_42	[p3l651t2252r891b2331],
30	)	CD	NUMBER	)	dep	27	SENT_42	[p3l651t2252r891b2331],
31	;	:	O	;	_	0	SENT_42	[p3l651t2252r891b2331],
32	AA	NNP	O	AA	dep	18	SENT_42	[p3l926t2252r1074b2327],
33	,	,	O	,	_	0	SENT_42	[p3l926t2252r1074b2327],
34	6	CD	PERCENT	6	num	35	SENT_42	[p3l1111t2253r1147b2314],
35	(	NN	PERCENT	(	appos	32	SENT_42	[p3l1182t2252r1488b2331],
36	11.8	CD	PERCENT	11.8	num	37	SENT_42	[p3l1182t2252r1488b2331],
37	%	NN	PERCENT	%	dep	35	SENT_42	[p3l1182t2252r1488b2331],
38	)	CD	NUMBER	)	dep	35	SENT_42	[p3l1182t2252r1488b2331],
39	,	,	O	,	_	0	SENT_42	[p3l1182t2252r1488b2331],
40	and	CC	O	and	_	0	SENT_42	[p3l1524t2251r1655b2314],
41	for	IN	O	for	dobj	13	SENT_42	[p3l1688t2252r1793b2314],
42	CYP2C9	NN	O	cyp2c9	pobj	41	SENT_42	[p3l1829t2254r2144b2314],
43	374	CD	NUMBER	374	num	44	SENT_42	[p3l7t2364r133b2421],
44	Letters	NNS	O	letter	dep	15	SENT_42	[p3l171t2372r380b2421],
45	to	TO	O	to	_	0	SENT_42	[p3l409t2380r461b2421],
46	the	DT	O	the	det	47	SENT_42	[p3l492t2369r576b2421],
47	Editor	NNP	O	Editor	prep_to	44	SENT_42	[p3l602t2369r788b2421],

1	P	NN	O	p	_	0	SENT_43	[p3l1273t2672r1319b2723],
2	=	JJ	O	=	amod	1	SENT_43	[p3l1337t2695r1373b2716],
3	0.04	CD	NUMBER	0.04	tmod	2	SENT_43	[p3l1398t2673r1532b2725],

1	Peak	JJ	O	peak	amod	2	SENT_44	[p3l797t3351r850b3504],
2	INR	NN	O	inr	_	0	SENT_44	[p3l796t3211r849b3325],
3	during	IN	O	during	_	0	SENT_44	[p3l796t2993r864b3187],
4	first	JJ	ORDINAL	first	amod	5	SENT_44	[p3l796t2856r850b2969],
5	week	NN	DURATION	week	prep_during	2	SENT_44	[p3l796t2670r850b2834],
6	1	CD	NUMBER	1	num	8	SENT_44	[p3l811t2581r860b2632],
7	:	:	O	:	_	0	SENT_44	[p3l811t2581r860b2632],
8	8	CD	NUMBER	8	dep	2	SENT_44	[p3l921t2688r991b2740],

1	Ol	JJ	O	ol	amod	2	SENT_45	[p3l955t2838r991b3496],
2	\	NN	O	\	_	0	SENT_45	[p3l955t2838r991b3496],
3	)	SYM	O	)	dep	2	SENT_45	[p3l955t2838r991b3496],
4	-	:	O	-	_	0	SENT_45	[p3l955t2838r991b3496],
5	|	NN	O	|	dep	2	SENT_45	[p3l955t2838r991b3496],
6	>	JJR	O	>	amod	7	SENT_45	[p3l955t2838r991b3496],
7	O3m	NN	O	o3m	dep	5	SENT_45	[p3l955t2838r991b3496],

1	O	NN	O	o	_	0	SENT_46	[p3l1211t3518r1246b3569],
2	1	CD	NUMBER	1	num	3	SENT_46	[p3l1588t3518r1607b3568],
3	2	CD	NUMBER	2	dep	1	SENT_46	[p3l1970t3518r2006b3568],

1	No	DT	O	no	_	0	SENT_47	[p3l1157t3626r1241b3678],
2	of	IN	O	of	_	0	SENT_47	[p3l1265t3626r1322b3678],
3	variant	JJ	O	variant	amod	5	SENT_47	[p3l1343t3626r1555b3679],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_47	[p3l1583t3625r1856b3679],
5	alleles	NNS	O	allele	prep_of	1	SENT_47	[p3l1875t3626r2072b3679],
6	'	POS	O	'	_	0	SENT_47	[p4l6t180r73b261],

1	3	CD	NUMBER	3	num	2	SENT_48	[p4l6t180r73b261],
2	P	NN	O	p	nsubj	3	SENT_48	[p4l1062t232r1449b316],
3	=	JJ	O	=	_	0	SENT_48	[p4l1062t232r1449b316],
4	0	CD	NUMBER	0	dobj	3	SENT_48	[p4l1062t232r1449b316],
5	.	.	O	.	_	0	SENT_48	[p4l1062t232r1449b316],

1	O1	CD	NUMBER	o1	num	2	SENT_49	[p4l1062t232r1449b316],
2	g	NN	O	g	_	0	SENT_49	[p4l11t334r93b449],
3	10	CD	NUMBER	10	num	6	SENT_49	[p4l178t323r344b404, p4l31t457r93b510],
4	(	NN	O	(	nn	6	SENT_49	[p4l178t323r344b404, p4l31t457r93b510],
5	D	NN	O	d	nn	6	SENT_49	[p4l178t323r344b404, p4l31t457r93b510],
6	E	NN	O	e	dep	2	SENT_49	[p4l33t514r92b593],
7	8	CD	NUMBER	8	number	8	SENT_49	[p4l233t557r288b639],
8	5	CD	NUMBER	5	dep	6	SENT_49	[p4l16t626r93b740],
9	"	``	O	"	punct	10	SENT_49	[p4l9t775r117b894],
10	Ba	NN	O	ba	dep	8	SENT_49	[p4l9t775r117b894],
11	6	CD	NUMBER	6	num	10	SENT_49	[p4l233t795r343b876],
12	—	NN	O	—	dep	2	SENT_49	[p4l233t795r343b876],
13	.5	CD	NUMBER	.5	num	12	SENT_49	[p4l11t904r92b978],

1	3	CD	NUMBER	3	number	2	SENT_50	[p4l11t1031r93b1143],
2	4	CD	NUMBER	4	num	4	SENT_50	[p4l232t1029r289b1108],
3	CE	NN	ORGANIZATION	ce	nn	4	SENT_50	[p4l11t1182r92b1250],
4	Z	NN	ORGANIZATION	z	_	0	SENT_50	[p4l11t1267r92b1361],
5	2	CD	PERCENT	2	number	6	SENT_50	[p4l232t1274r287b1354],
6	1	CD	PERCENT	1	num	7	SENT_50	[p4l11t1401r93b1516],
7	%	NN	PERCENT	%	dep	4	SENT_50	[p4l11t1401r93b1516],
8	an	DT	O	a	det	9	SENT_50	[p4l31t1523r93b1577],
9	O	NN	O	o	dep	7	SENT_50	[p4l233t1506r289b1588],
10	.	.	O	.	_	0	SENT_50	[p4l1246t1571r1247b1587],

1	‘	NN	O	‘	nn	3	SENT_51	[p4l11t1580r92b1642],
2	L	NN	O	l	nn	3	SENT_51	[p4l11t1580r92b1642],
3	AA	NN	O	aa	_	0	SENT_51	[p4l591t1647r737b1728],
4	AG	NNP	O	AG	dep	3	SENT_51	[p4l1165t1645r1314b1729],
5	GG	NNS	O	gg	dep	3	SENT_51	[p4l1753t1645r1914b1729],

1	VKORC1	NN	O	vkorc1	nn	2	SENT_52	[p4l779t1819r1208b1904],
2	genotype	NN	O	genotype	_	0	SENT_52	[p4l1249t1827r1700b1926],

1	Fig	NN	O	fig	_	0	SENT_53	[p4l47t1977r100b2007],
2	.	.	O	.	_	0	SENT_53	[p4l47t1977r100b2007],

1	1	LS	NUMBER	1	_	0	SENT_54	[p4l116t1977r137b2001],
2	.	.	O	.	_	0	SENT_54	[p4l116t1977r137b2001],

1	Box	NNP	O	Box	dep	5	SENT_55	[p4l155t1977r210b2001],
2	plot	NN	O	plot	nn	3	SENT_55	[p4l222t1976r278b2007],
3	showin	NN	O	showin	dep	1	SENT_55	[p4l291t1976r389b2001],
4	he	PRP	O	he	dep	5	SENT_55	[p4l429t1976r460b2001],
5	relationship	NN	O	relationship	dep	26	SENT_55	[p4l473t1976r639b2007],
6	between	IN	O	between	_	0	SENT_55	[p4l652t1976r772b2001],
7	:	:	O	:	_	0	SENT_55	[p4l652t1976r772b2001],
8	(	CD	NUMBER	(	prep_between	5	SENT_55	[p4l787t1976r832b2007],
9	A	DT	O	a	det	10	SENT_55	[p4l787t1976r832b2007],
10	)	NN	O	)	dep	8	SENT_55	[p4l787t1976r832b2007],
11	the	DT	O	the	det	14	SENT_55	[p4l845t1976r888b2001],
12	C	NN	O	c	nn	14	SENT_55	[p4l902t1977r924b2001],
13	YPZC9	NN	O	ypzc9	nn	14	SENT_55	[p4l929t1977r1026b2001],
14	enotype	NN	O	enotype	dep	22	SENT_55	[p4l1054t1980r1165b2007],
15	and	CC	O	and	_	0	SENT_55	[p4l1177t1976r1229b2001],
16	the	DT	O	the	det	17	SENT_55	[p4l1241t1976r1283b2001],
17	peak	NN	O	peak	conj_and	14	SENT_55	[p4l1296t1976r1363b2007],
18	International	NNP	MISC	International	dep	22	SENT_55	[p4l1375t1976r1560b2001],
19	Normalized	NNP	MISC	Normalized	nn	22	SENT_55	[p4l1572t1976r1738b2001],
20	Ratio	NNP	MISC	Ratio	nn	22	SENT_55	[p4l1751t1976r1829b2001],
21	(	CD	NUMBER	(	num	22	SENT_55	[p4l1843t1976r1928b2007],
22	INR	NNP	O	INR	dep	26	SENT_55	[p4l1843t1976r1928b2007],
23	)	CD	NUMBER	)	num	24	SENT_55	[p4l1843t1976r1928b2007],
24	durin	NN	O	durin	dep	22	SENT_55	[p4l1941t1976r2016b2001],
25	he	PRP	O	he	nsubj	26	SENT_55	[p4l2056t1976r2087b2001],
26	ﬁrst	VBD	O	ﬁrst	_	0	SENT_55	[p4l47t2017r101b2042],
27	week	NN	DURATION	week	dobj	26	SENT_55	[p4l113t2017r183b2042],
28	of	IN	O	of	_	0	SENT_55	[p4l196t2017r227b2042],
29	warfarin	NN	O	warfarin	nn	30	SENT_55	[p4l236t2017r355b2042],
30	erapy	NN	O	erapy	prep_of	27	SENT_55	[p4l397t2025r482b2048],
31	;	:	O	;	_	0	SENT_55	[p4l397t2025r482b2048],
32	(	NN	O	(	nn	33	SENT_55	[p4l496t2017r537b2048],
33	B	NN	O	b	nsubj	34	SENT_55	[p4l496t2017r537b2048],
34	)	VBD	O	)	parataxis	26	SENT_55	[p4l496t2017r537b2048],
35	the	DT	O	the	det	37	SENT_55	[p4l550t2017r593b2042],
36	VKORCI	NNP	O	VKORCI	nn	37	SENT_55	[p4l609t2018r740b2042],
37	genotype	NN	O	genotype	dobj	34	SENT_55	[p4l753t2021r880b2048],
38	and	CC	O	and	_	0	SENT_55	[p4l893t2017r944b2042],
39	the	DT	O	the	det	41	SENT_55	[p4l956t2017r998b2042],
40	pea	NN	O	pea	nn	41	SENT_55	[p4l1011t2025r1059b2048],
41	NR	NN	O	nr	dobj	34	SENT_55	[p4l1102t2018r1154b2041],
42	during	IN	O	during	_	0	SENT_55	[p4l1166t2017r1258b2048],
43	the	DT	O	the	det	45	SENT_55	[p4l1270t2017r1312b2042],
44	ﬁrst	NN	O	ﬁrst	nn	45	SENT_55	[p4l1324t2017r1379b2042],
45	week	NN	DURATION	week	prep_during	34	SENT_55	[p4l1390t2017r1460b2042],
46	of	IN	O	of	_	0	SENT_55	[p4l1473t2017r1504b2042],
47	warfarin	NN	O	warfarin	nn	48	SENT_55	[p4l1512t2017r1632b2042],
48	therapy	NN	O	therapy	prep_of	45	SENT_55	[p4l1645t2017r1758b2048],
49	.	.	O	.	_	0	SENT_55	[p4l1645t2017r1758b2048],

1	Boxes	NNPS	O	Boxes	nsubj	2	SENT_56	[p4l1773t2018r1855b2042],
2	indicate	VBP	O	indicate	_	0	SENT_56	[p4l1867t2017r1977b2042],
3	m	NN	O	m	nn	5	SENT_56	[p4l2043t2025r2070b2041],
4	d	NN	O	d	nn	5	SENT_56	[p4l2086t2017r2103b2042],
5	ian	NN	O	ian	dobj	2	SENT_56	[p4l47t2058r90b2083],
6	and	CC	O	and	_	0	SENT_56	[p4l103t2058r154b2083],
7	interquartile	NN	O	interquartile	nn	8	SENT_56	[p4l167t2058r340b2089],
8	ranges	NNS	O	range	dobj	2	SENT_56	[p4l353t2066r450b2089],
9	.	.	O	.	_	0	SENT_56	[p4l353t2066r450b2089],

1	Vertical	JJ	O	vertical	amod	2	SENT_57	[p4l464t2058r574b2083],
2	lines	NNS	O	line	nsubj	8	SENT_57	[p4l586t2058r648b2083],
3	above	IN	O	above	_	0	SENT_57	[p4l661t2058r744b2083],
4	and	CC	O	and	_	0	SENT_57	[p4l757t2058r808b2083],
5	below	IN	O	below	_	0	SENT_57	[p4l821t2058r903b2083],
6	the	DT	O	the	det	7	SENT_57	[p4l916t2058r958b2083],
7	boxes	NNS	O	box	prep_below	2	SENT_57	[p4l970t2058r1049b2083],
8	show	VBP	O	show	_	0	SENT_57	[p4l1062t2058r1134b2083],
9	the	DT	O	the	det	13	SENT_57	[p4l1146t2058r1188b2083],
10	minimum	NN	O	minimum	nn	13	SENT_57	[p4l1200t2058r1336b2083],
11	and	CC	O	and	_	0	SENT_57	[p4l1349t2058r1400b2083],
12	maximum	NN	O	maximum	conj_and	10	SENT_57	[p4l1412t2058r1553b2083],
13	values	NNS	O	value	dobj	8	SENT_57	[p4l1565t2058r1659b2083],
14	.	.	O	.	_	0	SENT_57	[p4l1565t2058r1659b2083],

1	Mean	NN	O	mean	nn	2	SENT_58	[p4l1674t2059r1754b2083],
2	values	NNS	O	value	nsubjpass	4	SENT_58	[p4l1766t2058r1852b2083],
3	are	VBP	O	be	auxpass	4	SENT_58	[p4l1866t2066r1907b2083],
4	indicated	VBN	O	indicate	_	0	SENT_58	[p4l1920t2058r2055b2083],
5	.	.	O	.	_	0	SENT_58	[p4l1920t2058r2055b2083],

1	were	VBD	O	be	_	0	SENT_59	[p4l7t2270r190b2311],
2	:	:	O	:	_	0	SENT_59	[p4l7t2270r190b2311],
3	*	CD	NUMBER	*	number	4	SENT_59	[p4l234t2250r443b2328],
4	1	CD	NUMBER	1	dobj	1	SENT_59	[p4l234t2250r443b2328],
5	/	:	O	/	punct	7	SENT_59	[p4l234t2250r443b2328],
6	*	CD	NUMBER	*	num	7	SENT_59	[p4l234t2250r443b2328],
7	1	CD	NUMBER	1	dep	4	SENT_59	[p4l234t2250r443b2328],
8	,	,	O	,	_	0	SENT_59	[p4l234t2250r443b2328],
9	35	CD	NUMBER	35	num	10	SENT_59	[p4l484t2251r560b2311],
10	patients	NNS	O	patient	appos	7	SENT_59	[p4l595t2250r877b2328],
11	(	IN	O	(	_	0	SENT_59	[p4l915t2250r1220b2328],
12	68.6	CD	PERCENT	68.6	num	13	SENT_59	[p4l915t2250r1220b2328],
13	%	NN	PERCENT	%	prep_(	4	SENT_59	[p4l915t2250r1220b2328],
14	)	CD	NUMBER	)	dep	13	SENT_59	[p4l915t2250r1220b2328],
15	;	:	O	;	_	0	SENT_59	[p4l915t2250r1220b2328],
16	*	CD	NUMBER	*	number	17	SENT_59	[p4l1262t2250r1472b2328],
17	1	CD	NUMBER	1	dep	13	SENT_59	[p4l1262t2250r1472b2328],
18	/	:	O	/	punct	20	SENT_59	[p4l1262t2250r1472b2328],
19	*	CD	NUMBER	*	num	20	SENT_59	[p4l1262t2250r1472b2328],
20	2	CD	NUMBER	2	dep	17	SENT_59	[p4l1262t2250r1472b2328],
21	,	,	O	,	_	0	SENT_59	[p4l1262t2250r1472b2328],
22	6	CD	PERCENT	6	num	23	SENT_59	[p4l1511t2251r1547b2311],
23	(	NN	PERCENT	(	appos	20	SENT_59	[p4l1584t2250r1890b2328],
24	11.8	CD	PERCENT	11.8	num	25	SENT_59	[p4l1584t2250r1890b2328],
25	%	NN	PERCENT	%	dep	17	SENT_59	[p4l1584t2250r1890b2328],
26	)	CD	NUMBER	)	dep	17	SENT_59	[p4l1584t2250r1890b2328],
27	;	:	O	;	_	0	SENT_59	[p4l1584t2250r1890b2328],
28	*	CD	NUMBER	*	number	29	SENT_59	[p4l1932t2250r2141b2328],
29	1	CD	NUMBER	1	dep	13	SENT_59	[p4l1932t2250r2141b2328],
30	/	:	O	/	punct	32	SENT_59	[p4l1932t2250r2141b2328],
31	*	CD	NUMBER	*	num	32	SENT_59	[p4l1932t2250r2141b2328],
32	3	CD	NUMBER	3	dep	29	SENT_59	[p4l1932t2250r2141b2328],
33	,	,	O	,	_	0	SENT_59	[p4l1932t2250r2141b2328],
34	9	CD	NUMBER	9	num	35	SENT_59	[p4l9t2357r44b2417],
35	(	NN	O	(	appos	32	SENT_59	[p4l88t2356r393b2434],
36	17.6	CD	PERCENT	17.6	number	37	SENT_59	[p4l88t2356r393b2434],
37	%	NN	PERCENT	%	amod	29	SENT_59	[p4l88t2356r393b2434],
38	)	CD	NUMBER	)	dep	29	SENT_59	[p4l88t2356r393b2434],
39	;	:	O	;	_	0	SENT_59	[p4l88t2356r393b2434],
40	*	CD	NUMBER	*	number	41	SENT_59	[p4l442t2356r651b2434],
41	2	CD	NUMBER	2	amod	47	SENT_59	[p4l442t2356r651b2434],
42	/	:	O	/	punct	44	SENT_59	[p4l442t2356r651b2434],
43	*	CD	NUMBER	*	num	44	SENT_59	[p4l442t2356r651b2434],
44	3	CD	NUMBER	3	dep	41	SENT_59	[p4l442t2356r651b2434],
45	,	,	O	,	_	0	SENT_59	[p4l442t2356r651b2434],
46	l	NN	O	l	tmod	44	SENT_59	[p4l703t2357r725b2416],
47	(	NN	O	(	dep	13	SENT_59	[p4l775t2356r972b2434],
48	2	CD	PERCENT	2	number	49	SENT_59	[p4l775t2356r972b2434],
49	%	NN	PERCENT	%	amod	47	SENT_59	[p4l775t2356r972b2434],
50	)	CD	NUMBER	)	tmod	13	SENT_59	[p4l775t2356r972b2434],
51	.	.	O	.	_	0	SENT_59	[p4l775t2356r972b2434],

1	All	DT	O	all	det	2	SENT_60	[p4l1016t2356r1124b2416],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_60	[p4l1165t2364r1520b2434],
3	were	VBD	O	be	_	0	SENT_60	[p4l1560t2376r1725b2417],
4	in	IN	O	in	_	0	SENT_60	[p4l1765t2356r1832b2416],
5	HardyWeinberg	NN	LOCATION	hardyweinberg	nn	6	SENT_60	[p4l1873t2356r2148b2434, p4l6t2461r354b2541],
6	equilibrium	NN	O	equilibrium	prep_in	3	SENT_60	[p4l403t2461r835b2540],
7	.	.	O	.	_	0	SENT_60	[p4l403t2461r835b2540],

1	A	DT	O	a	det	2	SENT_61	[p4l888t2462r950b2523],
2	mean	NN	O	mean	dep	6	SENT_61	[p4l997t2482r1191b2524],
3	of	IN	O	of	_	0	SENT_61	[p4l1241t2461r1319b2524],
4	3.9	CD	NUMBER	3.9	prep_of	2	SENT_61	[p4l1363t2463r1462b2524],
5	(	CD	NUMBER	(	dep	6	SENT_61	[p4l1514t2462r1600b2541],
6	i	FW	O	i	dep	18	SENT_61	[p4l1514t2462r1600b2541],
7	1.9	CD	NUMBER	1.9	num	8	SENT_61	[p4l1645t2462r1767b2540],
8	)	NN	O	)	dep	6	SENT_61	[p4l1645t2462r1767b2540],
9	and	CC	O	and	_	0	SENT_61	[p4l1819t2461r1950b2524],
10	16.1	CD	NUMBER	16.1	number	11	SENT_61	[p4l2007t2463r2137b2524],
11	(	CD	NUMBER	(	conj_and	6	SENT_61	[p4l9t2568r95b2646],
12	i	FW	O	i	dep	11	SENT_61	[p4l9t2568r95b2646],
13	8.1	CD	NUMBER	8.1	number	14	SENT_61	[p4l135t2568r263b2646],
14	)	CD	NUMBER	)	num	16	SENT_61	[p4l135t2568r263b2646],
15	INR	NN	O	inr	nn	16	SENT_61	[p4l319t2571r483b2629],
16	measurements	NNS	O	measurement	nsubjpass	18	SENT_61	[p4l535t2577r1044b2630],
17	were	VBD	O	be	auxpass	18	SENT_61	[p4l1098t2588r1262b2630],
18	taken	VBN	O	take	_	0	SENT_61	[p4l1317t2568r1514b2630],
19	within	IN	O	within	_	0	SENT_61	[p4l1566t2568r1793b2630],
20	the	DT	O	the	det	22	SENT_61	[p4l1847t2568r1954b2630],
21	ﬁrst	NN	O	ﬁrst	nn	22	SENT_61	[p4l2008t2568r2146b2630],
22	week	NN	DURATION	week	prep_within	18	SENT_61	[p4l7t2675r186b2736],
23	and	CC	O	and	_	0	SENT_61	[p4l219t2675r350b2736],
24	month	NN	DURATION	month	prep_within	18	SENT_61	[p4l381t2675r617b2736],
25	of	IN	O	of	_	0	SENT_61	[p4l650t2675r729b2736],
26	therapy	NN	O	therapy	prep_of	22	SENT_61	[p4l752t2675r1044b2753],
27	,	,	O	,	_	0	SENT_61	[p4l752t2675r1044b2753],
28	respectively	RB	O	respectively	advmod	18	SENT_61	[p4l1080t2675r1513b2753],
29	.	.	O	.	_	0	SENT_61	[p4l1080t2675r1513b2753],

1	Children	NNS	O	child	nsubj	15	SENT_62	[p4l94t2780r406b2843],
2	with	IN	O	with	_	0	SENT_62	[p4l437t2780r593b2843],
3	a	DT	O	a	det	9	SENT_62	[p4l627t2801r665b2843],
4	variant	JJ	O	variant	dep	5	SENT_62	[p4l696t2781r952b2843],
5	C	NN	O	c	amod	9	SENT_62	[p4l988t2783r1045b2843],
6	YP2C9	NN	O	yp2c9	nn	9	SENT_62	[p4l1056t2783r1304b2843],
7	allele	NN	O	allele	nn	9	SENT_62	[p4l1337t2781r1517b2843],
8	(	CD	NUMBER	(	num	9	SENT_62	[p4l1552t2781r1659b2860],
9	*	NN	O	*	prep_with	1	SENT_62	[p4l1552t2781r1659b2860],
10	2	CD	NUMBER	2	number	13	SENT_62	[p4l1552t2781r1659b2860],
11	or	CC	O	or	_	0	SENT_62	[p4l1693t2801r1768b2843],
12	*	CD	NUMBER	*	num	14	SENT_62	[p4l1804t2781r1907b2859],
13	3	CD	NUMBER	3	num	14	SENT_62	[p4l1804t2781r1907b2859],
14	)	NN	O	)	dep	9	SENT_62	[p4l1804t2781r1907b2859],
15	had	VBD	O	have	_	0	SENT_62	[p4l1941t2780r2074b2843],
16	a	DT	O	a	det	20	SENT_62	[p4l2108t2801r2146b2843],
17	higher	JJR	O	higher	amod	20	SENT_62	[p4l8t2887r233b2965],
18	mean	JJ	O	mean	amod	20	SENT_62	[p4l279t2907r473b2949],
19	peak	NN	O	peak	nn	20	SENT_62	[p4l520t2887r690b2965],
20	INR	NN	O	inr	dobj	15	SENT_62	[p4l739t2890r903b2948],
21	during	IN	O	during	_	0	SENT_62	[p4l951t2887r1185b2965],
22	week	NN	DURATION	week	prep_during	20	SENT_62	[p4l1232t2887r1411b2949],
23	1	CD	NUMBER	1	num	22	SENT_62	[p4l1467t2889r1490b2948],
24	than	IN	O	than	_	0	SENT_62	[p4l1546t2887r1706b2949],
25	those	DT	O	those	prep_than	15	SENT_62	[p4l1754t2887r1941b2949],
26	with	IN	O	with	_	0	SENT_62	[p4l1988t2887r2145b2949],
27	wild-type	JJ	O	wild-type	amod	28	SENT_62	[p4l7t2993r340b3071],
28	CYP2C9	NN	O	cyp2c9	prep_with	25	SENT_62	[p4l395t2995r730b3067],
29	,	,	O	,	_	0	SENT_62	[p4l395t2995r730b3067],
30	4.1	CD	NUMBER	4.1	appos	28	SENT_62	[p4l784t2994r880b3054],
31	:	:	O	:	_	0	SENT_62	[p4l925t2997r982b3054],
32	|	CD	NUMBER	|	num	34	SENT_62	[p4l925t2997r982b3054],
33	:	:	O	:	_	0	SENT_62	[p4l925t2997r982b3054],
34	1.7	CD	NUMBER	1.7	dep	28	SENT_62	[p4l1027t2995r1121b3054],
35	vs.	CC	O	vs.	prep	34	SENT_62	[p4l1172t3013r1262b3054],
36	3.2	CD	NUMBER	3.2	num	37	SENT_62	[p4l1320t2995r1421b3054],
37	:1	CD	NUMBER	:1	dep	35	SENT_62	[p4l1458t2997r1515b3054],
38	:	:	O	:	_	0	SENT_62	[p4l1458t2997r1515b3054],
39	1.4	CD	NUMBER	1.4	dep	28	SENT_62	[p4l1561t2994r1676b3067],
40	,	,	O	,	_	0	SENT_62	[p4l1561t2994r1676b3067],
41	respectively	RB	O	respectively	advmod	28	SENT_62	[p4l1729t2993r2145b3071],
42	(	CD	NUMBER	(	num	43	SENT_62	[p4l9t3100r91b3179],
43	P	NN	O	p	dep	28	SENT_62	[p4l9t3100r91b3179],
44	=	JJ	O	=	amod	43	SENT_62	[p4l139t3123r189b3140],
45	0.04	CD	NUMBER	0.04	tmod	44	SENT_62	[p4l240t3101r405b3175],
46	;	:	O	;	_	0	SENT_62	[p4l240t3101r405b3175],
47	Student	NN	O	student	poss	50	SENT_62	[p4l451t3099r780b3162],
48	’s	POS	O	’s	_	0	SENT_62	[p4l451t3099r780b3162],
49	t-test	NN	O	t-test	nn	50	SENT_62	[p4l826t3100r1047b3178],
50	)	NN	O	)	dep	43	SENT_62	[p4l826t3100r1047b3178],
51	.	.	O	.	_	0	SENT_62	[p4l826t3100r1047b3178],

1	The	DT	O	the	det	2	SENT_63	[p4l1092t3100r1228b3162],
2	child	NN	O	child	_	0	SENT_63	[p4l1268t3099r1441b3162],
3	with	IN	O	with	_	0	SENT_63	[p4l1480t3100r1637b3162],
4	the	DT	O	the	det	6	SENT_63	[p4l1677t3100r1784b3162],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_63	[p4l1829t3102r2145b3162],
6	*	NN	O	*	prep_with	2	SENT_63	[p4l12t3207r201b3285],
7	2	CD	NUMBER	2	dep	6	SENT_63	[p4l12t3207r201b3285],
8	/	:	O	/	punct	2	SENT_63	[p4l12t3207r201b3285],
9	*	CD	NUMBER	*	number	10	SENT_63	[p4l12t3207r201b3285],
10	3	CD	NUMBER	3	num	11	SENT_63	[p4l12t3207r201b3285],
11	genotype	NN	O	genotype	nsubj	12	SENT_63	[p4l268t3215r591b3285],
12	had	VBD	O	have	dep	2	SENT_63	[p4l657t3207r789b3268],
13	a	DT	O	a	det	15	SENT_63	[p4l856t3227r894b3268],
14	peak	JJ	O	peak	amod	15	SENT_63	[p4l958t3207r1129b3285],
15	INR	NN	O	inr	dobj	12	SENT_63	[p4l1195t3209r1359b3268],
16	in	IN	O	in	_	0	SENT_63	[p4l1423t3207r1490b3267],
17	week	NN	DURATION	week	prep_in	15	SENT_63	[p4l1555t3207r1734b3268],
18	1	CD	NUMBER	1	num	17	SENT_63	[p4l1808t3208r1830b3267],
19	of	IN	O	of	_	0	SENT_63	[p4l1906t3207r1983b3268],
20	5.5	CD	NUMBER	5.5	number	21	SENT_63	[p4l2044t3209r2142b3268],
21	(	CD	NUMBER	(	num	22	SENT_63	[p4l9t3313r172b3392],
22	Fig	NN	O	fig	prep_of	17	SENT_63	[p4l9t3313r172b3392],
23	.	.	O	.	_	0	SENT_63	[p4l9t3313r172b3392],

1	1A	NN	O	1a	_	0	SENT_64	[p4l225t3313r367b3391],
2	)	NN	O	)	dep	1	SENT_64	[p4l225t3313r367b3391],
3	.	.	O	.	_	0	SENT_64	[p4l225t3313r367b3391],

1	Children	NNS	O	child	nsubj	7	SENT_65	[p4l412t3312r724b3375],
2	with	IN	O	with	_	0	SENT_65	[p4l762t3312r919b3375],
3	the	DT	O	the	det	6	SENT_65	[p4l958t3313r1065b3375],
4	VKORCI	NNP	O	VKORCI	nn	6	SENT_65	[p4l1116t3315r1449b3375],
5	AA	NNP	O	AA	nn	6	SENT_65	[p4l1492t3315r1607b3374],
6	genotype	NN	O	genotype	prep_with	1	SENT_65	[p4l1650t3321r1973b3392],
7	had	VBD	O	have	dep	32	SENT_65	[p4l2012t3312r2145b3375],
8	a	DT	O	a	dobj	7	SENT_65	[p4l9t3439r47b3481],
9	higher	JJR	O	higher	amod	10	SENT_65	[p4l84t3419r310b3497],
10	mean	NN	O	mean	dep	15	SENT_65	[p4l346t3439r539b3481],
11	peak	JJ	O	peak	amod	12	SENT_65	[p4l576t3419r747b3497],
12	INR	NN	O	inr	dep	10	SENT_65	[p4l785t3422r949b3480],
13	(	NN	O	(	dep	15	SENT_65	[p4l988t3419r1110b3497],
14	5.1	CD	NUMBER	5.1	num	13	SENT_65	[p4l988t3419r1110b3497],
15	i	FW	O	i	dep	8	SENT_65	[p4l1156t3423r1212b3480],
16	2.1	CD	NUMBER	2.1	num	17	SENT_65	[p4l1250t3420r1380b3497],
17	)	NN	O	)	dep	15	SENT_65	[p4l1250t3420r1380b3497],
18	than	IN	O	than	_	0	SENT_65	[p4l1420t3419r1580b3481],
19	those	DT	O	those	prep_than	17	SENT_65	[p4l1618t3419r1805b3481],
20	with	IN	O	with	_	0	SENT_65	[p4l1842t3419r1999b3481],
21	the	DT	O	the	det	22	SENT_65	[p4l2037t3419r2144b3481],
22	GA	NN	O	ga	prep_with	17	SENT_65	[p4l11t3527r122b3587],
23	(	CD	NUMBER	(	number	24	SENT_65	[p4l179t3525r307b3603],
24	3.5	CD	NUMBER	3.5	num	22	SENT_65	[p4l179t3525r307b3603],
25	:	:	O	:	_	0	SENT_65	[p4l347t3529r404b3586],
26	|	CD	NUMBER	|	dep	15	SENT_65	[p4l347t3529r404b3586],
27	:	:	O	:	_	0	SENT_65	[p4l347t3529r404b3586],
28	1.4	CD	NUMBER	1.4	num	29	SENT_65	[p4l449t3525r572b3603],
29	)	CD	NUMBER	)	dep	15	SENT_65	[p4l449t3525r572b3603],
30	or	CC	O	or	_	0	SENT_65	[p4l626t3545r701b3586],
31	GG	NNS	O	gg	dep	15	SENT_65	[p4l755t3527r871b3587],
32	(	VBP	O	(	_	0	SENT_65	[p4l923t3525r1052b3603],
33	3.0	CD	NUMBER	3.0	num	34	SENT_65	[p4l923t3525r1052b3603],
34	:1	CD	NUMBER	:1	dobj	32	SENT_65	[p4l1091t3529r1148b3586],
35	:	:	O	:	_	0	SENT_65	[p4l1091t3529r1148b3586],
36	1.3	CD	NUMBER	1.3	number	37	SENT_65	[p4l1193t3525r1315b3603],
37	)	CD	NUMBER	)	num	38	SENT_65	[p4l1193t3525r1315b3603],
38	genotype	NN	O	genotype	dep	34	SENT_65	[p4l1369t3534r1692b3603],
39	(	CD	NUMBER	(	num	40	SENT_65	[p4l1745t3525r1827b3603],
40	P	NN	O	p	dep	38	SENT_65	[p4l1745t3525r1827b3603],
41	=	JJ	O	=	amod	42	SENT_65	[p4l1875t3548r1925b3566],
42	0.01	CD	NUMBER	0.01	nsubj	32	SENT_65	[p4l1976t3527r2141b3599],
43	,	,	O	,	_	0	SENT_65	[p4l1976t3527r2141b3599],
44	regression	NN	O	regression	nn	45	SENT_65	[p4l8t3632r368b3711],
45	analysis	NN	O	analysis	appos	42	SENT_65	[p4l425t3632r732b3711],
46	)	CD	NUMBER	)	number	47	SENT_65	[p4l425t3632r732b3711],
47	(	CD	NUMBER	(	num	48	SENT_65	[p4l791t3632r953b3711],
48	Fig	NN	O	fig	dep	45	SENT_65	[p4l791t3632r953b3711],
49	.	.	O	.	_	0	SENT_65	[p4l791t3632r953b3711],

1	1B	NN	O	1b	_	0	SENT_66	[p4l1022t3632r1155b3710],
2	)	NN	O	)	dep	1	SENT_66	[p4l1022t3632r1155b3710],
3	.	.	O	.	_	0	SENT_66	[p4l1022t3632r1155b3710],

1	Children	NNS	O	child	_	0	SENT_67	[p4l1218t3631r1529b3694],
2	with	IN	O	with	_	0	SENT_67	[p4l1584t3631r1741b3694],
3	a	DT	O	a	det	4	SENT_67	[p4l1797t3652r1835b3694],
4	variant	NN	O	variant	prep_with	1	SENT_67	[p4l1890t3632r2145b3694],

1	C	NN	O	c	nn	3	SENT_68	[p5l12t23r69b82],
2	YP2C9	NN	O	yp2c9	nn	3	SENT_68	[p5l80t22r328b82],
3	allele	NN	O	allele	nsubj	4	SENT_68	[p5l375t20r555b82],
4	had	VBD	O	have	_	0	SENT_68	[p5l601t20r733b82],
5	a	DT	O	a	det	7	SENT_68	[p5l780t40r818b82],
6	greater	JJR	O	greater	amod	7	SENT_68	[p5l864t29r1113b98],
7	proportion	NN	O	proportion	dobj	4	SENT_68	[p5l1157t20r1552b98],
8	of	IN	O	of	_	0	SENT_68	[p5l1599t20r1677b82],
9	INR	NN	O	inr	nn	10	SENT_68	[p5l1715t23r1879b81],
10	values	NNS	O	value	prep_of	7	SENT_68	[p5l1923t20r2144b82],
11	above	IN	O	above	_	0	SENT_68	[p5l9t126r219b187],
12	the	DT	O	the	det	15	SENT_68	[p5l274t126r381b187],
13	target	NN	O	target	nn	15	SENT_68	[p5l436t135r643b204],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_68	[p5l697t126r1099b204],
15	range	NN	O	range	prep_above	4	SENT_68	[p5l1153t146r1350b204],
16	during	IN	O	during	_	0	SENT_68	[p5l1405t126r1639b204],
17	month	NN	DURATION	month	prep_during	4	SENT_68	[p5l1691t126r1928b187],
18	1	CD	NUMBER	1	num	17	SENT_68	[p5l1989t128r2011b187],
19	of	IN	O	of	_	0	SENT_68	[p5l2075t126r2153b187],
20	warfarin	NN	O	warfarin	nn	21	SENT_68	[p5l7t232r313b295],
21	therapy	NN	O	therapy	prep_of	17	SENT_68	[p5l377t232r649b312],
22	than	IN	O	than	_	0	SENT_68	[p5l713t233r873b295],
23	those	DT	O	those	prep_than	4	SENT_68	[p5l937t232r1123b295],
24	with	IN	O	with	_	0	SENT_68	[p5l1186t232r1343b295],
25	wild-type	JJ	O	wild-type	amod	26	SENT_68	[p5l1404t232r1737b312],
26	CYP2C9	NN	O	cyp2c9	prep_with	23	SENT_68	[p5l1807t235r2141b308],
27	;	:	O	;	_	0	SENT_68	[p5l1807t235r2141b308],
28	19.3	CD	PERCENT	19.3	num	29	SENT_68	[p5l16t341r232b402],
29	%	NN	PERCENT	%	dep	23	SENT_68	[p5l16t341r232b402],
30	vs.	CC	O	vs.	prep	29	SENT_68	[p5l273t360r363b401],
31	15.9	CD	PERCENT	15.9	num	32	SENT_68	[p5l411t341r654b414],
32	%	NN	PERCENT	%	dep	30	SENT_68	[p5l411t341r654b414],
33	,	,	O	,	_	0	SENT_68	[p5l411t341r654b414],
34	respectively	RB	O	respectively	advmod	36	SENT_68	[p5l692t340r1108b418],
35	(	CD	NUMBER	(	num	36	SENT_68	[p5l1144t340r1225b418],
36	P	NN	O	p	appos	32	SENT_68	[p5l1144t340r1225b418],
37	=	JJ	O	=	amod	36	SENT_68	[p5l1273t363r1324b380],
38	0.08	CD	NUMBER	0.08	tmod	37	SENT_68	[p5l1375t342r1540b414],
39	;	:	O	;	_	0	SENT_68	[p5l1375t342r1540b414],
40	Mann	NNP	PERSON	Mann	dep	23	SENT_68	[p5l1579t340r2146b418],
41	.	.	O	.	_	0	SENT_68	[p5l1579t340r2146b418],

1	—	NN	O	—	_	0	SENT_69	[p5l1579t340r2146b418],
2	.	.	O	.	_	0	SENT_69	[p5l1579t340r2146b418],

1	Whitney	NNP	PERSON	Whitney	_	0	SENT_70	[p5l1579t340r2146b418],
2	U-test	JJ	O	u-test	amod	3	SENT_70	[p5l17t446r270b524],
3	)	NN	O	)	dep	1	SENT_70	[p5l17t446r270b524],
4	.	.	O	.	_	0	SENT_70	[p5l17t446r270b524],

1	The	DT	O	the	det	3	SENT_71	[p5l310t445r447b508],
2	single	JJ	O	single	amod	3	SENT_71	[p5l484t446r683b525],
3	child	NN	O	child	nsubj	10	SENT_71	[p5l719t445r891b508],
4	with	IN	O	with	_	0	SENT_71	[p5l926t445r1082b508],
5	two	CD	NUMBER	two	num	9	SENT_71	[p5l1118t455r1248b508],
6	variant	JJ	O	variant	amod	9	SENT_71	[p5l1284t446r1540b508],
7	C	NN	O	c	nn	9	SENT_71	[p5l1580t448r1636b508],
8	YP2C9	NN	O	yp2c9	nn	9	SENT_71	[p5l1648t448r1895b508],
9	alleles	NNS	O	allele	prep_with	3	SENT_71	[p5l1932t446r2144b508],
10	(	VBP	O	(	_	0	SENT_71	[p5l9t552r118b630],
11	*	NN	O	*	nsubj	17	SENT_71	[p5l9t552r118b630],
12	2	CD	NUMBER	2	num	11	SENT_71	[p5l9t552r118b630],
13	and	CC	O	and	_	0	SENT_71	[p5l156t552r287b614],
14	*	CD	NUMBER	*	number	15	SENT_71	[p5l328t552r431b630],
15	3	CD	NUMBER	3	num	16	SENT_71	[p5l328t552r431b630],
16	)	NN	O	)	conj_and	11	SENT_71	[p5l328t552r431b630],
17	had	VBD	O	have	ccomp	10	SENT_71	[p5l470t552r603b614],
18	63.1	CD	PERCENT	63.1	num	19	SENT_71	[p5l642t553r865b615],
19	%	NN	PERCENT	%	dobj	17	SENT_71	[p5l642t553r865b615],
20	of	IN	O	of	_	0	SENT_71	[p5l911t552r989b614],
21	the	DT	O	the	det	23	SENT_71	[p5l1018t552r1125b614],
22	INR	NN	O	inr	nn	23	SENT_71	[p5l1164t555r1328b613],
23	values	NNS	O	value	prep_of	19	SENT_71	[p5l1364t552r1584b614],
24	above	IN	O	above	_	0	SENT_71	[p5l1624t552r1834b614],
25	the	DT	O	the	det	27	SENT_71	[p5l1872t552r1979b614],
26	target	NN	O	target	nn	27	SENT_71	[p5l2017t561r2143b614, p5l8t667r112b736],
27	range	NN	O	range	prep_above	23	SENT_71	[p5l172t678r370b736],
28	during	IN	O	during	_	0	SENT_71	[p5l431t658r666b736],
29	the	DT	O	the	det	31	SENT_71	[p5l726t658r834b719],
30	same	JJ	O	same	amod	31	SENT_71	[p5l897t678r1073b719],
31	period	NN	O	period	prep_during	17	SENT_71	[p5l1133t658r1381b736],
32	.	.	O	.	_	0	SENT_71	[p5l1133t658r1381b736],

1	Children	NNS	O	child	nsubj	7	SENT_72	[p5l1448t658r1760b720],
2	with	IN	O	with	_	0	SENT_72	[p5l1820t658r1976b719],
3	the	DT	O	the	det	6	SENT_72	[p5l2037t658r2144b719],
4	VKORCI	NNP	O	VKORCI	nn	6	SENT_72	[p5l19t767r351b827],
5	AA	NNP	O	AA	nn	6	SENT_72	[p5l392t767r507b826],
6	genotype	NN	O	genotype	prep_with	1	SENT_72	[p5l549t773r872b844],
7	had	VBD	O	have	_	0	SENT_72	[p5l909t764r1041b827],
8	a	DT	O	a	det	10	SENT_72	[p5l1080t785r1118b827],
9	greater	JJR	O	greater	amod	10	SENT_72	[p5l1155t773r1405b844],
10	proportion	NN	O	proportion	dobj	7	SENT_72	[p5l1440t765r1835b844],
11	of	IN	O	of	_	0	SENT_72	[p5l1874t765r1952b827],
12	INR	NN	O	inr	nn	13	SENT_72	[p5l1982t767r2146b826],
13	values	NNS	O	value	prep_of	10	SENT_72	[p5l7t871r227b933],
14	above	IN	O	above	_	0	SENT_72	[p5l275t871r485b933],
15	the	DT	O	the	det	17	SENT_72	[p5l531t871r638b933],
16	target	NN	O	target	nn	17	SENT_72	[p5l684t880r892b949],
17	range	NN	O	range	prep_above	7	SENT_72	[p5l936t891r1133b949],
18	during	IN	O	during	_	0	SENT_72	[p5l1179t871r1413b949],
19	the	DT	DATE	the	det	21	SENT_72	[p5l1459t871r1566b933],
20	ﬁrst	JJ	DATE	ﬁrst	amod	21	SENT_72	[p5l1611t871r1749b933],
21	month	NN	DATE	month	prep_during	7	SENT_72	[p5l1793t871r2029b933],
22	of	IN	O	of	_	0	SENT_72	[p5l2075t871r2153b933],
23	warfarin	NN	O	warfarin	nn	24	SENT_72	[p5l7t977r313b1039],
24	therapy	NN	O	therapy	prep_of	21	SENT_72	[p5l391t977r663b1055],
25	(	CD	PERCENT	(	number	26	SENT_72	[p5l742t977r1026b1055],
26	21.5	CD	PERCENT	21.5	dep	27	SENT_72	[p5l742t977r1026b1055],
27	%	NN	PERCENT	%	dep	24	SENT_72	[p5l742t977r1026b1055],
28	)	CD	NUMBER	)	dep	7	SENT_72	[p5l742t977r1026b1055],
29	than	IN	O	than	mark	40	SENT_72	[p5l1106t977r1266b1038],
30	those	DT	O	those	nsubj	40	SENT_72	[p5l1343t977r1531b1038],
31	with	IN	O	with	_	0	SENT_72	[p5l1607t977r1764b1038],
32	the	DT	O	the	det	33	SENT_72	[p5l1841t977r1949b1038],
33	GA	NN	O	ga	prep_with	30	SENT_72	[p5l2030t979r2141b1039],
34	(	CD	PERCENT	(	number	35	SENT_72	[p5l9t1084r293b1163],
35	17.6	CD	PERCENT	17.6	num	36	SENT_72	[p5l9t1084r293b1163],
36	%	NN	PERCENT	%	dep	33	SENT_72	[p5l9t1084r293b1163],
37	)	CD	NUMBER	)	dep	33	SENT_72	[p5l9t1084r293b1163],
38	or	CC	O	or	_	0	SENT_72	[p5l340t1104r415b1146],
39	GG	NNS	PERCENT	gg	conj_or	33	SENT_72	[p5l461t1086r576b1146],
40	(	VBP	PERCENT	(	dep	28	SENT_72	[p5l621t1084r905b1163],
41	17.2	CD	PERCENT	17.2	num	42	SENT_72	[p5l621t1084r905b1163],
42	%	NN	PERCENT	%	dobj	40	SENT_72	[p5l621t1084r905b1163],
43	)	CD	NUMBER	)	num	44	SENT_72	[p5l621t1084r905b1163],
44	genotype	NN	O	genotype	dep	50	SENT_72	[p5l951t1092r1274b1163],
45	although	IN	O	although	dep	50	SENT_72	[p5l1319t1083r1638b1163],
46	this	DT	O	this	nsubj	50	SENT_72	[p5l1681t1083r1807b1146],
47	was	VBD	O	be	cop	50	SENT_72	[p5l1850t1104r1982b1146],
48	not	RB	O	not	neg	50	SENT_72	[p5l2026t1093r2145b1146],
49	statistically	RB	O	statistically	advmod	50	SENT_72	[p5l10t1191r410b1269],
50	signiﬁcant	JJ	O	signiﬁcant	dep	40	SENT_72	[p5l451t1191r832b1269],
51	.	.	O	.	_	0	SENT_72	[p5l451t1191r832b1269],

1	There	EX	O	there	expl	2	SENT_73	[p5l875t1191r1080b1252],
2	was	VBD	O	be	ccomp	24	SENT_73	[p5l1119t1211r1251b1252],
3	no	DT	O	no	det	4	SENT_73	[p5l1290t1211r1378b1252],
4	association	NN	O	association	nsubj	2	SENT_73	[p5l1420t1191r1817b1252],
5	between	IN	O	between	_	0	SENT_73	[p5l1855t1191r2145b1252],
6	genotype	NN	O	genotype	prep_between	4	SENT_73	[p5l8t1305r331b1376],
7	and	CC	O	and	_	0	SENT_73	[p5l374t1296r505b1359],
8	time	NN	O	time	prep_between	4	SENT_73	[p5l546t1297r699b1359],
9	to	TO	O	to	aux	10	SENT_73	[p5l741t1306r810b1359],
10	ﬁrst	VB	O	ﬁrst	infmod	4	SENT_73	[p5l852t1297r990b1359],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_73	[p5l1030t1297r1433b1376],
12	INR	NN	O	inr	dobj	10	SENT_73	[p5l1474t1299r1657b1372],
13	,	,	O	,	_	0	SENT_73	[p5l1474t1299r1657b1372],
14	time	NN	O	time	appos	12	SENT_73	[p5l1701t1297r1855b1359],
15	to	TO	O	to	aux	16	SENT_73	[p5l1897t1305r1966b1359],
16	ﬁrst	VB	O	ﬁrst	infmod	14	SENT_73	[p5l2008t1297r2146b1359],
17	supra-therapeutic	JJ	O	supra-therapeutic	amod	18	SENT_73	[p5l10t1403r640b1481],
18	INR	NN	O	inr	dobj	16	SENT_73	[p5l701t1406r884b1477],
19	,	,	O	,	_	0	SENT_73	[p5l701t1406r884b1477],
20	number	NN	O	number	nsubj	24	SENT_73	[p5l949t1403r1226b1465],
21	of	IN	O	of	_	0	SENT_73	[p5l1288t1403r1366b1465],
22	INR	NN	O	inr	nn	23	SENT_73	[p5l1419t1406r1583b1464],
23	values	NNS	O	value	prep_of	20	SENT_73	[p5l1642t1403r1863b1465],
24	>	JJR	O	>	_	0	SENT_73	[p5l1942t1415r1990b1455],
25	4.0	CD	NUMBER	4.0	num	26	SENT_73	[p5l2041t1405r2144b1465],
26	(	NN	O	(	dobj	24	SENT_73	[p5l9t1509r271b1587],
27	during	IN	O	during	_	0	SENT_73	[p5l9t1509r271b1587],
28	the	DT	DATE	the	det	30	SENT_73	[p5l311t1509r418b1570],
29	ﬁrst	JJ	DATE	ﬁrst	amod	30	SENT_73	[p5l458t1509r595b1570],
30	month	NN	DATE	month	prep_during	26	SENT_73	[p5l633t1509r870b1570],
31	or	CC	O	or	_	0	SENT_73	[p5l910t1529r985b1570],
32	the	DT	O	the	det	33	SENT_73	[p5l1024t1509r1132b1570],
33	ﬁrst	NN	O	ﬁrst	dobj	24	SENT_73	[p5l1171t1509r1309b1570],
34	3	CD	DURATION	3	num	35	SENT_73	[p5l1351t1511r1383b1570],
35	months	NNS	NUMBER	month	npadvmod	33	SENT_73	[p5l1421t1509r1688b1570],
36	of	IN	O	of	_	0	SENT_73	[p5l1730t1509r1808b1570],
37	warfarin	NN	O	warfarin	nn	39	SENT_73	[p5l1838t1509r2145b1570],
38	therapy	NN	O	therapy	nn	39	SENT_73	[p5l8t1615r328b1695],
39	)	NN	O	)	prep_of	33	SENT_73	[p5l8t1615r328b1695],
40	,	,	O	,	_	0	SENT_73	[p5l8t1615r328b1695],
41	time	NN	O	time	appos	39	SENT_73	[p5l369t1616r522b1678],
42	to	TO	O	to	_	0	SENT_73	[p5l560t1625r629b1678],
43	stable	JJ	O	stable	amod	45	SENT_73	[p5l670t1615r874b1678],
44	warfarin	NN	O	warfarin	nn	45	SENT_73	[p5l910t1616r1217b1678],
45	dose	NN	O	dose	prep_to	24	SENT_73	[p5l1254t1615r1413b1678],
46	or	CC	O	or	_	0	SENT_73	[p5l1452t1636r1527b1678],
47	number	NN	O	number	prep_to	24	SENT_73	[p5l1563t1615r1840b1678],
48	of	IN	O	of	_	0	SENT_73	[p5l1878t1616r1955b1678],
49	warfarin	NN	O	warfarin	nn	51	SENT_73	[p5l1983t1636r2143b1678, p5l8t1722r177b1784],
50	dose	NN	O	dose	nn	51	SENT_73	[p5l212t1722r371b1784],
51	changes	NNS	O	change	prep_of	45	SENT_73	[p5l405t1722r705b1800],
52	.	.	O	.	_	0	SENT_73	[p5l405t1722r705b1800],

1	No	DT	O	no	det	5	SENT_74	[p5l742t1725r854b1784],
2	hemorrhagic	JJ	O	hemorrhagic	amod	5	SENT_74	[p5l891t1722r1345b1800],
3	or	CC	O	or	_	0	SENT_74	[p5l1380t1742r1454b1784],
4	thrombotic	JJ	O	thrombotic	conj_or	2	SENT_74	[p5l1488t1722r1891b1784],
5	events	NNS	O	event	nsubj	6	SENT_74	[p5l1924t1731r2144b1784],
6	occurred	VBD	O	occur	_	0	SENT_74	[p5l9t1828r321b1889],
7	during	IN	O	during	_	0	SENT_74	[p5l360t1828r595b1906],
8	the	DT	O	the	det	9	SENT_74	[p5l634t1828r741b1889],
9	initiation	NN	O	initiation	prep_during	6	SENT_74	[p5l780t1828r1108b1889],
10	of	IN	O	of	_	0	SENT_74	[p5l1149t1828r1226b1889],
11	warfarin	NN	O	warfarin	nn	12	SENT_74	[p5l1256t1828r1563b1889],
12	therapy	NN	O	therapy	prep_of	9	SENT_74	[p5l1602t1828r1875b1906],
13	in	IN	O	in	_	0	SENT_74	[p5l1912t1828r1979b1889],
14	this	DT	O	this	det	15	SENT_74	[p5l2018t1828r2143b1889],
15	cohort	NN	O	cohort	prep_in	6	SENT_74	[p5l7t1934r243b1997],
16	in	IN	O	in	_	0	SENT_74	[p5l274t1935r340b1996],
17	spite	NN	O	spite	_	0	SENT_74	[p5l374t1935r536b2014],
18	of	IN	O	of	_	0	SENT_74	[p5l570t1934r648b1997],
19	a	DT	O	a	det	21	SENT_74	[p5l673t1955r710b1997],
20	peak	JJ	O	peak	amod	21	SENT_74	[p5l741t1934r912b2014],
21	INR	NN	O	inr	prep_in_spite_of	15	SENT_74	[p5l945t1937r1109b1996],
22	of	IN	O	of	_	0	SENT_74	[p5l1141t1935r1219b1997],
23	>	JJR	O	>	prep_of	21	SENT_74	[p5l1260t1946r1307b1987],
24	5.0	CD	NUMBER	5.0	dobj	6	SENT_74	[p5l1363t1937r1462b1997],
25	in	IN	O	in	_	0	SENT_74	[p5l1495t1935r1561b1996],
26	10	CD	NUMBER	10	num	27	SENT_74	[p5l1600t1936r1672b1997],
27	patients	NNS	O	patient	prep_in	24	SENT_74	[p5l1705t1935r2005b2014],
28	.	.	O	.	_	0	SENT_74	[p5l1705t1935r2005b2014],

1	Currently	RB	DATE	currently	advmod	11	SENT_75	[p5l94t2042r439b2120],
2	accepted	VBN	O	accept	amod	4	SENT_75	[p5l486t2042r793b2120],
3	dosing	NN	O	dosing	nn	4	SENT_75	[p5l839t2042r1074b2120],
4	regimes	NNS	O	regime	nsubjpass	11	SENT_75	[p5l1119t2042r1388b2120],
5	for	IN	O	for	_	0	SENT_75	[p5l1435t2042r1539b2103],
6	warfarin	NN	O	warfarin	nn	7	SENT_75	[p5l1582t2042r1889b2103],
7	initiation	NN	O	initiation	prep_for	4	SENT_75	[p5l1933t2042r2142b2103, p5l8t2148r147b2210],
8	in	IN	O	in	_	0	SENT_75	[p5l182t2148r248b2209],
9	children	NNS	O	child	prep_in	7	SENT_75	[p5l284t2147r567b2210],
10	are	VBP	O	be	auxpass	11	SENT_75	[p5l605t2168r711b2210],
11	based	VBN	O	base	_	0	SENT_75	[p5l747t2147r945b2210],
12	only	RB	O	only	advmod	11	SENT_75	[p5l984t2148r1135b2226],
13	on	IN	O	on	_	0	SENT_75	[p5l1173t2168r1260b2210],
14	the	DT	O	the	det	15	SENT_75	[p5l1297t2147r1402b2210],
15	patient	NN	O	patient	poss	20	SENT_75	[p5l1438t2148r1736b2227],
16	’s	POS	O	’s	_	0	SENT_75	[p5l1438t2148r1736b2227],
17	weight	NN	O	weight	nn	20	SENT_75	[p5l1772t2148r2004b2227],
18	[	NN	O	[	nn	20	SENT_75	[p5l2043t2149r2140b2226],
19	6	CD	NUMBER	6	num	20	SENT_75	[p5l2043t2149r2140b2226],
20	]	NN	O	]	prep_on	11	SENT_75	[p5l2043t2149r2140b2226],
21	.	.	O	.	_	0	SENT_75	[p5l2043t2149r2140b2226],

1	Although	IN	O	although	mark	10	SENT_76	[p5l7t2254r350b2332],
2	concurrent	JJ	O	concurrent	amod	3	SENT_76	[p5l402t2263r791b2316],
3	medication	NN	O	medication	nsubjpass	10	SENT_76	[p5l842t2254r1240b2316],
4	and	CC	O	and	_	0	SENT_76	[p5l1294t2254r1425b2316],
5	liver	NN	O	liver	nn	6	SENT_76	[p5l1477t2254r1632b2316],
6	function	NN	O	function	conj_and	3	SENT_76	[p5l1684t2254r1984b2316],
7	are	VBP	O	be	auxpass	10	SENT_76	[p5l2038t2274r2144b2316],
8	also	RB	O	also	advmod	10	SENT_76	[p5l9t2360r147b2421],
9	often	RB	O	often	advmod	10	SENT_76	[p5l225t2360r407b2421],
10	considered	VBN	O	consider	advcl	30	SENT_76	[p5l480t2360r883b2434],
11	,	,	O	,	_	0	SENT_76	[p5l480t2360r883b2434],
12	adjustments	NNS	O	adjustment	nsubjpass	30	SENT_76	[p5l962t2360r1390b2438],
13	in	IN	O	in	_	0	SENT_76	[p5l1465t2360r1532b2421],
14	warfarin	NN	O	warfarin	nn	15	SENT_76	[p5l1605t2360r1911b2421],
15	dose	NN	O	dose	prep_in	12	SENT_76	[p5l1985t2360r2144b2421],
16	according	VBG	O	accord	_	0	SENT_76	[p5l9t2466r359b2546],
17	to	TO	O	to	prepc_according_to	15	SENT_76	[p5l401t2476r470b2529],
18	other	JJ	O	other	amod	19	SENT_76	[p5l515t2467r702b2529],
19	factors	NNS	O	factor	pobj	15	SENT_76	[p5l743t2466r987b2529],
20	which	WDT	O	which	nsubj	22	SENT_76	[p5l1028t2466r1241b2529],
21	may	MD	O	may	aux	22	SENT_76	[p5l1281t2487r1433b2545],
22	inﬂuence	VB	O	inﬂuence	rcmod	15	SENT_76	[p5l1474t2467r1792b2529],
23	the	DT	O	the	det	26	SENT_76	[p5l1835t2467r1942b2529],
24	warfarin	NN	O	warfarin	nn	26	SENT_76	[p5l1983t2487r2143b2529, p5l8t2573r177b2635],
25	dose	NN	O	dose	nn	26	SENT_76	[p5l231t2573r389b2635],
26	requirement	NN	O	requirement	dobj	22	SENT_76	[p5l443t2573r877b2651],
27	are	VBP	O	be	auxpass	30	SENT_76	[p5l931t2593r1037b2635],
28	not	RB	O	not	dep	29	SENT_76	[p5l1090t2582r1209b2635],
29	uniformly	RB	O	uniformly	advmod	30	SENT_76	[p5l1261t2573r1618b2651],
30	applied	VBN	O	apply	_	0	SENT_76	[p5l1671t2573r1950b2651],
31	.	.	O	.	_	0	SENT_76	[p5l1671t2573r1950b2651],

1	The	DT	O	the	det	2	SENT_77	[p5l2009t2573r2145b2635],
2	role	NN	O	role	nsubjpass	20	SENT_77	[p5l7t2680r143b2742],
3	of	IN	O	of	_	0	SENT_77	[p5l185t2680r263b2742],
4	genetic	JJ	O	genetic	amod	5	SENT_77	[p5l296t2680r544b2759],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_77	[p5l582t2679r1138b2759],
6	in	IN	O	in	_	0	SENT_77	[p5l1180t2680r1246b2741],
7	determining	VBG	O	determine	prepc_in	5	SENT_77	[p5l1287t2679r1716b2759],
8	a	DT	O	a	det	9	SENT_77	[p5l1757t2700r1795b2742],
9	response	NN	O	response	dobj	7	SENT_77	[p5l1836t2700r2144b2759],
10	to	TO	O	to	_	0	SENT_77	[p5l8t2795r77b2848],
11	warfarin	NN	O	warfarin	prep_to	7	SENT_77	[p5l116t2787r423b2848],
12	during	IN	O	during	_	0	SENT_77	[p5l463t2787r697b2865],
13	the	DT	O	the	det	15	SENT_77	[p5l737t2787r844b2848],
14	initiation	NN	O	initiation	nn	15	SENT_77	[p5l883t2787r1211b2848],
15	phase	NN	O	phase	prep_during	7	SENT_77	[p5l1249t2787r1451b2865],
16	of	IN	O	of	_	0	SENT_77	[p5l1493t2787r1570b2848],
17	therapy	NN	O	therapy	prep_of	15	SENT_77	[p5l1602t2787r1875b2865],
18	is	VBZ	O	be	auxpass	20	SENT_77	[p5l1912t2787r1964b2848],
19	well	RB	O	well	advmod	20	SENT_77	[p5l2003t2787r2145b2848],
20	established	VBN	O	establish	_	0	SENT_77	[p5l7t2892r400b2955],
21	in	IN	O	in	_	0	SENT_77	[p5l469t2893r536b2954],
22	adult	JJ	O	adult	amod	24	SENT_77	[p5l608t2892r791b2955],
23	patient	NN	O	patient	nn	24	SENT_77	[p5l859t2893r1109b2972],
24	populations	NNS	O	population	prep_in	20	SENT_77	[p5l1178t2893r1604b2972],
25	with	IN	O	with	_	0	SENT_77	[p5l1675t2893r1831b2955],
26	studies	NNS	O	study	prep_with	20	SENT_77	[p5l1903t2892r2143b2955],
27	showing	VBG	O	show	ccomp	20	SENT_77	[p5l9t2999r303b3077],
28	that	IN	O	that	complm	57	SENT_77	[p5l364t2999r506b3061],
29	individuals	NNS	O	individual	nsubj	57	SENT_77	[p5l565t2999r958b3061],
30	with	IN	O	with	_	0	SENT_77	[p5l1018t2999r1175b3061],
31	C	NN	O	c	nn	32	SENT_77	[p5l1240t3001r1296b3061],
32	YP2C9	NN	O	yp2c9	prep_with	29	SENT_77	[p5l1308t3001r1555b3061],
33	variant	JJ	O	variant	amod	34	SENT_77	[p5l1614t2999r1870b3061],
34	alleles	NNS	O	allele	nsubj	35	SENT_77	[p5l1931t2999r2143b3061],
35	have	VBP	O	have	rcmod	32	SENT_77	[p5l7t3105r172b3166],
36	a	DT	O	a	det	38	SENT_77	[p5l258t3125r296b3166],
37	higher	JJR	O	higher	amod	38	SENT_77	[p5l381t3105r607b3183],
38	incidence	NN	O	incidence	nsubj	43	SENT_77	[p5l690t3105r1021b3166],
39	of	IN	O	of	_	0	SENT_77	[p5l1109t3105r1187b3166],
40	supra-therapeutic	JJ	O	supra-therapeutic	amod	41	SENT_77	[p5l1265t3105r1896b3183],
41	INR	NN	O	inr	prep_of	38	SENT_77	[p5l1981t3107r2146b3166],
42	(	CD	NUMBER	(	npadvmod	43	SENT_77	[p5l9t3212r100b3291],
43	>	JJR	O	>	xcomp	35	SENT_77	[p5l9t3212r100b3291],
44	4.0	CD	NUMBER	4.0	num	45	SENT_77	[p5l151t3212r282b3290],
45	)	NN	O	)	dep	32	SENT_77	[p5l151t3212r282b3290],
46	[	CD	NUMBER	[	number	47	SENT_77	[p5l340t3213r615b3290],
47	1,2,7,8	CD	NUMBER	1,2,7,8	num	48	SENT_77	[p5l340t3213r615b3290],
48	]	NN	O	]	dep	32	SENT_77	[p5l340t3213r615b3290],
49	and	CC	O	and	_	0	SENT_77	[p5l673t3211r804b3274],
50	a	DT	O	a	det	52	SENT_77	[p5l858t3232r896b3274],
51	higher	JJR	O	higher	amod	52	SENT_77	[p5l950t3211r1176b3291],
52	rate	NN	O	rate	conj_and	32	SENT_77	[p5l1228t3221r1364b3274],
53	of	IN	O	of	_	0	SENT_77	[p5l1421t3212r1498b3274],
54	serious	JJ	O	serious	amod	56	SENT_77	[p5l1545t3212r1791b3274],
55	bleeding	NN	O	bleeding	nn	56	SENT_77	[p5l1846t3211r2145b3291],
56	events	NNS	O	event	prep_of	52	SENT_77	[p5l7t3327r227b3380],
57	[	VBP	O	[	ccomp	27	SENT_77	[p5l267t3319r412b3395],
58	1,2	CD	NUMBER	1,2	num	59	SENT_77	[p5l267t3319r412b3395],
59	]	CD	NUMBER	]	dobj	57	SENT_77	[p5l267t3319r412b3395],
60	during	IN	O	during	_	0	SENT_77	[p5l452t3318r687b3396],
61	the	DT	O	the	det	62	SENT_77	[p5l724t3318r832b3380],
62	ﬁrst	NN	O	ﬁrst	prep_during	57	SENT_77	[p5l868t3318r1006b3379],
63	3	CD	DURATION	3	num	64	SENT_77	[p5l1046t3320r1078b3380],
64	months	NNS	NUMBER	month	tmod	62	SENT_77	[p5l1115t3318r1383b3380],
65	of	IN	O	of	_	0	SENT_77	[p5l1423t3318r1500b3380],
66	warfarin	NN	O	warfarin	nn	67	SENT_77	[p5l1528t3318r1835b3380],
67	therapy	NN	O	therapy	prep_of	62	SENT_77	[p5l1872t3318r2145b3396],
68	in	IN	O	in	_	0	SENT_77	[p5l7t3424r73b3485],
69	addition	NN	O	addition	_	0	SENT_77	[p5l123t3424r422b3485],
70	to	TO	O	to	_	0	SENT_77	[p5l470t3432r539b3485],
71	taking	VBG	O	take	conj_in	27	SENT_77	[p5l590t3424r816b3502],
72	longer	RBR	O	longer	advmod	71	SENT_77	[p5l864t3424r1089b3502],
73	to	TO	O	to	aux	74	SENT_77	[p5l1137t3432r1206b3485],
74	reach	VB	O	reach	xcomp	71	SENT_77	[p5l1257t3424r1449b3485],
75	a	DT	O	a	det	79	SENT_77	[p5l1498t3444r1536b3485],
76	stable	JJ	O	stable	amod	79	SENT_77	[p5l1586t3424r1790b3485],
77	warfarin	NN	O	warfarin	nn	79	SENT_77	[p5l1838t3424r2145b3485],
78	dose	NN	O	dose	nn	79	SENT_77	[p5l8t3530r166b3592],
79	[	NN	O	[	dobj	74	SENT_77	[p5l204t3532r369b3608],
80	2,8	CD	NUMBER	2,8	num	81	SENT_77	[p5l204t3532r369b3608],
81	]	NN	O	]	dep	79	SENT_77	[p5l204t3532r369b3608],
82	.	.	O	.	_	0	SENT_77	[p5l204t3532r369b3608],

1	Only	RB	O	only	advmod	4	SENT_78	[p5l93t3637r266b3715],
2	one	CD	NUMBER	one	num	4	SENT_78	[p5l323t3657r448b3698],
3	small	JJ	O	small	amod	4	SENT_78	[p5l506t3637r691b3698],
4	study	NN	O	study	nsubj	10	SENT_78	[p5l749t3637r941b3715],
5	in	IN	O	in	_	0	SENT_78	[p5l996t3637r1063b3697],
6	29	CD	NUMBER	29	num	7	SENT_78	[p5l1119t3638r1198b3698],
7	children	NNS	O	child	prep_in	4	SENT_78	[p5l1255t3637r1545b3698],
8	has	VBZ	O	have	aux	10	SENT_78	[p5l1600t3637r1718b3698],
9	previously	RB	DATE	previously	advmod	10	SENT_78	[p5l1774t3637r2145b3715],
10	examined	VBN	O	examine	_	0	SENT_78	[p6l7t20r348b83],
11	the	DT	O	the	det	12	SENT_78	[p6l385t21r493b83],
12	inﬂuence	NN	O	inﬂuence	dobj	10	SENT_78	[p6l529t21r847b83],
13	of	IN	O	of	_	0	SENT_78	[p6l885t21r964b83],
14	the	DT	O	the	det	17	SENT_78	[p6l992t21r1100b83],
15	C	NN	O	c	nn	17	SENT_78	[p6l1141t23r1197b83],
16	YP2C9	NN	O	yp2c9	nn	17	SENT_78	[p6l1209t23r1457b83],
17	genotype	NN	O	genotype	prep_of	12	SENT_78	[p6l1494t29r1816b100],
18	on	IN	O	on	_	0	SENT_78	[p6l1855t41r1943b83],
19	anticoagulation	NN	O	anticoagulation	nn	20	SENT_78	[p6l1981t21r2142b83, p6l7t127r429b205],
20	outcomes	NNS	O	outcome	prep_on	10	SENT_78	[p6l481t136r820b189],
21	in	IN	O	in	_	0	SENT_78	[p6l870t127r937b188],
22	children	NNS	O	child	prep_in	20	SENT_78	[p6l987t127r1296b202],
23	;	:	O	;	_	0	SENT_78	[p6l987t127r1296b202],
24	it	PRP	O	it	nsubj	25	SENT_78	[p6l1349t127r1397b188],
25	showed	VBD	O	show	parataxis	10	SENT_78	[p6l1449t127r1714b189],
26	that	IN	O	that	complm	42	SENT_78	[p6l1765t127r1907b189],
27	those	DT	O	those	nsubj	42	SENT_78	[p6l1957t127r2144b189],
28	who	WP	O	who	nsubj	38	SENT_78	[p6l6t233r156b294],
29	were	VBD	O	be	cop	38	SENT_78	[p6l225t253r389b295],
30	heterozygous	JJ	O	heterozygous	amod	38	SENT_78	[p6l457t233r929b311],
31	for	IN	O	for	_	0	SENT_78	[p6l998t233r1102b294],
32	a	DT	O	a	det	36	SENT_78	[p6l1170t253r1208b294],
33	variant	JJ	O	variant	amod	36	SENT_78	[p6l1275t233r1530b294],
34	C	NN	O	c	nn	36	SENT_78	[p6l1602t235r1658b295],
35	YP2C9	NN	O	yp2c9	nn	36	SENT_78	[p6l1670t235r1918b295],
36	gene	NN	O	gene	prep_for	30	SENT_78	[p6l1985t253r2144b311],
37	(	NN	O	(	nn	38	SENT_78	[p6l9t340r74b419],
38	n	NN	O	n	rcmod	27	SENT_78	[p6l9t340r74b419],
39	=	JJ	O	=	amod	38	SENT_78	[p6l124t363r175b380],
40	7	CD	NUMBER	7	tmod	39	SENT_78	[p6l226t340r290b418],
41	)	RB	O	)	advmod	38	SENT_78	[p6l226t340r290b418],
42	achieved	VBD	O	achieve	ccomp	25	SENT_78	[p6l328t339r636b402],
43	a	DT	O	a	det	45	SENT_78	[p6l673t360r710b402],
44	target	NN	O	target	nn	45	SENT_78	[p6l746t349r953b419],
45	INR	NN	O	inr	dobj	42	SENT_78	[p6l989t342r1153b401],
46	sooner	RBR	O	sooner	advmod	42	SENT_78	[p6l1190t360r1447b415],
47	,	,	O	,	_	0	SENT_78	[p6l1190t360r1447b415],
48	taking	VBG	O	take	xcomp	42	SENT_78	[p6l1486t339r1711b419],
49	on	RP	O	on	prt	48	SENT_78	[p6l1748t360r1836b402],
50	average	JJ	O	average	amod	52	SENT_78	[p6l1873t360r2144b419],
51	3.7	CD	DURATION	3.7	num	52	SENT_78	[p6l10t448r110b508],
52	days	NNS	NUMBER	day	tmod	48	SENT_78	[p6l147t446r305b524],
53	to	TO	O	to	aux	54	SENT_78	[p6l341t455r410b508],
54	do	VB	O	do	xcomp	48	SENT_78	[p6l448t446r535b508],
55	so	RB	O	so	advmod	54	SENT_78	[p6l573t466r645b508],
56	compared	VBN	O	compare	_	0	SENT_78	[p6l682t446r1037b524],
57	with	IN	O	with	prepc_compared_with	54	SENT_78	[p6l1071t446r1228b508],
58	7	CD	DURATION	7	num	59	SENT_78	[p6l1264t449r1300b508],
59	days	NNS	NUMBER	day	pobj	54	SENT_78	[p6l1336t446r1495b524],
60	for	IN	O	for	_	0	SENT_78	[p6l1531t446r1636b508],
61	children	NNS	O	child	prep_for	59	SENT_78	[p6l1669t446r1959b508],
62	who	WP	O	who	nsubj	64	SENT_78	[p6l1993t446r2142b508],
63	were	VBD	O	be	cop	64	SENT_78	[p6l6t572r171b613],
64	wild-type	JJ	O	wild-type	rcmod	61	SENT_78	[p6l207t552r540b630],
65	for	IN	O	for	_	0	SENT_78	[p6l577t552r682b613],
66	C	NN	O	c	nn	67	SENT_78	[p6l722t554r778b614],
67	YP2C9	NN	O	yp2c9	prep_for	64	SENT_78	[p6l790t554r1038b614],
68	[	CD	NUMBER	[	number	69	SENT_78	[p6l1077t553r1177b629],
69	9	CD	NUMBER	9	num	70	SENT_78	[p6l1077t553r1177b629],
70	]	NN	O	]	dep	64	SENT_78	[p6l1077t553r1177b629],
71	.	.	O	.	_	0	SENT_78	[p6l1077t553r1177b629],

1	In	IN	O	in	_	0	SENT_79	[p6l1219t554r1294b613],
2	addition	NN	O	addition	prep_in	11	SENT_79	[p6l1331t552r1650b626],
3	,	,	O	,	_	0	SENT_79	[p6l1331t552r1650b626],
4	heterozygosity	NN	O	heterozygosity	nsubjpass	11	SENT_79	[p6l1690t552r2142b630, p6l7t659r97b737],
5	for	IN	O	for	_	0	SENT_79	[p6l160t659r264b721],
6	the	DT	O	the	det	9	SENT_79	[p6l326t658r434b721],
7	C	NN	O	c	nn	9	SENT_79	[p6l502t661r558b721],
8	YP2C9	NN	O	yp2c9	nn	9	SENT_79	[p6l569t661r817b721],
9	genotype	NN	O	genotype	prep_for	4	SENT_79	[p6l880t667r1203b738],
10	was	VBD	O	be	auxpass	11	SENT_79	[p6l1265t679r1397b721],
11	associated	VBN	O	associate	_	0	SENT_79	[p6l1462t658r1825b721],
12	with	IN	O	with	_	0	SENT_79	[p6l1887t658r2043b721],
13	a	DT	O	a	det	15	SENT_79	[p6l2107t679r2144b721],
14	greater	JJR	O	greater	amod	15	SENT_79	[p6l8t774r257b844],
15	proportion	NN	O	proportion	prep_with	11	SENT_79	[p6l287t766r682b844],
16	of	IN	O	of	_	0	SENT_79	[p6l715t766r793b827],
17	INR	NN	O	inr	nn	18	SENT_79	[p6l817t768r981b827],
18	measurements	NNS	O	measurement	prep_of	15	SENT_79	[p6l1011t774r1521b827],
19	above	IN	O	above	_	0	SENT_79	[p6l1554t766r1765b827],
20	the	DT	O	the	det	22	SENT_79	[p6l1797t766r1905b827],
21	target	NN	O	target	nn	22	SENT_79	[p6l1938t774r2145b844],
22	range	NN	O	range	prep_above	11	SENT_79	[p6l7t892r204b951],
23	[	CD	NUMBER	[	number	24	SENT_79	[p6l239t873r338b950],
24	9	CD	NUMBER	9	num	25	SENT_79	[p6l239t873r338b950],
25	]	NN	O	]	dep	11	SENT_79	[p6l239t873r338b950],
26	.	.	O	.	_	0	SENT_79	[p6l239t873r338b950],

1	The	DT	O	the	det	2	SENT_80	[p6l375t872r510b934],
2	effect	NN	O	effect	nsubjpass	13	SENT_80	[p6l543t872r735b934],
3	of	IN	O	of	_	0	SENT_80	[p6l768t872r846b934],
4	the	DT	O	the	det	6	SENT_80	[p6l869t871r977b934],
5	VKORCI	NNP	O	VKORCI	nn	6	SENT_80	[p6l1019t874r1351b934],
6	genotype	NN	O	genotype	prep_of	2	SENT_80	[p6l1387t881r1710b951],
7	on	IN	O	on	_	0	SENT_80	[p6l1743t892r1832b934],
8	an	DT	O	a	det	10	SENT_80	[p6l1864t892r1948b934],
9	anticoagulation	NN	O	anticoagulation	nn	10	SENT_80	[p6l1981t872r2142b934, p6l7t978r429b1056],
10	response	NN	O	response	prep_on	6	SENT_80	[p6l461t998r769b1056],
11	was	VBD	O	be	auxpass	13	SENT_80	[p6l800t998r933b1040],
12	not	RB	O	not	neg	13	SENT_80	[p6l966t987r1085b1040],
13	reported	VBN	O	report	_	0	SENT_80	[p6l1116t978r1438b1056],
14	.	.	O	.	_	0	SENT_80	[p6l1116t978r1438b1056],

1	The	DT	O	the	det	3	SENT_81	[p6l92t1084r228b1145],
2	present	JJ	DATE	present	amod	3	SENT_81	[p6l289t1092r548b1162],
3	study	NN	O	study	nsubj	4	SENT_81	[p6l611t1084r803b1162],
4	identiﬁed	VBD	O	identiﬁed	_	0	SENT_81	[p6l863t1084r1195b1145],
5	that	IN	O	that	complm	31	SENT_81	[p6l1257t1084r1400b1145],
6	the	DT	O	the	det	8	SENT_81	[p6l1461t1084r1568b1145],
7	C	NN	O	c	nn	8	SENT_81	[p6l1636t1086r1692b1146],
8	YP2C9	NN	O	yp2c9	nsubj	31	SENT_81	[p6l1703t1086r1951b1146],
9	and	CC	O	and	_	0	SENT_81	[p6l2013t1084r2144b1145],
10	VKORCI	NN	O	vkorcus	nn	11	SENT_81	[p6l18t1193r351b1253],
11	genotypes	NNS	O	genotype	nsubj	31	SENT_81	[p6l394t1199r749b1270],
12	both	CC	O	both	advmod	31	SENT_81	[p6l789t1190r954b1253],
13	have	VBP	O	have	aux	31	SENT_81	[p6l992t1191r1157b1253],
14	a	DT	O	a	det	16	SENT_81	[p6l1196t1211r1234b1253],
15	signiﬁcant	JJ	O	signiﬁcant	amod	16	SENT_81	[p6l1274t1191r1638b1270],
16	effect	NN	O	effect	npadvmod	30	SENT_81	[p6l1677t1191r1869b1253],
17	on	IN	O	on	_	0	SENT_81	[p6l1909t1211r1997b1253],
18	the	DT	O	the	det	20	SENT_81	[p6l2036t1191r2144b1253],
19	anticoagulation	NN	O	anticoagulation	nn	20	SENT_81	[p6l8t1297r570b1375],
20	response	NN	O	response	prep_on	16	SENT_81	[p6l603t1317r911b1375],
21	at	IN	O	at	_	0	SENT_81	[p6l946t1306r1012b1359],
22	an	DT	O	a	det	24	SENT_81	[p6l1047t1317r1131b1359],
23	early	JJ	O	early	amod	24	SENT_81	[p6l1165t1297r1338b1375],
24	stage	NN	O	stage	prep_at	20	SENT_81	[p6l1373t1306r1550b1375],
25	of	IN	O	of	_	0	SENT_81	[p6l1585t1297r1664b1359],
26	warfarin	NN	O	warfarin	nn	27	SENT_81	[p6l1687t1297r1994b1359],
27	initiation	NN	O	initiation	prep_of	24	SENT_81	[p6l2027t1297r2142b1358, p6l8t1403r242b1465],
28	in	IN	O	in	_	0	SENT_81	[p6l280t1403r347b1464],
29	children	NNS	O	child	prep_in	27	SENT_81	[p6l385t1403r675b1464],
30	as	IN	O	as	advmod	31	SENT_81	[p6l714t1423r783b1465],
31	detailed	VBN	O	detail	ccomp	4	SENT_81	[p6l824t1403r1103b1465],
32	above	IN	O	above	prep	31	SENT_81	[p6l1143t1403r1372b1465],
33	.	.	O	.	_	0	SENT_81	[p6l1143t1403r1372b1465],

1	However	RB	O	however	advmod	4	SENT_82	[p6l1416t1405r1758b1477],
2	,	,	O	,	_	0	SENT_82	[p6l1416t1405r1758b1477],
3	we	PRP	O	we	nsubj	4	SENT_82	[p6l1798t1423r1893b1465],
4	found	VBD	O	find	_	0	SENT_82	[p6l1933t1403r2145b1465],
5	no	DT	O	no	det	6	SENT_82	[p6l7t1530r95b1572],
6	relationship	NN	O	relationship	dobj	4	SENT_82	[p6l129t1510r553b1589],
7	between	IN	O	between	_	0	SENT_82	[p6l587t1509r877b1572],
8	the	DT	O	the	det	10	SENT_82	[p6l910t1509r1017b1572],
9	C	NN	O	c	nn	10	SENT_82	[p6l1055t1512r1111b1572],
10	YP2C9	NN	O	yp2c9	prep_between	6	SENT_82	[p6l1123t1512r1370b1572],
11	and	CC	O	and	_	0	SENT_82	[p6l1404t1509r1535b1572],
12	VKORCI	NN	O	vkorcus	nn	13	SENT_82	[p6l1578t1512r1910b1572],
13	genotypes	NNS	O	genotype	conj_and	10	SENT_82	[p6l1947t1530r2142b1589, p6l8t1625r190b1695],
14	and	CC	O	and	_	0	SENT_82	[p6l229t1617r360b1678],
15	the	DT	O	the	det	16	SENT_82	[p6l398t1617r506b1678],
16	proportion	NN	O	proportion	conj_and	6	SENT_82	[p6l542t1617r937b1695],
17	of	IN	O	of	_	0	SENT_82	[p6l976t1617r1054b1678],
18	INR	NN	O	inr	nn	19	SENT_82	[p6l1084t1619r1248b1678],
19	values	NNS	O	value	prep_of	16	SENT_82	[p6l1283t1617r1504b1678],
20	above	IN	O	above	_	0	SENT_82	[p6l1543t1617r1753b1678],
21	the	DT	O	the	det	23	SENT_82	[p6l1792t1617r1899b1678],
22	target	NN	O	target	nn	23	SENT_82	[p6l1937t1625r2145b1695],
23	range	NN	O	range	prep_above	19	SENT_82	[p6l7t1743r204b1802],
24	beyond	IN	O	beyond	_	0	SENT_82	[p6l248t1722r510b1801],
25	the	DT	DATE	the	det	27	SENT_82	[p6l553t1722r661b1785],
26	ﬁrst	JJ	DATE	ﬁrst	amod	27	SENT_82	[p6l703t1723r841b1785],
27	month	NN	DATE	month	nsubj	30	SENT_82	[p6l881t1723r1118b1785],
28	of	IN	O	of	_	0	SENT_82	[p6l1162t1723r1240b1785],
29	therapy	NN	O	therapy	prep_of	27	SENT_82	[p6l1274t1723r1547b1802],
30	suggesting	VBG	O	suggest	prepc_beyond	4	SENT_82	[p6l1591t1723r1961b1802],
31	that	IN	O	that	complm	46	SENT_82	[p6l2003t1723r2145b1785],
32	adjustment	NN	O	adjustment	nsubj	46	SENT_82	[p6l8t1829r406b1907],
33	of	IN	O	of	_	0	SENT_82	[p6l455t1829r533b1891],
34	warfarin	NN	O	warfarin	nn	35	SENT_82	[p6l573t1829r879b1891],
35	doses	NNS	O	dose	prep_of	32	SENT_82	[p6l928t1829r1119b1891],
36	prior	RB	O	prior	_	0	SENT_82	[p6l1167t1829r1347b1907],
37	to	TO	O	to	_	0	SENT_82	[p6l1396t1838r1465b1891],
38	months	NNS	DURATION	month	prep_prior_to	46	SENT_82	[p6l1514t1829r1781b1891],
39	two	CD	NUMBER	two	num	38	SENT_82	[p6l1831t1838r1962b1891],
40	and	CC	O	and	_	0	SENT_82	[p6l2013t1829r2144b1891],
41	three	CD	NUMBER	three	prep_prior_to	46	SENT_82	[p6l8t1935r185b1996],
42	of	IN	O	of	_	0	SENT_82	[p6l225t1935r303b1996],
43	initiation	NN	O	initiation	nn	44	SENT_82	[p6l332t1935r660b1996],
44	therapy	NN	O	therapy	prep_of	38	SENT_82	[p6l698t1935r971b2013],
45	had	VBD	O	have	aux	46	SENT_82	[p6l1009t1935r1141b1996],
46	counteracted	VBN	O	counteract	ccomp	30	SENT_82	[p6l1179t1935r1642b1996],
47	the	DT	O	the	det	48	SENT_82	[p6l1681t1935r1788b1996],
48	inﬂuence	NN	O	inﬂuence	dobj	46	SENT_82	[p6l1826t1935r2144b1996],
49	of	IN	O	of	_	0	SENT_82	[p6l9t2042r87b2104],
50	the	DT	O	the	det	52	SENT_82	[p6l111t2042r218b2104],
51	C	NN	O	c	nn	52	SENT_82	[p6l256t2044r312b2104],
52	YP2C9	NN	O	yp2c9	prep_of	48	SENT_82	[p6l324t2044r572b2104],
53	and	CC	O	and	_	0	SENT_82	[p6l604t2041r735b2104],
54	VKORCI	NN	O	vkorcus	nn	55	SENT_82	[p6l778t2044r1111b2104],
55	genotypes	NNS	O	genotype	prep_of	48	SENT_82	[p6l1148t2051r1522b2121],
56	.	.	O	.	_	0	SENT_82	[p6l1148t2051r1522b2121],

1	This	DT	O	this	det	2	SENT_83	[p6l92t2148r246b2210],
2	study	NN	O	study	nsubjpass	4	SENT_83	[p6l295t2148r487b2226],
3	was	VBD	O	be	auxpass	4	SENT_83	[p6l531t2168r664b2210],
4	limited	VBN	O	limit	_	0	SENT_83	[p6l711t2148r958b2210],
5	by	IN	O	by	_	0	SENT_83	[p6l1003t2148r1089b2226],
6	the	DT	O	the	det	12	SENT_83	[p6l1135t2148r1243b2210],
7	relatively	RB	O	relatively	advmod	8	SENT_83	[p6l1290t2148r1617b2226],
8	small	JJ	O	small	amod	12	SENT_83	[p6l1665t2148r1849b2210],
9	patient	NN	O	patient	nn	12	SENT_83	[p6l1895t2148r2145b2226],
10	cohort	NN	O	cohort	nn	12	SENT_83	[p6l7t2254r243b2315],
11	(	NN	O	(	nn	12	SENT_83	[p6l280t2254r344b2332],
12	n	NN	O	n	agent	4	SENT_83	[p6l280t2254r344b2332],
13	=	JJ	O	=	amod	15	SENT_83	[p6l395t2277r445b2295],
14	51	CD	NUMBER	51	tmod	13	SENT_83	[p6l499t2254r603b2332],
15	)	NN	O	)	dep	12	SENT_83	[p6l499t2254r603b2332],
16	and	CC	O	and	_	0	SENT_83	[p6l642t2254r773b2315],
17	the	DT	O	the	det	19	SENT_83	[p6l809t2254r917b2315],
18	retrospective	JJ	O	retrospective	amod	19	SENT_83	[p6l954t2254r1411b2332],
19	nature	NN	O	nature	agent	4	SENT_83	[p6l1447t2262r1677b2315],
20	of	IN	O	of	_	0	SENT_83	[p6l1715t2254r1794b2315],
21	data	NNS	O	datum	nn	22	SENT_83	[p6l1822t2254r1977b2315],
22	collection	NN	O	collection	prep_of	19	SENT_83	[p6l2013t2254r2142b2315, p6l7t2361r263b2423],
23	.	.	O	.	_	0	SENT_83	[p6l2013t2254r2142b2315, p6l7t2361r263b2423],

1	The	DT	O	the	det	2	SENT_84	[p6l316t2361r452b2423],
2	results	NNS	O	result	nsubj	6	SENT_84	[p6l501t2361r729b2423],
3	of	IN	O	of	_	0	SENT_84	[p6l779t2361r857b2423],
4	this	DT	O	this	det	5	SENT_84	[p6l896t2360r1022b2423],
5	study	NN	O	study	prep_of	2	SENT_84	[p6l1073t2360r1264b2439],
6	are	VBP	O	be	_	0	SENT_84	[p6l1313t2381r1420b2423],
7	mostly	RB	O	mostly	advmod	6	SENT_84	[p6l1466t2361r1707b2439],
8	in	IN	O	in	_	0	SENT_84	[p6l1754t2361r1821b2422],
9	keeping	VBG	O	keep	prepc_in	6	SENT_84	[p6l1868t2360r2145b2440],
10	with	IN	O	with	_	0	SENT_84	[p6l6t2468r163b2529],
11	the	DT	O	the	det	13	SENT_84	[p6l202t2468r309b2529],
12	published	VBN	O	publish	amod	13	SENT_84	[p6l348t2468r695b2546],
13	reports	NNS	O	report	prep_with	9	SENT_84	[p6l734t2476r986b2546],
14	of	IN	O	of	_	0	SENT_84	[p6l1028t2468r1106b2529],
15	the	DT	O	the	det	16	SENT_84	[p6l1137t2468r1244b2529],
16	impact	NN	O	impact	prep_of	13	SENT_84	[p6l1283t2468r1527b2546],
17	of	IN	O	of	_	0	SENT_84	[p6l1568t2468r1646b2529],
18	the	DT	O	the	det	20	SENT_84	[p6l1677t2468r1784b2529],
19	C	NN	O	c	nn	20	SENT_84	[p6l1829t2470r1885b2530],
20	YP2C9	NN	O	yp2c9	prep_of	16	SENT_84	[p6l1897t2470r2145b2530],
21	and	CC	O	and	_	0	SENT_84	[p6l8t2573r139b2636],
22	VKORCI	NN	O	vkorcus	nn	23	SENT_84	[p6l189t2576r521b2636],
23	genotypes	NNS	O	genotype	prep_of	13	SENT_84	[p6l565t2582r920b2653],
24	on	IN	O	on	_	0	SENT_84	[p6l961t2594r1050b2636],
25	the	DT	O	the	det	27	SENT_84	[p6l1088t2574r1195b2636],
26	anticoagulation	NN	O	anticoagulation	nn	27	SENT_84	[p6l1236t2574r1797b2653],
27	response	NN	O	response	prep_on	23	SENT_84	[p6l1836t2594r2144b2653],
28	during	IN	O	during	_	0	SENT_84	[p6l8t2680r242b2758],
29	warfarin	NN	O	warfarin	nn	31	SENT_84	[p6l272t2680r579b2742],
30	initiation	NN	O	initiation	nn	31	SENT_84	[p6l610t2680r938b2742],
31	therapy	NN	O	therapy	prep_during	27	SENT_84	[p6l970t2680r1243b2758],
32	in	IN	O	in	_	0	SENT_84	[p6l1273t2680r1340b2741],
33	adult	JJ	O	adult	amod	35	SENT_84	[p6l1373t2680r1555b2742],
34	patient	NN	O	patient	nn	35	SENT_84	[p6l1586t2680r1836b2758],
35	populations	NNS	O	population	prep_in	31	SENT_84	[p6l1866t2680r2142b2758, p6l8t2786r180b2847],
36	and	CC	O	and	_	0	SENT_84	[p6l223t2786r354b2847],
37	provide	VB	O	provide	prepc_in	6	SENT_84	[p6l393t2786r665b2864],
38	further	JJ	O	further	amod	39	SENT_84	[p6l707t2786r956b2847],
39	support	NN	O	support	dobj	37	SENT_84	[p6l998t2794r1274b2864],
40	to	TO	O	to	_	0	SENT_84	[p6l1314t2795r1383b2847],
41	the	DT	O	the	det	42	SENT_84	[p6l1426t2786r1533b2847],
42	development	NN	O	development	prep_to	37	SENT_84	[p6l1574t2786r2033b2864],
43	of	IN	O	of	_	0	SENT_84	[p6l2075t2786r2153b2847],
44	personalized	JJ	O	personalized	amod	48	SENT_84	[p6l6t2892r455b2972],
45	pharmacogenetics-based	JJ	O	pharmacogenetics-based	amod	48	SENT_84	[p6l544t2892r1424b2972],
46	warfarin	NN	O	warfarin	nn	48	SENT_84	[p6l1513t2893r1820b2955],
47	dosing	NN	O	dosing	nn	48	SENT_84	[p6l1911t2892r2145b2972],
48	algorithms	NNS	O	algorithm	prep_of	42	SENT_84	[p6l8t2999r390b3077],
49	in	IN	O	in	_	0	SENT_84	[p6l423t2999r489b3060],
50	children	NNS	O	child	prep_in	37	SENT_84	[p6l521t2999r829b3061],
51	.	.	O	.	_	0	SENT_84	[p6l521t2999r829b3061],

1	©	RB	O	©	dep	2	SENT_85	[p6l223t3235r276b3289],
2	2012	CD	DATE	2012	dep	4	SENT_85	[p6l301t3238r439b3289],
3	International	NNP	ORGANIZATION	International	nn	4	SENT_85	[p6l468t3236r865b3289],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_85	[p6l894t3236r1108b3302],
5	on	IN	O	on	_	0	SENT_85	[p6l1136t3253r1210b3289],
6	Thrombosis	NNP	O	Thrombosis	prep_on	4	SENT_85	[p6l1237t3236r1598b3289],
7	and	CC	O	and	_	0	SENT_85	[p6l1627t3236r1737b3289],
8	Haemostasis	NNP	PERSON	Haemostasis	prep_on	4	SENT_85	[p6l1765t3236r2144b3289],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_86	[p6l7t3340r692b3420],

1	T.T.B.	NNP	O	T.T.B.	nsubjpass	3	SENT_87	[p6l8t3515r226b3572],
2	was	VBD	O	be	auxpass	3	SENT_87	[p6l268t3532r394b3572],
3	supported	VBN	O	support	_	0	SENT_87	[p6l436t3513r777b3588],
4	by	IN	O	by	_	0	SENT_87	[p6l815t3513r897b3588],
5	a	DT	O	a	det	14	SENT_87	[p6l936t3532r972b3572],
6	Baxter	NNP	O	Baxter	nn	9	SENT_87	[p6l1012t3515r1235b3572],
7	and	CC	O	and	_	0	SENT_87	[p6l1275t3513r1399b3572],
8	Royal	NNP	ORGANIZATION	Royal	nn	9	SENT_87	[p6l1440t3513r1643b3588],
9	College	NNP	ORGANIZATION	College	dep	14	SENT_87	[p6l1683t3513r1935b3588],
10	of	IN	ORGANIZATION	of	_	0	SENT_87	[p6l1976t3513r2050b3572],
11	Pathologists	NNPS	ORGANIZATION	Pathologists	prep_of	9	SENT_87	[p6l7t3615r426b3690],
12	research	NN	O	research	nn	14	SENT_87	[p6l464t3615r745b3674],
13	training	NN	O	training	nn	14	SENT_87	[p6l782t3615r1050b3690],
14	fellowship	NN	O	fellowship	agent	3	SENT_87	[p6l1087t3615r1432b3690],
15	for	IN	O	for	_	0	SENT_87	[p6l1471t3615r1570b3674],
16	the	DT	O	the	det	17	SENT_87	[p6l1607t3615r1710b3674],
17	duration	NN	O	duration	prep_for	14	SENT_87	[p6l1748t3615r2042b3674],
18	of	IN	O	of	_	0	SENT_87	[p6l9t3717r83b3776],
19	this	DT	O	this	det	20	SENT_87	[p6l117t3717r236b3776],
20	work	NN	O	work	prep_of	17	SENT_87	[p6l277t3717r470b3776],
21	.	.	O	.	_	0	SENT_87	[p6l277t3717r470b3776],

1	The	DT	O	the	det	2	SENT_88	[p6l516t3717r646b3776],
2	authors	NNS	O	author	nsubj	3	SENT_88	[p6l688t3717r946b3776],
3	acknowledge	VBP	O	acknowledge	_	0	SENT_88	[p6l989t3717r1428b3792],
4	the	DT	O	the	det	5	SENT_88	[p6l1470t3717r1573b3776],
5	contribution	NN	O	contribution	dobj	3	SENT_88	[p6l1614t3717r2042b3776],
6	of	IN	O	of	_	0	SENT_88	[p7l9t21r83b80],
7	the	DT	O	the	prep_of	5	SENT_88	[p7l135t20r237b80],
8	following	VBG	O	follow	amod	7	SENT_88	[p7l297t21r618b96],
9	who	WP	O	who	nsubj	11	SENT_88	[p7l676t20r819b80],
10	were	VBD	O	be	cop	11	SENT_88	[p7l879t40r1036b80],
11	responsible	JJ	O	responsible	rcmod	7	SENT_88	[p7l1096t20r1477b96],
12	for	IN	O	for	_	0	SENT_88	[p7l1538t21r1637b80],
13	study	NN	O	study	nn	14	SENT_88	[p7l1697t20r1880b95],
14	coordination	NN	O	coordination	prep_for	11	SENT_88	[p7l1938t40r2040b80, p7l9t122r369b181],
15	and	CC	O	and	_	0	SENT_88	[p7l405t122r530b181],
16	the	DT	O	the	det	17	SENT_88	[p7l566t122r668b181],
17	recruitment	NN	O	recruitment	prep_of	5	SENT_88	[p7l704t122r1100b181],
18	of	IN	O	of	_	0	SENT_88	[p7l1137t122r1211b181],
19	children	NNS	O	child	prep_of	17	SENT_88	[p7l1238t122r1513b181],
20	at	IN	O	at	_	0	SENT_88	[p7l1550t131r1613b181],
21	each	DT	O	each	prep_at	19	SENT_88	[p7l1648t122r1800b181],
22	of	IN	O	of	_	0	SENT_88	[p7l1837t122r1911b181],
23	the	DT	O	the	det	25	SENT_88	[p7l1939t122r2041b181],
24	study	NN	O	study	nn	25	SENT_88	[p7l9t223r192b298],
25	sites	NNS	O	site	prep_of	21	SENT_88	[p7l227t223r387b295],
26	;	:	O	;	_	0	SENT_88	[p7l227t223r387b295],
27	Patricia	NNP	PERSON	Patricia	nn	28	SENT_88	[p7l423t223r687b282],
28	Walsh	NNP	PERSON	Walsh	conj_and	7	SENT_88	[p7l719t223r954b294],
29	,	,	O	,	_	0	SENT_88	[p7l719t223r954b294],
30	RN	NNP	O	RN	appos	28	SENT_88	[p7l993t225r1135b294],
31	,	,	O	,	_	0	SENT_88	[p7l993t225r1135b294],
32	The	DT	O	the	det	37	SENT_88	[p7l1172t223r1301b282],
33	Newcastle	NNP	ORGANIZATION	Newcastle	nn	37	SENT_88	[p7l1335t223r1682b282],
34	Hospitals	NNPS	ORGANIZATION	Hospitals	nn	37	SENT_88	[p7l1717t223r2041b298],
35	NHS	NNP	ORGANIZATION	NHS	nn	37	SENT_88	[p7l7t327r179b385],
36	Foundation	NNP	ORGANIZATION	Foundation	nn	37	SENT_88	[p7l215t325r620b385],
37	Trust	NNP	ORGANIZATION	Trust	appos	28	SENT_88	[p7l652t328r854b397],
38	,	,	O	,	_	0	SENT_88	[p7l652t328r854b397],
39	Newcastle	NNP	ORGANIZATION	Newcastle	appos	28	SENT_88	[p7l888t326r1235b385],
40	upon	IN	O	upon	_	0	SENT_88	[p7l1267t345r1442b401],
41	Tyne	NNP	PERSON	Tyne	prep_upon	39	SENT_88	[p7l1474t328r1663b400],
42	,	,	O	,	_	0	SENT_88	[p7l1474t328r1663b400],
43	UK	NNP	LOCATION	UK	appos	28	SENT_88	[p7l1699t328r1845b397],
44	;	:	O	;	_	0	SENT_88	[p7l1699t328r1845b397],
45	Darlene	NNP	PERSON	Darlene	nn	46	SENT_88	[p7l1881t328r2040b385, p7l8t427r140b487],
46	Castle	NNP	PERSON	Castle	conj_and	17	SENT_88	[p7l177t427r404b499],
47	,	,	O	,	_	0	SENT_88	[p7l177t427r404b499],
48	RN	NNP	O	RN	appos	46	SENT_88	[p7l445t430r586b499],
49	,	,	O	,	_	0	SENT_88	[p7l445t430r586b499],
50	Dewi	NNP	PERSON	Dewi	nn	51	SENT_88	[p7l624t427r801b487],
51	Clark	NNP	PERSON	Clark	appos	46	SENT_88	[p7l838t427r1047b499],
52	,	,	O	,	_	0	SENT_88	[p7l838t427r1047b499],
53	BSc	NNP	O	BSc	appos	46	SENT_88	[p7l1086t429r1234b499],
54	,	,	O	,	_	0	SENT_88	[p7l1086t429r1234b499],
55	The	NNP	O	The	nn	56	SENT_88	[p7l1272t427r1401b487],
56	Hospital	NNP	O	Hospital	appos	46	SENT_88	[p7l1437t427r1730b502],
57	for	IN	O	for	_	0	SENT_88	[p7l1766t427r1865b487],
58	Sick	NNP	O	Sick	nn	59	SENT_88	[p7l1901t427r2042b487],
59	Children	NNP	O	Children	prep_for	56	SENT_88	[p7l9t529r324b600],
60	,	,	O	,	_	0	SENT_88	[p7l9t529r324b600],
61	Toronto	NNP	LOCATION	Toronto	nn	63	SENT_88	[p7l358t531r663b600],
62	,	,	O	,	_	0	SENT_88	[p7l358t531r663b600],
63	Canada	NNP	LOCATION	Canada	appos	46	SENT_88	[p7l698t529r980b601],
64	;	:	O	;	_	0	SENT_88	[p7l698t529r980b601],
65	Gillian	NNP	PERSON	Gillian	nn	66	SENT_88	[p7l1016t529r1249b588],
66	Taylor	NNP	PERSON	Taylor	conj_and	17	SENT_88	[p7l1280t529r1527b604],
67	,	,	O	,	_	0	SENT_88	[p7l1280t529r1527b604],
68	RN	NNP	O	RN	appos	66	SENT_88	[p7l1563t531r1705b600],
69	,	,	O	,	_	0	SENT_88	[p7l1563t531r1705b600],
70	Birmingham	NNP	LOCATION	Birmingham	nn	71	SENT_88	[p7l1740t529r2040b604, p7l7t631r156b690],
71	Children	NNP	LOCATION	Children	poss	73	SENT_88	[p7l208t631r557b691],
72	’s	POS	LOCATION	’s	_	0	SENT_88	[p7l208t631r557b691],
73	Hospital	NNP	LOCATION	Hospital	appos	66	SENT_88	[p7l610t631r923b706],
74	,	,	O	,	_	0	SENT_88	[p7l610t631r923b706],
75	Birmingham	NNP	LOCATION	Birmingham	appos	73	SENT_88	[p7l979t631r1424b706],
76	,	,	O	,	_	0	SENT_88	[p7l979t631r1424b706],
77	UK	NNP	LOCATION	UK	appos	66	SENT_88	[p7l1479t633r1626b703],
78	;	:	O	;	_	0	SENT_88	[p7l1479t633r1626b703],
79	and	CC	O	and	_	0	SENT_88	[p7l1682t631r1807b690],
80	Anne	NNP	PERSON	Anne	nn	81	SENT_88	[p7l1858t631r2041b690],
81	Littley	NNP	PERSON	Littley	conj_and	7	SENT_88	[p7l9t733r249b808],
82	,	,	O	,	_	0	SENT_88	[p7l9t733r249b808],
83	RN	NNP	O	RN	appos	81	SENT_88	[p7l285t735r427b804],
84	,	,	O	,	_	0	SENT_88	[p7l285t735r427b804],
85	Royal	NNP	ORGANIZATION	Royal	nn	87	SENT_88	[p7l462t733r666b808],
86	Manchester	NNP	ORGANIZATION	Manchester	nn	87	SENT_88	[p7l697t733r1097b792],
87	Children	NNP	ORGANIZATION	Children	poss	89	SENT_88	[p7l1128t733r1477b792],
88	’s	POS	ORGANIZATION	’s	_	0	SENT_88	[p7l1128t733r1477b792],
89	Hospital	NNP	ORGANIZATION	Hospital	appos	81	SENT_88	[p7l1508t733r1820b808],
90	,	,	O	,	_	0	SENT_88	[p7l1508t733r1820b808],
91	Manchester	NNP	LOCATION	Manchester	appos	89	SENT_88	[p7l1855t735r2040b792, p7l7t835r262b907],
92	,	,	O	,	_	0	SENT_88	[p7l1855t735r2040b792, p7l7t835r262b907],
93	UK	NNP	LOCATION	UK	appos	81	SENT_88	[p7l296t838r442b895],
94	.	.	O	.	_	0	SENT_88	[p7l296t838r442b895],

1	We	PRP	O	we	nsubj	3	SENT_89	[p7l476t838r589b895],
2	are	VBP	O	be	cop	3	SENT_89	[p7l620t855r722b895],
3	grateful	JJ	O	grateful	_	0	SENT_89	[p7l754t836r1016b911],
4	to	TO	O	to	_	0	SENT_89	[p7l1047t844r1113b895],
5	Julian	NNP	PERSON	Julian	nn	6	SENT_89	[p7l1145t836r1350b895],
6	Leathart	NNP	PERSON	Leathart	prep_to	3	SENT_89	[p7l1382t835r1676b895],
7	for	IN	O	for	_	0	SENT_89	[p7l1707t836r1806b895],
8	assisting	VBG	O	assist	prepc_for	6	SENT_89	[p7l1837t836r2040b895, p7l7t937r111b1012],
9	with	IN	O	with	_	0	SENT_89	[p7l147t937r296b997],
10	the	DT	O	the	det	11	SENT_89	[p7l334t937r436b997],
11	genotyping	NN	O	genotyping	prep_with	8	SENT_89	[p7l475t937r871b1012],
12	.	.	O	.	_	0	SENT_89	[p7l475t937r871b1012],

1	The	DT	O	the	det	2	SENT_90	[p7l913t937r1043b997],
2	authors	NNS	O	author	nsubj	4	SENT_90	[p7l1082t937r1339b997],
3	also	RB	O	also	advmod	4	SENT_90	[p7l1379t937r1510b997],
4	wish	VBP	O	wish	_	0	SENT_90	[p7l1549t937r1702b997],
5	to	TO	O	to	aux	6	SENT_90	[p7l1739t946r1805b997],
6	thank	VB	O	thank	xcomp	4	SENT_90	[p7l1845t937r2042b997],
7	the	DT	O	the	det	8	SENT_90	[p7l8t1039r110b1098],
8	children	NNS	O	child	dobj	6	SENT_90	[p7l155t1039r431b1098],
9	and	CC	O	and	_	0	SENT_90	[p7l477t1039r602b1098],
10	young	JJ	O	young	amod	11	SENT_90	[p7l646t1058r858b1114],
11	adults	NNS	O	adult	conj_and	8	SENT_90	[p7l903t1039r1107b1098],
12	and	CC	O	and	_	0	SENT_90	[p7l1154t1039r1279b1098],
13	their	PRP$	O	they	poss	14	SENT_90	[p7l1324t1039r1481b1098],
14	parents/careers	NNS	O	parents/careers	conj_and	8	SENT_90	[p7l1524t1039r2041b1114],
15	who	WP	O	who	nsubj	16	SENT_90	[p7l7t1142r149b1201],
16	participated	VBD	O	participate	rcmod	14	SENT_90	[p7l207t1142r618b1217],
17	in	IN	O	in	_	0	SENT_90	[p7l675t1142r738b1200],
18	the	DT	O	the	det	19	SENT_90	[p7l796t1142r898b1201],
19	study	NN	O	study	prep_in	16	SENT_90	[p7l957t1142r1156b1217],
20	.	.	O	.	_	0	SENT_90	[p7l957t1142r1156b1217],

1	No	DT	O	no	det	2	SENT_91	[p7l1217t1144r1324b1201],
2	compensation	NN	O	compensation	nsubjpass	4	SENT_91	[p7l1382t1142r1859b1217],
3	was	VBD	O	be	auxpass	4	SENT_91	[p7l1915t1161r2041b1201],
4	received	VBN	O	receive	_	0	SENT_91	[p7l8t1243r282b1303],
5	for	IN	O	for	_	0	SENT_91	[p7l314t1243r413b1303],
6	the	DT	O	the	det	7	SENT_91	[p7l443t1243r545b1303],
7	contribution	NN	O	contribution	prep_for	4	SENT_91	[p7l576t1243r1004b1303],
8	of	IN	O	of	_	0	SENT_91	[p7l1036t1243r1110b1303],
9	any	DT	O	any	prep_of	7	SENT_91	[p7l1134t1263r1255b1318],
10	of	IN	O	of	_	0	SENT_91	[p7l1286t1243r1361b1303],
11	these	DT	O	these	det	12	SENT_91	[p7l1383t1243r1552b1303],
12	individuals	NNS	O	individual	prep_of	9	SENT_91	[p7l1583t1243r1974b1303],
13	.	.	O	.	_	0	SENT_91	[p7l1583t1243r1974b1303],

1	Contribution	NN	O	contribution	_	0	SENT_92	[p7l11t1473r448b1534],
2	of	IN	O	of	_	0	SENT_92	[p7l482t1472r551b1534],
3	authors	NNS	O	author	prep_of	1	SENT_92	[p7l580t1473r839b1534],

1	T.T.B.	NNP	O	T.T.B.	nsubj	6	SENT_93	[p7l8t1630r249b1699],
2	,	,	O	,	_	0	SENT_93	[p7l8t1630r249b1699],
3	P.J.A.	NNP	O	P.J.A.	nsubj	6	SENT_93	[p7l316t1628r520b1687],
4	and	CC	O	and	_	0	SENT_93	[p7l590t1628r714b1687],
5	F.K.	NNP	PERSON	F.K.	nsubj	6	SENT_93	[p7l780t1630r934b1687],
6	designed	VBD	O	design	_	0	SENT_93	[p7l1003t1628r1296b1703],
7	the	DT	O	the	det	8	SENT_93	[p7l1361t1628r1463b1687],
8	study	NN	O	study	dobj	6	SENT_93	[p7l1529t1628r1728b1703],
9	.	.	O	.	_	0	SENT_93	[p7l1529t1628r1728b1703],

1	T.T.B.	NNP	O	T.T.B.	nsubj	10	SENT_94	[p7l1797t1630r2038b1699],
2	,	,	O	,	_	0	SENT_94	[p7l1797t1630r2038b1699],
3	M.D.W.	NNP	O	M.D.W.	nsubj	10	SENT_94	[p7l9t1732r314b1801],
4	,	,	O	,	_	0	SENT_94	[p7l9t1732r314b1801],
5	L.R.B.	NNP	O	L.R.B.	nsubj	10	SENT_94	[p7l367t1732r616b1801],
6	,	,	O	,	_	0	SENT_94	[p7l367t1732r616b1801],
7	J.D.G.	NNP	O	J.D.G.	conj_and	1	SENT_94	[p7l667t1730r893b1789],
8	and	CC	O	and	_	0	SENT_94	[p7l947t1729r1072b1789],
9	F.K.	NNP	PERSON	F.K.	conj_and	1	SENT_94	[p7l1122t1732r1276b1788],
10	conducted	VBD	O	conduct	_	0	SENT_94	[p7l1329t1729r1681b1789],
11	the	DT	O	the	det	12	SENT_94	[p7l1730t1729r1833b1789],
12	trial	NN	O	trial	dobj	10	SENT_94	[p7l1882t1729r2037b1789],
13	.	.	O	.	_	0	SENT_94	[p7l1882t1729r2037b1789],

1	T.B.B.	NNP	O	T.B.B.	nsubj	4	SENT_95	[p7l8t1833r226b1890],
2	and	CC	O	and	_	0	SENT_95	[p7l275t1831r399b1890],
3	F.K.	NNP	PERSON	F.K.	conj_and	1	SENT_95	[p7l443t1833r597b1890],
4	performed	VBD	O	perform	_	0	SENT_95	[p7l643t1831r1000b1906],
5	the	DT	O	the	det	7	SENT_95	[p7l1044t1831r1146b1890],
6	genotyping	NN	O	genotyping	nn	7	SENT_95	[p7l1189t1831r1569b1906],
7	experiments	NNS	O	experiment	dobj	4	SENT_95	[p7l1611t1831r2037b1906],
8	.	.	O	.	_	0	SENT_95	[p7l1611t1831r2037b1906],

1	T.T.B.	NNP	O	T.T.B.	nsubj	6	SENT_96	[p7l8t1936r226b1993],
2	and	CC	O	and	_	0	SENT_96	[p7l297t1934r421b1993],
3	F.K.	NNP	PERSON	F.K.	conj_and	1	SENT_96	[p7l488t1936r642b1993],
4	analyzed	VBD	O	analyze	_	0	SENT_96	[p7l712t1934r1010b2009],
5	and	CC	O	and	_	0	SENT_96	[p7l1076t1934r1200b1993],
6	interpreted	VBD	O	interpret	conj_and	4	SENT_96	[p7l1265t1934r1638b2009],
7	the	DT	O	the	det	8	SENT_96	[p7l1704t1934r1806b1993],
8	data	NNS	O	datum	dobj	6	SENT_96	[p7l1872t1934r2037b1993],
9	.	.	O	.	_	0	SENT_96	[p7l1872t1934r2037b1993],

1	T.T.B.	NNP	O	T.T.B.	nsubj	4	SENT_97	[p7l8t2038r226b2094],
2	and	CC	O	and	_	0	SENT_97	[p7l276t2035r400b2095],
3	P.J.A.	NNP	O	P.J.A.	conj_and	1	SENT_97	[p7l443t2035r647b2095],
4	performed	VBD	O	perform	_	0	SENT_97	[p7l694t2035r1051b2110],
5	the	DT	O	the	det	7	SENT_97	[p7l1096t2035r1198b2095],
6	statistical	JJ	O	statistical	amod	7	SENT_97	[p7l1244t2035r1563b2095],
7	analysis	NN	O	analysis	dobj	4	SENT_97	[p7l1607t2035r1891b2110],
8	.	.	O	.	_	0	SENT_97	[p7l1607t2035r1891b2110],

1	All	DT	O	all	det	2	SENT_98	[p7l1939t2035r2042b2094],
2	authors	NNS	O	author	nsubj	3	SENT_98	[p7l9t2137r266b2196],
3	wrote	VBD	O	write	_	0	SENT_98	[p7l297t2145r489b2196],
4	the	DT	O	the	det	5	SENT_98	[p7l521t2137r623b2196],
5	manuscript	NN	O	manuscript	dobj	3	SENT_98	[p7l653t2137r1054b2212],
6	.	.	O	.	_	0	SENT_98	[p7l653t2137r1054b2212],

1	Disclosure	NN	O	disclosure	_	0	SENT_99	[p7l12t2367r372b2428],
2	of	IN	O	of	_	0	SENT_99	[p7l404t2366r472b2428],
3	Conflict	NN	O	conflict	prep_of	1	SENT_99	[p7l504t2366r778b2428],
4	of	IN	O	of	_	0	SENT_99	[p7l807t2366r875b2428],
5	Interest	NN	O	interest	prep_of	1	SENT_99	[p7l908t2371r1168b2428],

1	The	DT	O	the	det	2	SENT_100	[p7l8t2522r137b2581],
2	authors	NNS	O	author	nsubj	3	SENT_100	[p7l169t2522r427b2581],
3	state	VBP	O	state	_	0	SENT_100	[p7l460t2530r615b2581],
4	that	IN	O	that	complm	6	SENT_100	[p7l646t2522r781b2581],
5	they	PRP	O	they	nsubj	6	SENT_100	[p7l811t2522r955b2597],
6	have	VBP	O	have	ccomp	3	SENT_100	[p7l985t2522r1142b2581],
7	no	DT	O	no	det	8	SENT_100	[p7l1172t2541r1256b2581],
8	conﬂict	NN	O	conﬂict	dobj	6	SENT_100	[p7l1288t2522r1538b2581],
9	of	IN	O	of	_	0	SENT_100	[p7l1570t2522r1644b2581],
10	interest	NN	O	interest	prep_of	8	SENT_100	[p7l1666t2522r1933b2581],
11	.	.	O	.	_	0	SENT_100	[p7l1666t2522r1933b2581],

1	Letters	NNS	O	letter	_	0	SENT_101	[p7l1378t2874r1584b2923],
2	to	TO	O	to	_	0	SENT_101	[p7l1613t2882r1664b2922],
3	the	DT	O	the	det	4	SENT_101	[p7l1695t2871r1777b2923],
4	Editor	NNP	O	Editor	prep_to	1	SENT_101	[p7l1803t2871r1987b2922],
5	375	CD	NUMBER	375	num	4	SENT_101	[p7l2021t2867r2146b2923],

1	References	NNS	O	reference	_	0	SENT_102	[p7l57t3081r441b3145],

1	1	CD	NUMBER	1	num	3	SENT_103	[p7l60t3254r78b3303],
2	Aithal	NNP	O	Aithal	nn	3	SENT_103	[p7l133t3252r320b3303],
3	GP	NNP	O	GP	_	0	SENT_103	[p7l350t3253r462b3314],
4	,	,	O	,	_	0	SENT_103	[p7l350t3253r462b3314],
5	Day	NNP	DURATION	Day	nn	6	SENT_103	[p7l495t3254r619b3317],
6	CP	NNP	O	CP	appos	3	SENT_103	[p7l649t3253r754b3314],
7	,	,	O	,	_	0	SENT_103	[p7l649t3253r754b3314],
8	Kesteven	NNP	PERSON	Kesteven	nn	9	SENT_103	[p7l786t3254r1056b3303],
9	PJ	NNP	PERSON	PJ	appos	3	SENT_103	[p7l1085t3254r1171b3314],
10	,	,	O	,	_	0	SENT_103	[p7l1085t3254r1171b3314],
11	Daly	NNP	PERSON	Daly	nn	12	SENT_103	[p7l1203t3252r1347b3317],
12	AK	NNP	O	AK	appos	3	SENT_103	[p7l1375t3252r1499b3303],
13	.	.	O	.	_	0	SENT_103	[p7l1375t3252r1499b3303],

1	Association	NNP	O	Association	_	0	SENT_104	[p7l1531t3252r1879b3303],
2	of	IN	O	of	_	0	SENT_104	[p7l1910t3252r1974b3303],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_104	[p7l1996t3252r2147b3317, p7l133t3338r461b3403],
4	in	IN	O	in	_	0	SENT_104	[p7l496t3339r551b3389],
5	the	DT	O	the	det	8	SENT_104	[p7l586t3338r675b3389],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_104	[p7l709t3338r1057b3403],
7	P450	NN	O	p450	nn	8	SENT_104	[p7l1090t3340r1234b3390],
8	CYP2C9	NN	O	cyp2c9	prep_in	1	SENT_104	[p7l1271t3339r1532b3390],
9	with	IN	O	with	_	0	SENT_104	[p7l1567t3338r1696b3390],
10	warfarin	NN	O	warfarin	nn	12	SENT_104	[p7l1729t3338r1982b3389],
11	dose	NN	O	dose	nn	12	SENT_104	[p7l2017t3338r2148b3389],
12	requirement	NN	O	requirement	prep_with	1	SENT_104	[p7l134t3425r493b3489],
13	and	CC	O	and	_	0	SENT_104	[p7l521t3425r630b3476],
14	risk	NN	O	risk	conj_and	12	SENT_104	[p7l658t3425r767b3476],
15	of	IN	O	of	_	0	SENT_104	[p7l796t3425r861b3476],
16	bleeding	VBG	O	bleed	amod	17	SENT_104	[p7l883t3424r1130b3489],
17	complications	NNS	O	complication	prep_of	1	SENT_104	[p7l1158t3425r1584b3489],
18	.	.	O	.	_	0	SENT_104	[p7l1158t3425r1584b3489],

1	Lancet	NNP	O	Lancet	_	0	SENT_105	[p7l1617t3428r1816b3476],
2	1999	CD	DATE	1999	num	1	SENT_105	[p7l1850t3426r1996b3486],
3	;	:	O	;	_	0	SENT_105	[p7l1850t3426r1996b3486],
4	353	CD	NUMBER	353	num	6	SENT_105	[p7l2027t3426r2144b3476],
5	:	:	O	:	_	0	SENT_105	[p7l2027t3426r2144b3476],
6	717-19	CD	NUMBER	717-19	dep	1	SENT_105	[p7l135t3511r356b3562],
7	.	.	O	.	_	0	SENT_105	[p7l135t3511r356b3562],

1	2	CD	NUMBER	2	_	0	SENT_106	[p7l53t3599r84b3648],
2	Higashi	NNP	ORGANIZATION	Higashi	nn	3	SENT_106	[p7l135t3597r362b3662],
3	MK	NNP	ORGANIZATION	MK	dep	1	SENT_106	[p7l395t3599r534b3659],
4	,	,	O	,	_	0	SENT_106	[p7l395t3599r534b3659],
5	Veenstra	NNP	ORGANIZATION	Veenstra	nn	6	SENT_106	[p7l567t3599r828b3648],
6	DL	NNP	ORGANIZATION	DL	appos	3	SENT_106	[p7l860t3599r977b3659],
7	,	,	O	,	_	0	SENT_106	[p7l860t3599r977b3659],
8	Kondo	NNP	PERSON	Kondo	nn	9	SENT_106	[p7l1012t3597r1219b3648],
9	LM	NNP	O	LM	appos	3	SENT_106	[p7l1253t3599r1381b3659],
10	,	,	O	,	_	0	SENT_106	[p7l1253t3599r1381b3659],
11	Wittowsky	NNP	ORGANIZATION	Wittowsky	nn	12	SENT_106	[p7l1414t3597r1737b3662],
12	AK	NNP	ORGANIZATION	AK	appos	3	SENT_106	[p7l1767t3598r1893b3659],
13	,	,	O	,	_	0	SENT_106	[p7l1767t3598r1893b3659],
14	Srinouanprachanh	NNP	ORGANIZATION	Srinouanprachanh	nn	15	SENT_106	[p7l1930t3598r2147b3649, p7l135t3684r486b3748],
15	SL	NNP	ORGANIZATION	SL	appos	3	SENT_106	[p7l544t3685r640b3745],
16	,	,	O	,	_	0	SENT_106	[p7l544t3685r640b3745],
17	Farin	NNP	PERSON	Farin	nn	18	SENT_106	[p7l699t3684r861b3735],
18	FM	NNP	O	FM	appos	3	SENT_106	[p7l917t3686r1045b3745],
19	,	,	O	,	_	0	SENT_106	[p7l917t3686r1045b3745],
20	Rettie	NNP	O	Rettie	nn	21	SENT_106	[p7l1105t3684r1280b3735],
21	AE	NNP	O	AE	appos	3	SENT_106	[p7l1334t3684r1447b3734],
22	.	.	O	.	_	0	SENT_106	[p7l1334t3684r1447b3734],

1	Association	NNP	O	Association	_	0	SENT_107	[p7l1506t3684r1854b3735],
2	between	IN	O	between	dep	1	SENT_107	[p7l1909t3683r2149b3735],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_108	[p8l135t19r396b69],
2	genetic	JJ	O	genetic	amod	3	SENT_108	[p8l444t18r648b82],
3	variants	NNS	O	variant	dep	1	SENT_108	[p8l693t18r929b69],
4	and	CC	O	and	_	0	SENT_108	[p8l977t18r1085b69],
5	anticoagulation-related	JJ	O	anticoagulation-related	amod	6	SENT_108	[p8l1132t18r1820b82],
6	outcomes	NNS	O	outcome	dep	1	SENT_108	[p8l1868t25r2148b69],
7	during	IN	O	during	_	0	SENT_108	[p8l134t103r328b168],
8	warfarin	NN	O	warfarin	nn	9	SENT_108	[p8l353t103r606b154],
9	therapy	NN	O	therapy	prep_during	1	SENT_108	[p8l632t103r871b168],
10	.	.	O	.	_	0	SENT_108	[p8l632t103r871b168],

1	JAMA	NNP	O	JAMA	_	0	SENT_109	[p8l900t105r1100b155],
2	2002	CD	DATE	2002	num	1	SENT_109	[p8l1129t105r1282b165],
3	;	:	O	;	_	0	SENT_109	[p8l1129t105r1282b165],
4	287	CD	NUMBER	287	num	6	SENT_109	[p8l1310t105r1427b155],
5	:	:	O	:	_	0	SENT_109	[p8l1310t105r1427b155],
6	1690-8	CD	NUMBER	1690-8	dep	1	SENT_109	[p8l1464t105r1680b155],
7	.	.	O	.	_	0	SENT_109	[p8l1464t105r1680b155],

1	3	CD	NUMBER	3	num	3	SENT_110	[p8l55t191r82b241],
2	Biss	NNP	ORGANIZATION	Biss	nn	3	SENT_110	[p8l135t190r250b241],
3	TT	NN	ORGANIZATION	tt	nsubj	38	SENT_110	[p8l289t192r396b251],
4	,	,	O	,	_	0	SENT_110	[p8l289t192r396b251],
5	Avery	NNP	PERSON	Avery	nn	6	SENT_110	[p8l437t190r616b254],
6	PJ	NNP	PERSON	PJ	conj_and	3	SENT_110	[p8l653t192r740b251],
7	,	,	O	,	_	0	SENT_110	[p8l653t192r740b251],
8	Brandao	NNP	ORGANIZATION	Brandao	nn	9	SENT_110	[p8l782t190r1035b241],
9	LR	NNP	ORGANIZATION	LR	conj_and	3	SENT_110	[p8l1077t192r1189b251],
10	,	,	O	,	_	0	SENT_110	[p8l1077t192r1189b251],
11	Chalmers	NNP	ORGANIZATION	Chalmers	nn	12	SENT_110	[p8l1232t190r1512b241],
12	EA	NN	ORGANIZATION	ea	conj_and	3	SENT_110	[p8l1551t190r1664b251],
13	,	,	O	,	_	0	SENT_110	[p8l1551t190r1664b251],
14	Williams	NNP	ORGANIZATION	Williams	nn	15	SENT_110	[p8l1705t190r1966b241],
15	MD	NNP	ORGANIZATION	MD	nsubj	38	SENT_110	[p8l2006t192r2146b251],
16	,	,	O	,	_	0	SENT_110	[p8l2006t192r2146b251],
17	Grainger	NNP	PERSON	Grainger	nn	18	SENT_110	[p8l135t276r401b340],
18	JD	NNP	O	JD	nsubj	38	SENT_110	[p8l448t278r551b337],
19	,	,	O	,	_	0	SENT_110	[p8l448t278r551b337],
20	Leathart	NNP	O	Leathart	nn	21	SENT_110	[p8l604t276r859b327],
21	JB	NNP	O	JB	nsubj	38	SENT_110	[p8l907t277r997b337],
22	,	,	O	,	_	0	SENT_110	[p8l907t277r997b337],
23	Hanley	NNP	PERSON	Hanley	nn	24	SENT_110	[p8l1050t276r1262b340],
24	JP	NNP	O	JP	nsubj	38	SENT_110	[p8l1310t278r1397b337],
25	,	,	O	,	_	0	SENT_110	[p8l1310t278r1397b337],
26	Daly	NNP	ORGANIZATION	Daly	nn	27	SENT_110	[p8l1449t276r1592b340],
27	AK	NNP	ORGANIZATION	AK	nsubj	38	SENT_110	[p8l1640t276r1765b337],
28	,	,	O	,	_	0	SENT_110	[p8l1640t276r1765b337],
29	Kamali	NNP	PERSON	Kamali	nn	31	SENT_110	[p8l1817t276r2036b327],
30	F.	NNP	O	F.	nn	31	SENT_110	[p8l2086t278r2144b326],
31	VKORC1	NNP	O	VKORC1	nsubj	38	SENT_110	[p8l133t362r425b412],
32	and	CC	O	and	_	0	SENT_110	[p8l490t361r598b412],
33	CYP2C9	NNP	O	CYP2C9	nn	34	SENT_110	[p8l656t362r917b412],
34	genotype	NN	O	genotype	nsubj	38	SENT_110	[p8l976t368r1243b425],
35	and	CC	O	and	_	0	SENT_110	[p8l1301t361r1409b412],
36	patient	NN	O	patient	nn	37	SENT_110	[p8l1465t361r1672b425],
37	characteristics	NNS	O	characteristic	conj_and	3	SENT_110	[p8l1728t361r2147b412],
38	explain	VBP	O	explain	_	0	SENT_110	[p8l134t448r347b512],
39	a	DT	O	a	det	41	SENT_110	[p8l393t464r424b498],
40	large	JJ	O	large	amod	41	SENT_110	[p8l470t447r614b512],
41	proportion	NN	O	proportion	dobj	38	SENT_110	[p8l659t448r984b512],
42	of	IN	O	of	_	0	SENT_110	[p8l1032t447r1096b498],
43	the	DT	O	the	det	44	SENT_110	[p8l1136t447r1225b498],
44	variability	NN	O	variability	prep_of	41	SENT_110	[p8l1270t447r1573b512],
45	in	IN	O	in	_	0	SENT_110	[p8l1617t448r1673b498],
46	warfarin	NN	O	warfarin	nn	48	SENT_110	[p8l1718t447r1971b498],
47	dose	NN	O	dose	nn	48	SENT_110	[p8l2017t447r2148b498],
48	requirement	NN	O	requirement	prep_in	44	SENT_110	[p8l134t534r493b598],
49	among	IN	O	among	_	0	SENT_110	[p8l519t550r720b598],
50	children	NNS	O	child	prep_among	48	SENT_110	[p8l745t534r999b585],
51	.	.	O	.	_	0	SENT_110	[p8l745t534r999b585],

1	Blood	NN	O	blood	_	0	SENT_111	[p8l1029t534r1203b585],
2	2012	CD	DATE	2012	num	1	SENT_111	[p8l1223t535r1376b595],
3	;	:	O	;	_	0	SENT_111	[p8l1223t535r1376b595],
4	119	CD	NUMBER	119	num	6	SENT_111	[p8l1408t535r1521b585],
5	:	:	O	:	_	0	SENT_111	[p8l1408t535r1521b585],
6	868-73	CD	NUMBER	868-73	dep	1	SENT_111	[p8l1553t535r1773b585],
7	.	.	O	.	_	0	SENT_111	[p8l1553t535r1773b585],

1	4	LS	NUMBER	4	dep	2	SENT_112	[p8l53t620r85b669],
2	Moreau	NN	ORGANIZATION	moreau	_	0	SENT_112	[p8l135t621r371b670],
3	C	NN	ORGANIZATION	c	dep	17	SENT_112	[p8l406t620r468b680],
4	,	,	O	,	_	0	SENT_112	[p8l406t620r468b680],
5	Bajolle	NNP	O	Bajolle	nn	6	SENT_112	[p8l506t619r710b683],
6	F	NN	O	f	appos	3	SENT_112	[p8l745t621r804b680],
7	,	,	O	,	_	0	SENT_112	[p8l745t621r804b680],
8	Siguret	NNP	O	Siguret	nn	9	SENT_112	[p8l844t619r1051b683],
9	V	NNP	O	V	appos	6	SENT_112	[p8l1084t621r1148b680],
10	,	,	O	,	_	0	SENT_112	[p8l1084t621r1148b680],
11	Lasne	NNP	O	Lasne	nn	12	SENT_112	[p8l1187t621r1360b670],
12	D	NNP	O	D	appos	6	SENT_112	[p8l1395t621r1466b680],
13	,	,	O	,	_	0	SENT_112	[p8l1395t621r1466b680],
14	Golmard	NNP	PERSON	Golmard	nn	15	SENT_112	[p8l1504t619r1773b670],
15	JL	NNP	O	JL	appos	6	SENT_112	[p8l1807t621r1898b680],
16	,	,	O	,	_	0	SENT_112	[p8l1807t621r1898b680],
17	Elie	NNP	PERSON	Elie	prep	2	SENT_112	[p8l1936t619r2047b670],
18	C	NNP	PERSON	C	dep	17	SENT_112	[p8l2083t620r2145b680],
19	,	,	O	,	_	0	SENT_112	[p8l2083t620r2145b680],
20	Beaune	NNP	LOCATION	Beaune	nn	21	SENT_112	[p8l135t707r351b756],
21	P	NN	O	p	appos	18	SENT_112	[p8l382t707r438b767],
22	,	,	O	,	_	0	SENT_112	[p8l382t707r438b767],
23	Cheurﬁ	JJ	O	cheurﬁ	amod	24	SENT_112	[p8l473t705r693b757],
24	R	NN	O	r	dep	17	SENT_112	[p8l726t708r791b767],
25	,	,	O	,	_	0	SENT_112	[p8l726t708r791b767],
26	Bonnet	NN	PERSON	bonnet	nn	27	SENT_112	[p8l826t707r1039b756],
27	D	NN	PERSON	d	dep	2	SENT_112	[p8l1070t707r1140b767],
28	,	,	O	,	_	0	SENT_112	[p8l1070t707r1140b767],
29	Loriot	NNP	LOCATION	Loriot	nn	30	SENT_112	[p8l1175t706r1365b756],
30	MA	NNP	LOCATION	MA	appos	27	SENT_112	[p8l1397t705r1531b756],
31	.	.	O	.	_	0	SENT_112	[p8l1397t705r1531b756],

1	Vitamin	NN	O	vitamin	nn	3	SENT_113	[p8l1565t706r1806b756],
2	K	NN	O	k	nn	3	SENT_113	[p8l1837t707r1892b756],
3	antagonists	NNS	O	antagonist	nsubj	17	SENT_113	[p8l1923t713r2147b770, p8l134t792r265b843],
4	in	IN	O	in	_	0	SENT_113	[p8l291t792r346b842],
5	children	NNS	O	child	prep_in	3	SENT_113	[p8l372t792r611b843],
6	with	IN	O	with	_	0	SENT_113	[p8l636t792r765b843],
7	heart	NN	O	heart	nn	8	SENT_113	[p8l790t792r942b843],
8	disease	NN	O	disease	prep_with	5	SENT_113	[p8l967t792r1186b843],
9	:	:	O	:	_	0	SENT_113	[p8l967t792r1186b843],
10	height	NN	O	height	nn	13	SENT_113	[p8l1215t792r1398b856],
11	and	CC	O	and	_	0	SENT_113	[p8l1424t792r1533b843],
12	VKORC1	NN	O	vkorc1	conj_and	10	SENT_113	[p8l1557t793r1849b843],
13	genotype	NN	O	genotype	dep	5	SENT_113	[p8l1882t799r2148b856],
14	are	VBP	O	be	cop	17	SENT_113	[p8l135t894r223b928],
15	the	DT	O	the	det	17	SENT_113	[p8l273t877r362b928],
16	main	JJ	O	main	amod	17	SENT_113	[p8l411t877r559b928],
17	determinants	NNS	O	determinant	_	0	SENT_113	[p8l608t877r993b928],
18	of	IN	O	of	_	0	SENT_113	[p8l1044t877r1108b928],
19	the	DT	O	the	det	22	SENT_113	[p8l1151t877r1240b928],
20	warfarin	NN	O	warfarin	nn	22	SENT_113	[p8l1289t877r1542b928],
21	dose	NN	O	dose	nn	22	SENT_113	[p8l1591t877r1722b928],
22	requirement	NN	O	requirement	prep_of	17	SENT_113	[p8l1772t877r2144b941],
23	.	.	O	.	_	0	SENT_113	[p8l1772t877r2144b941],

1	Blood	NN	O	blood	_	0	SENT_114	[p8l134t963r308b1014],
2	2012	CD	DATE	2012	num	1	SENT_114	[p8l328t964r481b1025],
3	;	:	O	;	_	0	SENT_114	[p8l328t964r481b1025],
4	119	CD	NUMBER	119	num	6	SENT_114	[p8l513t964r626b1014],
5	:	:	O	:	_	0	SENT_114	[p8l513t964r626b1014],
6	861-7	CD	NUMBER	861-7	dep	1	SENT_114	[p8l659t964r843b1014],
7	.	.	O	.	_	0	SENT_114	[p8l659t964r843b1014],

1	5	CD	NUMBER	5	num	3	SENT_115	[p8l56t1052r83b1101],
2	Daly	NNP	ORGANIZATION	Daly	nn	3	SENT_115	[p8l134t1050r278b1114],
3	AK	NNP	ORGANIZATION	AK	_	0	SENT_115	[p8l307t1050r433b1111],
4	,	,	O	,	_	0	SENT_115	[p8l307t1050r433b1111],
5	Steen	NNP	PERSON	Steen	nn	6	SENT_115	[p8l468t1051r625b1101],
6	VM	NNP	O	VM	appos	3	SENT_115	[p8l654t1052r788b1111],
7	,	,	O	,	_	0	SENT_115	[p8l654t1052r788b1111],
8	Fairbrother	NNP	PERSON	Fairbrother	nn	9	SENT_115	[p8l822t1050r1169b1101],
9	KS	NN	O	k	appos	3	SENT_115	[p8l1199t1051r1309b1111],
10	,	,	O	,	_	0	SENT_115	[p8l1199t1051r1309b1111],
11	Idle	NNP	O	Idle	nn	12	SENT_115	[p8l1343t1050r1454b1101],
12	JR.	NNP	O	JR.	appos	3	SENT_115	[p8l1484t1052r1581b1101],
13	.	.	O	.	_	0	SENT_115	[p8l1484t1052r1581b1101],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_116	[p8l1617t1051r1886b1101],
2	multiallelism	NN	O	multiallelism	dep	1	SENT_116	[p8l1916t1050r2147b1101, p8l134t1135r318b1186],
3	.	.	O	.	_	0	SENT_116	[p8l1916t1050r2147b1101, p8l134t1135r318b1186],

1	Methods	NNS	O	method	_	0	SENT_117	[p8l348t1135r601b1186],
2	Enzymol	JJ	O	enzymol	amod	3	SENT_117	[p8l626t1135r882b1200],
3	1996	CD	DATE	1996	dep	1	SENT_117	[p8l911t1136r1056b1196],
4	;	:	O	;	_	0	SENT_117	[p8l911t1136r1056b1196],
5	272	CD	NUMBER	272	num	7	SENT_117	[p8l1085t1136r1202b1186],
6	:	:	O	:	_	0	SENT_117	[p8l1085t1136r1202b1186],
7	199-210	CD	NUMBER	199-210	dep	1	SENT_117	[p8l1239t1136r1488b1186],
8	.	.	O	.	_	0	SENT_117	[p8l1239t1136r1488b1186],

1	6	CD	NUMBER	6	num	3	SENT_118	[p8l54t1222r84b1272],
2	Monagle	NN	ORGANIZATION	monagle	nn	3	SENT_118	[p8l135t1221r397b1285],
3	P	NN	ORGANIZATION	p	_	0	SENT_118	[p8l433t1223r490b1282],
4	,	,	O	,	_	0	SENT_118	[p8l433t1223r490b1282],
5	Chan	NNP	ORGANIZATION	Chan	nn	6	SENT_118	[p8l530t1221r688b1272],
6	AKC	NNP	ORGANIZATION	AKC	appos	3	SENT_118	[p8l724t1221r900b1282],
7	,	,	O	,	_	0	SENT_118	[p8l724t1221r900b1282],
8	Goldenberg	NNP	ORGANIZATION	Goldenberg	nn	9	SENT_118	[p8l940t1221r1290b1285],
9	NA	NNP	ORGANIZATION	NA	appos	6	SENT_118	[p8l1326t1221r1451b1282],
10	,	,	O	,	_	0	SENT_118	[p8l1326t1221r1451b1282],
11	Ichord	NNP	ORGANIZATION	Ichord	nn	12	SENT_118	[p8l1491t1221r1688b1272],
12	RN	NNP	ORGANIZATION	RN	appos	6	SENT_118	[p8l1727t1223r1850b1282],
13	,	,	O	,	_	0	SENT_118	[p8l1727t1223r1850b1282],
14	Journeycake	NNP	PERSON	Journeycake	nn	15	SENT_118	[p8l1888t1223r2147b1285, p8l134t1307r265b1358],
15	JM	NN	O	jm	appos	6	SENT_118	[p8l296t1309r410b1368],
16	,	,	O	,	_	0	SENT_118	[p8l296t1309r410b1368],
17	Nowak-Gottl	NNP	O	Nowak-Gottl	nn	18	SENT_118	[p8l442t1307r844b1358],
18	U	NNP	O	U	appos	6	SENT_118	[p8l875t1309r946b1368],
19	,	,	O	,	_	0	SENT_118	[p8l875t1309r946b1368],
20	Vesely	NNP	O	Vesely	nn	21	SENT_118	[p8l978t1307r1169b1371],
21	SK	NNP	O	SK	appos	6	SENT_118	[p8l1201t1308r1307b1358],
22	.	.	O	.	_	0	SENT_118	[p8l1201t1308r1307b1358],

1	Antithrombotic	JJ	MISC	antithrombotic	amod	2	SENT_119	[p8l1341t1307r1808b1358],
2	therapy	NN	O	therapy	_	0	SENT_119	[p8l1839t1307r2063b1372],
3	in	IN	O	in	_	0	SENT_119	[p8l2093t1307r2148b1357],
4	neonates	NNS	O	neonate	prep_in	2	SENT_119	[p8l134t1400r393b1444],
5	and	CC	O	and	_	0	SENT_119	[p8l420t1393r528b1444],
6	children	NNS	O	child	prep_in	2	SENT_119	[p8l554t1393r808b1444],
7	.	.	O	.	_	0	SENT_119	[p8l554t1393r808b1444],

1	Chest	NN	O	chest	_	0	SENT_120	[p8l842t1393r1002b1444],
2	2012	CD	DATE	2012	num	1	SENT_120	[p8l1028t1394r1180b1455],
3	;	:	O	;	_	0	SENT_120	[p8l1028t1394r1180b1455],
4	141	CD	NUMBER	141	dep	1	SENT_120	[p8l1212t1394r1325b1444],
5	:	:	O	:	_	0	SENT_120	[p8l1212t1394r1325b1444],
6	e737S	NN	O	e737	nn	8	SENT_120	[p8l1355t1394r1719b1444],
7	—	CD	NUMBER	—	num	8	SENT_120	[p8l1355t1394r1719b1444],
8	80lS	NN	O	80l	dep	4	SENT_120	[p8l1355t1394r1719b1444],
9	.	.	O	.	_	0	SENT_120	[p8l1355t1394r1719b1444],

1	7	CD	NUMBER	7	_	0	SENT_121	[p8l54t1481r84b1530],
2	Joffe	NNP	ORGANIZATION	Joffe	nn	3	SENT_121	[p8l133t1479r277b1530],
3	HV	NNP	ORGANIZATION	HV	dep	1	SENT_121	[p8l308t1481r429b1540],
4	,	,	O	,	_	0	SENT_121	[p8l308t1481r429b1540],
5	Xu	NNP	PERSON	Xu	nn	6	SENT_121	[p8l461t1481r552b1530],
6	R	NNP	PERSON	R	appos	3	SENT_121	[p8l584t1481r649b1540],
7	,	,	O	,	_	0	SENT_121	[p8l584t1481r649b1540],
8	Johnson	NNP	PERSON	Johnson	nn	9	SENT_121	[p8l682t1479r930b1530],
9	FB	NNP	O	FB	appos	3	SENT_121	[p8l962t1481r1067b1540],
10	,	,	O	,	_	0	SENT_121	[p8l962t1481r1067b1540],
11	Longtine	NNP	PERSON	Longtine	nn	12	SENT_121	[p8l1101t1479r1366b1543],
12	J	NNP	PERSON	J	appos	3	SENT_121	[p8l1396t1481r1441b1540],
13	,	,	O	,	_	0	SENT_121	[p8l1396t1481r1441b1540],
14	Kucher	NNP	O	Kucher	nn	15	SENT_121	[p8l1474t1479r1695b1530],
15	N	NNP	O	N	appos	3	SENT_121	[p8l1724t1481r1795b1540],
16	,	,	O	,	_	0	SENT_121	[p8l1724t1481r1795b1540],
17	Goldhaber	NNP	PERSON	Goldhaber	nn	18	SENT_121	[p8l1829t1479r2149b1530],
18	SZ	NNP	O	SZ	appos	3	SENT_121	[p8l136t1566r232b1616],
19	.	.	O	.	_	0	SENT_121	[p8l136t1566r232b1616],

1	Warfarin	NNP	O	Warfarin	nn	2	SENT_122	[p8l271t1565r542b1616],
2	dosing	NN	O	dosing	_	0	SENT_122	[p8l579t1565r773b1630],
3	and	CC	O	and	_	0	SENT_122	[p8l810t1565r918b1616],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_122	[p8l954t1565r1301b1629],
5	P450	NN	O	p450	conj_and	2	SENT_122	[p8l1337t1566r1480b1616],
6	2C9	NN	O	2c9	nn	7	SENT_122	[p8l1518t1566r1634b1616],
7	polymorphisms	NNS	O	polymorphism	dep	2	SENT_122	[p8l1670t1565r2144b1630],
8	.	.	O	.	_	0	SENT_122	[p8l1670t1565r2144b1630],

1	T	NN	O	t	nn	2	SENT_123	[p8l140t1655r185b1702],
2	hromb	NN	O	hromb	_	0	SENT_123	[p8l181t1652r363b1703],
3	Haemost	NNP	O	Haemost	dep	2	SENT_123	[p8l389t1655r650b1703],
4	2004	CD	DATE	2004	num	3	SENT_123	[p8l675t1653r827b1713],
5	;	:	O	;	_	0	SENT_123	[p8l675t1653r827b1713],
6	91	CD	NUMBER	91	num	8	SENT_123	[p8l856t1653r938b1703],
7	:	:	O	:	_	0	SENT_123	[p8l856t1653r938b1703],
8	1123-8	CD	NUMBER	1123-8	dep	2	SENT_123	[p8l975t1653r1190b1703],
9	.	.	O	.	_	0	SENT_123	[p8l975t1653r1190b1703],

1	8	CD	NUMBER	8	_	0	SENT_124	[p8l55t1738r82b1788],
2	Meckley	NNP	ORGANIZATION	Meckley	nn	3	SENT_124	[p8l135t1737r385b1801],
3	LM	NNP	ORGANIZATION	LM	dep	1	SENT_124	[p8l429t1739r557b1798],
4	,	,	O	,	_	0	SENT_124	[p8l429t1739r557b1798],
5	Wittowsky	NNP	ORGANIZATION	Wittowsky	nn	6	SENT_124	[p8l601t1737r924b1801],
6	AK	NNP	ORGANIZATION	AK	appos	3	SENT_124	[p8l966t1737r1091b1798],
7	,	,	O	,	_	0	SENT_124	[p8l966t1737r1091b1798],
8	Rieder	NNP	PERSON	Rieder	nn	9	SENT_124	[p8l1139t1737r1334b1788],
9	MJ	NNP	PERSON	MJ	appos	3	SENT_124	[p8l1378t1739r1490b1798],
10	,	,	O	,	_	0	SENT_124	[p8l1378t1739r1490b1798],
11	Rettie	NNP	PERSON	Rettie	nn	12	SENT_124	[p8l1538t1737r1713b1788],
12	AE	NNP	O	AE	appos	3	SENT_124	[p8l1756t1737r1870b1798],
13	,	,	O	,	_	0	SENT_124	[p8l1756t1737r1870b1798],
14	Veentra	NNP	O	Veentra	nn	15	SENT_124	[p8l1915t1739r2148b1788],
15	DL	NNP	O	DL	appos	3	SENT_124	[p8l134t1825r250b1874],
16	.	.	O	.	_	0	SENT_124	[p8l134t1825r250b1874],

1	An	DT	O	a	det	2	SENT_125	[p8l283t1823r373b1873],
2	analysis	NN	O	analysis	_	0	SENT_125	[p8l403t1823r634b1887],
3	of	IN	O	of	_	0	SENT_125	[p8l665t1823r730b1874],
4	the	DT	O	the	det	6	SENT_125	[p8l753t1823r842b1874],
5	relative	JJ	O	relative	amod	6	SENT_125	[p8l872t1823r1087b1874],
6	effects	NNS	O	effect	prep_of	2	SENT_125	[p8l1117t1823r1301b1874],
7	of	IN	O	of	_	0	SENT_125	[p8l1332t1823r1397b1874],
8	VKORC1	NN	O	vkorc1	nn	11	SENT_125	[p8l1419t1824r1711b1874],
9	and	CC	O	and	_	0	SENT_125	[p8l1747t1823r1855b1874],
10	CYP2C9	NN	O	cyp2c9	nn	11	SENT_125	[p8l1886t1824r2147b1874],
11	variants	NNS	O	variant	prep_of	6	SENT_125	[p8l133t1909r370b1960],
12	on	IN	O	on	_	0	SENT_125	[p8l409t1926r482b1960],
13	anticoagulation	NN	O	anticoagulation	nn	15	SENT_125	[p8l519t1909r982b1974],
14	related	JJ	O	related	amod	15	SENT_125	[p8l1018t1909r1219b1960],
15	outcomes	NNS	O	outcome	prep_on	2	SENT_125	[p8l1257t1916r1536b1960],
16	in	IN	O	in	_	0	SENT_125	[p8l1573t1909r1629b1959],
17	warfarin-treated	JJ	O	warfarin-treated	amod	18	SENT_125	[p8l1665t1909r2148b1960],
18	patients	NNS	O	patient	prep_in	2	SENT_125	[p8l133t1995r381b2059],
19	.	.	O	.	_	0	SENT_125	[p8l133t1995r381b2059],

1	T	NN	O	t	nn	2	SENT_126	[p8l417t1998r462b2045],
2	lzromb	NN	O	lzromb	_	0	SENT_126	[p8l458t1995r640b2046],
3	Haemost	NNP	O	Haemost	dep	2	SENT_126	[p8l666t1998r927b2046],
4	2008	CD	DATE	2008	num	3	SENT_126	[p8l952t1996r1104b2057],
5	;	:	O	;	_	0	SENT_126	[p8l952t1996r1104b2057],
6	100	CD	NUMBER	100	num	8	SENT_126	[p8l1136t1996r1249b2046],
7	:	:	O	:	_	0	SENT_126	[p8l1136t1996r1249b2046],
8	229-39	CD	NUMBER	229-39	dep	2	SENT_126	[p8l1280t1996r1502b2046],
9	.	.	O	.	_	0	SENT_126	[p8l1280t1996r1502b2046],

1	9	CD	NUMBER	9	num	3	SENT_127	[p8l54t2082r83b2132],
2	Ruud	NN	PERSON	ruud	nn	3	SENT_127	[p8l136t2081r301b2132],
3	E	NN	PERSON	e	nsubjpass	19	SENT_127	[p8l332t2083r391b2142],
4	,	,	O	,	_	0	SENT_127	[p8l332t2083r391b2142],
5	Holmstrom	NN	PERSON	holmstrom	nn	6	SENT_127	[p8l425t2081r768b2132],
6	H	NN	O	h	appos	3	SENT_127	[p8l798t2083r868b2142],
7	,	,	O	,	_	0	SENT_127	[p8l798t2083r868b2142],
8	Bergan	NNP	PERSON	Bergan	nn	9	SENT_127	[p8l902t2083r1111b2146],
9	S	NNP	O	S	appos	3	SENT_127	[p8l1143t2082r1192b2142],
10	,	,	O	,	_	0	SENT_127	[p8l1143t2082r1192b2142],
11	Wesenberg	NNP	PERSON	Wesenberg	nn	14	SENT_127	[p8l1225t2081r1550b2146],
12	F.	NNP	O	F.	nn	14	SENT_127	[p8l1581t2083r1638b2132],
13	Oral	NNP	O	Oral	nn	14	SENT_127	[p8l1673t2081r1804b2132],
14	anticoagulation	NN	O	anticoagulation	appos	3	SENT_127	[p8l1836t2081r2146b2146, p8l134t2167r304b2218],
15	with	IN	O	with	_	0	SENT_127	[p8l348t2167r478b2218],
16	warfarin	NN	O	warfarin	prep_with	14	SENT_127	[p8l521t2167r774b2218],
17	is	VBZ	O	be	auxpass	19	SENT_127	[p8l818t2167r861b2218],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_127	[p8l908t2167r1262b2232],
19	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_127	[p8l1305t2167r1606b2218],
20	by	IN	O	by	_	0	SENT_127	[p8l1651t2167r1722b2232],
21	steroids	NNS	O	steroid	agent	19	SENT_127	[p8l1768t2167r1993b2218],
22	and	CC	O	and	_	0	SENT_127	[p8l2040t2167r2148b2218],
23	CYP2C9	NN	O	cyp2c9	nn	24	SENT_127	[p8l135t2254r396b2304],
24	polymorphisms	NNS	O	polymorphism	agent	19	SENT_127	[p8l437t2253r895b2318],
25	in	IN	O	in	_	0	SENT_127	[p8l936t2253r991b2303],
26	children	NNS	O	child	prep_in	19	SENT_127	[p8l1031t2253r1270b2304],
27	with	IN	O	with	_	0	SENT_127	[p8l1309t2253r1439b2304],
28	cancer	NN	O	cancer	prep_with	26	SENT_127	[p8l1479t2270r1683b2304],
29	.	.	O	.	_	0	SENT_127	[p8l1479t2270r1683b2304],

1	Pediatr	NNP	O	Pediatr	nn	3	SENT_128	[p8l1728t2254r1941b2304],
2	Blood	NNP	O	Blood	nn	3	SENT_128	[p8l1981t2253r2154b2304],
3	Cancer	NNP	O	Cancer	_	0	SENT_128	[p8l138t2341r340b2390],
4	2008	CD	DATE	2008	num	3	SENT_128	[p8l366t2340r519b2401],
5	;	:	O	;	_	0	SENT_128	[p8l366t2340r519b2401],
6	50	CD	NUMBER	50	num	8	SENT_128	[p8l547t2340r629b2390],
7	:	:	O	:	_	0	SENT_128	[p8l547t2340r629b2390],
8	710-13	CD	NUMBER	710-13	dep	3	SENT_128	[p8l661t2340r881b2390],
9	.	.	O	.	_	0	SENT_128	[p8l661t2340r881b2390],

1	Protein	NN	O	protein	_	0	SENT_129	[p8l51t2641r273b2695],
2	2	CD	NUMBER	2	num	1	SENT_129	[p8l305t2641r360b2703],
3	,	,	O	,	_	0	SENT_129	[p8l305t2641r360b2703],
4	protein	NN	O	protein	appos	1	SENT_129	[p8l394t2641r617b2712],
5	Z-dependent	JJ	MISC	z-dependent	amod	10	SENT_129	[p8l649t2637r1060b2712],
6	protease	NN	O	protease	nn	10	SENT_129	[p8l1089t2642r1361b2712],
7	inhibitor	NN	O	inhibitor	nn	10	SENT_129	[p8l1393t2637r1666b2695],
8	(	NN	O	(	nn	10	SENT_129	[p8l1692t2639r2088b2712],
9	serpinA10	NN	O	serpina10	nn	10	SENT_129	[p8l1692t2639r2088b2712],
10	)	NN	O	)	dep	1	SENT_129	[p8l1692t2639r2088b2712],
11	,	,	O	,	_	0	SENT_129	[p8l1692t2639r2088b2712],
12	and	CC	O	and	_	0	SENT_129	[p8l48t2720r162b2777],
13	the	DT	O	the	det	17	SENT_129	[p8l192t2720r293b2777],
14	acute	JJ	O	acute	amod	17	SENT_129	[p8l321t2720r711b2794],
15	—	JJ	O	—	amod	17	SENT_129	[p8l321t2720r711b2794],
16	phase	NN	O	phase	nn	17	SENT_129	[p8l321t2720r711b2794],
17	response	NN	O	response	conj_and	10	SENT_129	[p8l742t2737r1026b2794],

1	T.	NNP	PERSON	T.	nn	3	SENT_130	[p8l46t2850r79b2877],
2	J.	NNP	PERSON	J.	nn	3	SENT_130	[p8l100t2850r125b2877],
3	GIRARD	NNP	PERSON	GIRARD	_	0	SENT_130	[p8l147t2850r319b2882],
4	,	,	O	,	_	0	SENT_130	[p8l147t2850r319b2882],
5	N.	NNP	PERSON	N.	nn	7	SENT_130	[p8l343t2850r379b2877],
6	M.	NNP	PERSON	M.	nn	7	SENT_130	[p8l402t2850r448b2877],
7	LASKY	NNP	PERSON	LASKY	conj_and	3	SENT_130	[p8l472t2850r611b2882],
8	,	,	O	,	_	0	SENT_130	[p8l472t2850r611b2882],
9	E.	NNP	PERSON	E.	nn	11	SENT_130	[p8l634t2850r662b2877],
10	A.	NNP	PERSON	A.	nn	11	SENT_130	[p8l683t2850r720b2877],
11	TULEY	NNP	PERSON	TULEY	conj_and	3	SENT_130	[p8l742t2850r869b2877],
12	and	CC	O	and	_	0	SENT_130	[p8l889t2848r945b2877],
13	G.	NNP	PERSON	G.	nn	17	SENT_130	[p8l961t2850r999b2877],
14	J.	NNP	PERSON	J.	nn	17	SENT_130	[p8l1020t2850r1045b2877],
15	BROZE	NNP	PERSON	BROZE	nn	17	SENT_130	[p8l1069t2850r1199b2877],
16	JR	NNP	O	JR	nn	17	SENT_130	[p8l1218t2850r1258b2877],
17	Division	NNP	O	Division	conj_and	3	SENT_130	[p8l46t2897r162b2922],
18	of	IN	O	of	_	0	SENT_130	[p8l175t2896r206b2922],
19	Hematology	NNP	O	Hematology	prep_of	17	SENT_130	[p8l216t2896r394b2929],
20	,	,	O	,	_	0	SENT_130	[p8l216t2896r394b2929],
21	Washington	NNP	ORGANIZATION	Washington	nn	23	SENT_130	[p8l413t2896r580b2929],
22	University	NNP	ORGANIZATION	University	nn	23	SENT_130	[p8l596t2897r739b2929],
23	School	NNP	ORGANIZATION	School	appos	19	SENT_130	[p8l750t2896r845b2922],
24	of	IN	ORGANIZATION	of	_	0	SENT_130	[p8l857t2896r888b2922],
25	Medicine	NNP	ORGANIZATION	Medicine	prep_of	23	SENT_130	[p8l897t2896r1036b2926],
26	,	,	O	,	_	0	SENT_130	[p8l897t2896r1036b2926],
27	St	NNP	LOCATION	St	nn	28	SENT_130	[p8l1052t2897r1080b2922],
28	Louis	NNP	LOCATION	Louis	dep	3	SENT_130	[p8l1091t2897r1170b2926],
29	,	,	O	,	_	0	SENT_130	[p8l1091t2897r1170b2926],
30	MO	NNP	DURATION	MO	nn	32	SENT_130	[p8l1186t2897r1250b2926],
31	,	,	O	,	_	0	SENT_130	[p8l1186t2897r1250b2926],
32	USA	NNP	LOCATION	USA	appos	28	SENT_130	[p8l1267t2897r1326b2922],

1	To	TO	O	to	aux	2	SENT_131	[p8l46t3040r82b3064],
2	cite	VB	O	cite	dep	7	SENT_131	[p8l101t3040r151b3064],
3	this	DT	O	this	det	4	SENT_131	[p8l169t3038r221b3064],
4	article	NN	O	article	dobj	2	SENT_131	[p8l240t3038r335b3064],
5	:	:	O	:	_	0	SENT_131	[p8l240t3038r335b3064],
6	Girard	NNP	PERSON	Girard	nn	7	SENT_131	[p8l357t3038r441b3064],
7	TJ	NNP	O	TJ	_	0	SENT_131	[p8l460t3040r497b3069],
8	,	,	O	,	_	0	SENT_131	[p8l460t3040r497b3069],
9	Lasky	NNP	ORGANIZATION	Lasky	nn	10	SENT_131	[p8l519t3038r595b3072],
10	NM	NNP	ORGANIZATION	NM	appos	7	SENT_131	[p8l615t3040r675b3069],
11	,	,	O	,	_	0	SENT_131	[p8l615t3040r675b3069],
12	Tuley	NNP	PERSON	Tuley	nn	13	SENT_131	[p8l695t3038r771b3072],
13	EA	NN	PERSON	ea	appos	7	SENT_131	[p8l791t3040r834b3069],
14	,	,	O	,	_	0	SENT_131	[p8l791t3040r834b3069],
15	Broze	NNP	O	Broze	nn	17	SENT_131	[p8l857t3040r932b3064],
16	GJ	NNP	O	GJ	nn	17	SENT_131	[p8l952t3040r983b3064],
17	Jr.	NNP	O	Jr.	appos	13	SENT_131	[p8l1003t3040r1031b3064],
18	.	.	O	.	_	0	SENT_131	[p8l1003t3040r1031b3064],

1	Protein	NN	O	protein	_	0	SENT_132	[p8l1053t3040r1149b3064],
2	2	CD	NUMBER	2	num	1	SENT_132	[p8l1170t3040r1194b3069],
3	,	,	O	,	_	0	SENT_132	[p8l1170t3040r1194b3069],
4	protein	NN	O	protein	appos	1	SENT_132	[p8l1216t3040r1312b3072],
5	Z-dependent	JJ	MISC	z-dependent	amod	10	SENT_132	[p8l1333t3038r1515b3072],
6	protease	NN	O	protease	nn	10	SENT_132	[p8l1534t3040r1652b3072],
7	inhibitor	NN	O	inhibitor	nn	10	SENT_132	[p8l1673t3038r1788b3064],
8	(	NN	O	(	nn	10	SENT_132	[p8l1807t3039r1977b3072],
9	serpinA10	NN	O	serpina10	nn	10	SENT_132	[p8l1807t3039r1977b3072],
10	)	NN	O	)	dep	4	SENT_132	[p8l1807t3039r1977b3072],
11	,	,	O	,	_	0	SENT_132	[p8l1807t3039r1977b3072],
12	and	CC	O	and	_	0	SENT_132	[p8l1998t3038r2047b3064],
13	the	DT	O	the	det	15	SENT_132	[p8l2067t3038r2112b3064],
14	acute-phase	NN	O	acute-phase	nn	15	SENT_132	[p8l9t3107r377b3179],
15	response	NN	O	response	appos	1	SENT_132	[p8l408t3124r685b3179],
16	.	.	O	.	_	0	SENT_132	[p8l408t3124r685b3179],

1	J	NNP	O	J	nn	3	SENT_133	[p8l713t3111r741b3162],
2	Thromb	NNP	O	Thromb	nn	3	SENT_133	[p8l773t3107r1005b3162],
3	Haemost	NNP	O	Haemost	_	0	SENT_133	[p8l1033t3111r1306b3162],
4	2013	CD	DATE	2013	num	3	SENT_133	[p8l1330t3111r1501b3171],
5	;	:	O	;	_	0	SENT_133	[p8l1330t3111r1501b3171],
6	11	CD	NUMBER	11	num	8	SENT_133	[p8l1533t3112r1623b3161],
7	:	:	O	:	_	0	SENT_133	[p8l1533t3112r1623b3161],
8	375-8	CD	NUMBER	375-8	dep	3	SENT_133	[p8l1655t3111r1860b3162],
9	.	.	O	.	_	0	SENT_133	[p8l1655t3111r1860b3162],

1	Correspondence	NN	O	correspondence	_	0	SENT_134	[p8l10t3341r516b3407],
2	:	:	O	:	_	0	SENT_134	[p8l10t3341r516b3407],
3	George	NNP	PERSON	George	nn	4	SENT_134	[p8l560t3342r779b3407],
4	J	NNP	PERSON	J	dep	1	SENT_134	[p8l818t3343r847b3393],
5	.	.	O	.	_	0	SENT_134	[p8l854t3385r862b3393],

1	Broze	NN	PERSON	broze	nn	2	SENT_135	[p8l906t3342r1078b3393],
2	Jr	NNP	PERSON	Jr	_	0	SENT_135	[p8l1117t3343r1190b3404],
3	,	,	O	,	_	0	SENT_135	[p8l1117t3343r1190b3404],
4	Division	NNP	O	Division	appos	2	SENT_135	[p8l1231t3341r1488b3393],
5	of	IN	O	of	_	0	SENT_135	[p8l1527t3341r1593b3393],
6	Hematology	NNP	O	Hematology	prep_of	4	SENT_135	[p8l1625t3341r2017b3407],
7	,	,	O	,	_	0	SENT_135	[p8l1625t3341r2017b3407],
8	PO	NNP	O	PO	nn	9	SENT_135	[p8l2057t3342r2152b3393],
9	Box	NNP	O	Box	appos	2	SENT_135	[p8l10t3434r129b3485],
10	8125	CD	NUMBER	8125	num	9	SENT_135	[p8l157t3434r312b3496],
11	,	,	O	,	_	0	SENT_135	[p8l157t3434r312b3496],
12	660	CD	NUMBER	660	num	9	SENT_135	[p8l342t3434r444b3485],
13	S.	NNP	O	S.	nn	15	SENT_135	[p8l474t3433r524b3485],
14	Euclid	NNP	O	Euclid	nn	15	SENT_135	[p8l556t3432r748b3485],
15	Ave	NNP	O	Ave	dep	9	SENT_135	[p8l774t3432r911b3496],
16	,	,	O	,	_	0	SENT_135	[p8l774t3432r911b3496],
17	St	NNP	LOCATION	St	nn	18	SENT_135	[p8l943t3433r1001b3485],
18	Louis	NNP	LOCATION	Louis	appos	2	SENT_135	[p8l1028t3432r1214b3496],
19	,	,	O	,	_	0	SENT_135	[p8l1028t3432r1214b3496],
20	MO	NNP	DURATION	MO	appos	2	SENT_135	[p8l1245t3433r1366b3485],
21	63110	CD	NUMBER	63110	num	20	SENT_135	[p8l1395t3434r1586b3496],
22	,	,	O	,	_	0	SENT_135	[p8l1395t3434r1586b3496],
23	USA	NNP	LOCATION	USA	appos	2	SENT_135	[p8l1616t3432r1781b3485],
24	.	.	O	.	_	0	SENT_135	[p8l1616t3432r1781b3485],

1	Tel.	NNP	O	Tel.	_	0	SENT_136	[p8l8t3525r138b3577],
2	:	:	O	:	_	0	SENT_136	[p8l8t3525r138b3577],
3	+1	CD	NUMBER	+1	number	4	SENT_136	[p8l182t3526r267b3576],
4	314 362 8811	CD	NUMBER	314 362 8811	dep	1	SENT_136	[p8l571t3526r726b3588],[p8l305t3526r407b3577],
5	;	:	O	;	_	0	SENT_136	[p8l571t3526r726b3588],
6	fax	NN	O	fax	dep	4	SENT_136	[p8l755t3524r863b3577],
7	:	:	O	:	_	0	SENT_136	[p8l755t3524r863b3577],
8	+1	CD	NUMBER	+1	number	9	SENT_136	[p8l906t3526r992b3576],
9	314 362 8826	CD	NUMBER	314 362 8826	dep	6	SENT_136	[p8l1296t3526r1449b3577],[p8l1029t3526r1132b3577],
10	.	.	O	.	_	0	SENT_136	[p8l1296t3526r1449b3577],

1	E-mail	NN	O	e-mail	_	0	SENT_137	[p8l9t3617r225b3669],
2	:	:	O	:	_	0	SENT_137	[p8l9t3617r225b3669],
3	gbroze@im.wustl.edu	NN	O	gbroze@im.wustl.edu	nn	4	SENT_137	[p8l256t3616r918b3683],
4	DOI	NNP	O	DOI	dep	1	SENT_137	[p8l9t3709r162b3761],
5	:	:	O	:	_	0	SENT_137	[p8l9t3709r162b3761],
6	10.1111	CD	NUMBER	10.1111	dep	4	SENT_137	[p8l200t3708r728b3775],
7	/	:	O	/	punct	4	SENT_137	[p8l200t3708r728b3775],
8	jth	NN	O	jth	nn	9	SENT_137	[p8l200t3708r728b3775],
9	.12084	NN	NUMBER	.12084	dep	1	SENT_137	[p8l200t3708r728b3775],

1	Received	VBN	O	receive	_	0	SENT_138	[p9l10t19r280b72],
2	29	CD	DATE	29	dobj	1	SENT_138	[p9l307t21r374b72],
3	October	NNP	DATE	October	tmod	1	SENT_138	[p9l403t19r648b72],
4	2012	CD	DATE	2012	num	3	SENT_138	[p9l674t21r831b83],
5	,	,	O	,	_	0	SENT_138	[p9l674t21r831b83],
6	accepted	VBN	O	accept	partmod	1	SENT_138	[p9l861t19r1120b86],
7	7	CD	DATE	7	nsubj	13	SENT_138	[p9l1148t22r1178b72],
8	November	NNP	DATE	November	nn	13	SENT_138	[p9l1206t19r1527b72],
9	2012	CD	DATE	2012	num	13	SENT_138	[p9l1553t21r1692b72],
10	©	CD	DATE	©	num	13	SENT_138	[p9l7t110r60b164],
11	2012	CD	DATE	2012	num	13	SENT_138	[p9l85t113r224b164],
12	International	NNP	ORGANIZATION	International	nn	13	SENT_138	[p9l251t111r650b164],
13	Society	NNP	ORGANIZATION	Society	xcomp	6	SENT_138	[p9l679t111r895b177],
14	on	IN	O	on	_	0	SENT_138	[p9l922t128r997b164],
15	Thrombosis	NNP	O	Thrombosis	prep_on	13	SENT_138	[p9l1023t111r1386b164],
16	and	CC	O	and	_	0	SENT_138	[p9l1414t111r1525b164],
17	Haemostasis	NNP	PERSON	Haemostasis	prep_on	13	SENT_138	[p9l1552t111r1934b164],

1	Protein	NN	O	protein	nn	2	SENT_139	[p9l8t423r265b484],
2	Z	NN	O	z	nsubj	14	SENT_139	[p9l292t425r345b483],
3	(	CD	NUMBER	(	num	5	SENT_139	[p9l374t423r549b501],
4	PZ	NN	O	pz	nn	5	SENT_139	[p9l374t423r549b501],
5	)	NN	O	)	dep	2	SENT_139	[p9l374t423r549b501],
6	,	,	O	,	_	0	SENT_139	[p9l374t423r549b501],
7	a	DT	O	a	det	11	SENT_139	[p9l580t443r617b484],
8	vitamin	NN	O	vitamin	nn	11	SENT_139	[p9l643t423r911b484],
9	K-dependent	JJ	MISC	k-dependent	amod	11	SENT_139	[p9l938t423r1397b501],
10	plasma	NN	O	plasma	nn	11	SENT_139	[p9l1423t423r1673b501],
11	protein	NN	O	protein	appos	2	SENT_139	[p9l1699t423r1971b501],
12	,	,	O	,	_	0	SENT_139	[p9l1699t423r1971b501],
13	dramatically	RB	O	dramatically	advmod	14	SENT_139	[p9l2001t423r2144b484, p9l7t528r329b606],
14	enhances	VBZ	O	enhance	_	0	SENT_139	[p9l368t528r684b589],
15	inhibition	NN	O	inhibition	dobj	14	SENT_139	[p9l725t528r1068b589],
16	of	IN	O	of	_	0	SENT_139	[p9l1109t528r1187b589],
17	coagulation	NN	O	coagulation	nn	19	SENT_139	[p9l1217t528r1631b606],
18	factor	NN	O	factor	nn	19	SENT_139	[p9l1671t528r1879b589],
19	Xa	NN	O	xa	prep_of	15	SENT_139	[p9l1917t530r2022b589],
20	by	IN	O	by	_	0	SENT_139	[p9l2061t528r2147b606],
21	the	DT	O	the	det	31	SENT_139	[p9l8t635r114b696],
22	PZ-dependent	JJ	O	pz-dependent	amod	29	SENT_139	[p9l161t635r659b713],
23	protease	NN	O	protease	nn	29	SENT_139	[p9l704t643r998b713],
24	inhibitor	NN	O	inhibitor	nn	29	SENT_139	[p9l1045t635r1352b696],
25	(	NN	O	(	nn	29	SENT_139	[p9l1400t635r1587b713],
26	ZPI	NN	O	zpus	nn	29	SENT_139	[p9l1400t635r1587b713],
27	)	CD	NUMBER	)	num	29	SENT_139	[p9l1400t635r1587b713],
28	serpinAlO	NN	O	serpinalo	nn	29	SENT_139	[p9l1637t635r1993b713],
29	[	NN	O	[	nn	31	SENT_139	[p9l2043t636r2141b712],
30	l	NN	O	l	nn	31	SENT_139	[p9l2043t636r2141b712],
31	]	NN	O	]	prep_by	14	SENT_139	[p9l2043t636r2141b712],
32	.	.	O	.	_	0	SENT_139	[p9l2043t636r2141b712],

1	ZPI	NN	O	zpus	nsubj	4	SENT_140	[p9l8t743r142b801],
2	also	RB	O	also	advmod	4	SENT_140	[p9l169t740r305b802],
3	directly	RB	O	directly	advmod	4	SENT_140	[p9l332t740r592b818],
4	inhibits	VBZ	O	inhibit	_	0	SENT_140	[p9l617t740r877b802],
5	FXIa	NN	O	fxium	nn	6	SENT_140	[p9l904t743r1093b802],
6	[	NN	O	[	dobj	4	SENT_140	[p9l1121t742r1219b818],
7	2	CD	NUMBER	2	num	8	SENT_140	[p9l1121t742r1219b818],
8	]	NN	O	]	dep	6	SENT_140	[p9l1121t742r1219b818],
9	.	.	O	.	_	0	SENT_140	[p9l1121t742r1219b818],

1	The	DT	O	the	det	2	SENT_141	[p9l1248t740r1383b802],
2	fact	NN	O	fact	nsubj	17	SENT_141	[p9l1408t740r1539b802],
3	that	IN	O	that	complm	9	SENT_141	[p9l1563t740r1703b802],
4	PZ	NNP	ORGANIZATION	PZ	nn	8	SENT_141	[p9l1727t743r1831b801],
5	and	CC	O	and	_	0	SENT_141	[p9l1856t740r1985b802],
6	ZPI	NNP	O	ZPI	nn	8	SENT_141	[p9l2010t743r2145b801],
7	knockout	JJ	O	knockout	amod	8	SENT_141	[p9l8t846r345b907],
8	mice	NNS	O	mouse	nsubj	9	SENT_141	[p9l402t846r563b907],
9	show	VBP	O	show	dep	2	SENT_141	[p9l624t846r805b907],
10	enhanced	VBN	O	enhance	amod	11	SENT_141	[p9l862t846r1193b907],
11	responses	NNS	O	response	dobj	9	SENT_141	[p9l1252t866r1585b924],
12	in	IN	O	in	_	0	SENT_141	[p9l1644t846r1710b907],
13	models	NNS	O	model	prep_in	9	SENT_141	[p9l1767t846r2016b907],
14	of	IN	O	of	_	0	SENT_141	[p9l2077t846r2153b907],
15	induced	VBN	O	induce	amod	16	SENT_141	[p9l7t953r284b1014],
16	thrombosis	NN	O	thrombosis	prep_of	13	SENT_141	[p9l315t953r708b1014],
17	supports	VBZ	O	support	_	0	SENT_141	[p9l742t961r1043b1031],
18	a	DT	O	a	det	21	SENT_141	[p9l1076t973r1114b1014],
19	physiologically	RB	O	physiologically	advmod	20	SENT_141	[p9l1143t953r1670b1031],
20	relevant	JJ	O	relevant	amod	21	SENT_141	[p9l1701t953r1982b1014],
21	role	NN	O	role	dobj	17	SENT_141	[p9l2012t953r2146b1014],
22	for	IN	O	for	_	0	SENT_141	[p9l8t1058r111b1120],
23	the	DT	O	the	det	24	SENT_141	[p9l135t1058r241b1120],
24	PZ	NNP	O	PZ	prep_for	21	SENT_141	[p9l265t1061r548b1119],
25	.	.	O	.	_	0	SENT_141	[p9l265t1061r548b1119],

1	—	NN	O	—	_	0	SENT_142	[p9l265t1061r548b1119],
2	.	.	O	.	_	0	SENT_142	[p9l265t1061r548b1119],

1	ZPI	NN	O	zpus	nn	2	SENT_143	[p9l265t1061r548b1119],
2	system	NN	O	system	_	0	SENT_143	[p9l574t1067r807b1136],
3	in	IN	O	in	_	0	SENT_143	[p9l830t1058r896b1119],
4	the	DT	O	the	det	5	SENT_143	[p9l920t1058r1026b1120],
5	regulation	NN	O	regulation	prep_in	2	SENT_143	[p9l1051t1058r1408b1136],
6	of	IN	O	of	_	0	SENT_143	[p9l1434t1058r1512b1120],
7	coagulation	NN	O	coagulation	prep_of	5	SENT_143	[p9l1527t1058r1941b1136],
8	[	CD	NUMBER	[	number	9	SENT_143	[p9l1968t1060r2129b1136],
9	3,4	CD	NUMBER	3,4	dep	2	SENT_143	[p9l1968t1060r2129b1136],
10	]	NN	O	]	dep	9	SENT_143	[p9l1968t1060r2129b1136],
11	.	.	O	.	_	0	SENT_143	[p9l1968t1060r2129b1136],

1	The	DT	O	the	det	3	SENT_144	[p9l93t1164r229b1226],
2	broad	JJ	O	broad	amod	3	SENT_144	[p9l279t1164r490b1226],
3	range	NN	O	range	nsubj	9	SENT_144	[p9l538t1184r735b1242],
4	of	IN	O	of	_	0	SENT_144	[p9l786t1164r864b1226],
5	plasma	NN	O	plasma	nn	7	SENT_144	[p9l903t1164r1158b1242],
6	PZ	NN	O	pz	nn	7	SENT_144	[p9l1206t1167r1310b1225],
7	levels	NNS	O	level	prep_of	3	SENT_144	[p9l1359t1164r1549b1226],
8	has	VBZ	O	have	aux	9	SENT_144	[p9l1598t1164r1716b1226],
9	led	VBN	O	lead	_	0	SENT_144	[p9l1765t1164r1868b1226],
10	to	TO	O	to	_	0	SENT_144	[p9l1917t1173r1986b1226],
11	the	DT	O	the	det	12	SENT_144	[p9l2037t1164r2145b1226],
12	suggestion	NN	O	suggestion	prep_to	9	SENT_144	[p9l10t1271r384b1349],
13	that	IN	O	that	complm	18	SENT_144	[p9l436t1271r578b1332],
14	the	DT	O	the	det	16	SENT_144	[p9l630t1271r737b1332],
15	inﬂammatory	JJ	O	inﬂammatory	amod	16	SENT_144	[p9l789t1271r1277b1349],
16	response	NN	O	response	nsubj	18	SENT_144	[p9l1329t1291r1637b1349],
17	might	MD	O	might	aux	18	SENT_144	[p9l1688t1271r1896b1349],
18	affect	VB	O	affect	ccomp	9	SENT_144	[p9l1949t1271r2146b1332],
19	PZ	NN	O	pz	nn	20	SENT_144	[p9l8t1378r112b1437],
20	expression	NN	O	expression	nsubj	23	SENT_144	[p9l200t1376r574b1454],
21	[	CD	NUMBER	[	number	22	SENT_144	[p9l664t1377r764b1453],
22	5	CD	NUMBER	5	num	23	SENT_144	[p9l664t1377r764b1453],
23	]	NN	O	]	xcomp	18	SENT_144	[p9l664t1377r764b1453],
24	.	.	O	.	_	0	SENT_144	[p9l664t1377r764b1453],

1	Potentially	RB	O	potentially	advmod	2	SENT_145	[p9l856t1376r1245b1454],
2	consistent	JJ	O	consistent	_	0	SENT_145	[p9l1332t1376r1689b1437],
3	with	IN	O	with	_	0	SENT_145	[p9l1775t1376r1932b1437],
4	this	DT	O	this	prep_with	2	SENT_145	[p9l2019t1376r2144b1437],

